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The localization and translation of messenger ribonucleic acids (mRNAs) play 
crucial roles in cellular function and disease pathogenesis, and are regulated by numerous 
RNA-binding proteins (RBPs) and small non-coding ribonucleic acids (RNAs), called 
trans-acting factors. In recent years, biochemical and imaging methods used to study 
RNA interactions with these trans-acting elements have made several important 
discoveries in identifying these factors, characterizing how they regulate gene expression, 
and determining the RNA sequence to which they bind. However, the spatiotemporal 
information regarding these interactions in subcellular compartments have been difficult 
to determine or to quantify accurately.  
Imaging techniques, such as fluorescence resonance energy transfer (FRET) and 
fluorescence complementation (FC), have been used to study RNA–protein interactions. 
In these methods, the RNA is labelled with either SytoxOrange or the MS2 system. 
Although the Sytox system is bright, it lacks RNA specificity. In comparison, the MS2-
based approach is specific but suffers from limited sensitivity for detecting RNA–protein 
interactions and lacks the ability to detect these interactions at native levels, requiring 
expression of the RNA or RBP. To image and to quantify native RNA and RNA–protein 
interactions simultaneously in situ, we developed a proximity ligation assay (PLA) using 
peptide-modified, multiply-labelled tetravalent RNA imaging probes (MTRIPs). This 
method combines sequence-specific imaging of native RNA with proximity ligation and 
rolling circle amplification (RCA) and allows for the visualization of RNA-protein 
interactions. 
 xiv 
The goal of this research was to develop and to apply a new method for imaging 
and quantifying interactions between native, non-engineered RNAs and proteins with 
single interaction-sensitivity. This method has three important properties. It is compatible 
with different fixation methods, and immunostaining can be performed in addition to the 
methodology. It can detect the RNA in live cells and the interaction in situ. Lastly, it can 
produce results that can be quantified easily. We have developed this technique and 
tested its specificity and sensitivity using two model systems: interactions between the 
genomic RNA and the N protein of human respiratory syncytial virus as well as those 
between exogenous transcripts with or without the Human antigen R (HuR) binding site 
and HuR. To validate this method, its accuracy and utility will be demonstrated in three 
model systems: poly(A)+ or β-actin mRNAs binding to different cytoskeleton for 
localization, poly(A)+ or β-actin mRNAs interacting with HuR for stabilization, and 
programmed cell death 4 (PDCD4) mRNA binding to HuR or T-cell intracellular antigen 







 In eukaryotic cells, RNA transcripts are processed extensively. This begins in the 
nucleus, where they are spliced of unnecessary segments (Padgett, Grabowski et al. 1986, 
Shapiro and Senapathy 1987, Black 2003), capped with a nucleotide linkage at the 5' end, 
and extended with adenylate at the 3' end to form a poly(A) tail. The transcripts are then 
transported to the cytoplasm, where they are further processed for translation and post-
transcriptional regulation. These cytoplasmic processes are directed mainly by RNA-
binding proteins and small RNAs, which interact with the mRNAs to form 
ribonucleoprotein (RNP) complexes.  
These trans-acting factors regulate the stability (Sachs 1993, Chen, Xu et al. 
1995, Ross 1995, Fan and Steitz 1998), localization (Martin and Ephrussi 2009, Jung, 
Lifland et al. 2013), and translation (Pain 1996, Selbach, Schwanhausser et al. 2008, 
Sonenberg and Hinnebusch 2009) of mRNAs through their interactions with cis-acting 
elements in the target RNA sequence. The importance of interactions between RBP and 
mRNAs is reflected in various diseases that are associated with incorrectly expressed 
RBP or interrupted interactions between RBPs and mRNAs (Cooper, Wan et al. 2009).  
Fluctuations in the expression level of RBP has been strongly correlated with 
tumorigenesis (Kim, Hur et al. 2009, Barrios-Garcia, Tecalco-Cruz et al. 2014, 
Kechavarzi and Janga 2014, Kotta-Loizou, Giaginis et al. 2014). In order to elucidate 
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how changes in the RBP-mRNA interactions lead to cancer, understanding the frequency, 
localization, and function of these interactions is necessary. However, conventional 
biochemical assays, such as immunoprecipitation, or imaging methods, such as 
fluorescence complementation, are inadequate for meeting these needs. A new technique 
for imaging and quantifying mRNA-RBP interactions in situ is necessary. 
mRNA-RBP interactions are important for regulating gene expression 
Interactions between the bases within transcripts result in complex higher order 
structures, which expose the RNA backbone and bases to binding with certain protein 
groups (Mattaj 1993). For example, Watson-Crick paired helical RNA stems are not as 
effective for specific protein recognition as double-stranded RNAs. The double-stranded 
RNAs form A-form helices with accessible minor grooves present hydrogen bond donors 
and acceptors regardless of the bases, facilitating protein binding (Steitz 1990).  
RBPs also may induce conformational changes in the RNA structure (Mattaj 
1993). The RNP motif or RNA recognition motif (RRM) consists of 90 to 100 amino 
acids which form an RNA-binding domain (RBD) that is present in multiple copies in 
RBPs. The RNP consensus sequence (RNP-CS) consists of two sequences (RNP1 and 
RNP2) with hydrophobic amino acids throughout the motif. (Swanson, Nakagawa et al. 
1987, Bandziulis, Swanson et al. 1989, Kenan, Query et al. 1991) Although RNP1 and 
RNP2 are highly conserved, they do not distinguish between different RNA sequences. 
The variable regions in the loops and the termini as well as single-stranded RNA 
determine RNA-binding specificity. These irregularities have the effect of widening the 
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major groove (Li, Quon et al. 2010), and this bias toward accessible binding sites can be 
used to predict in vitro interactions between RNA and RBP (Gao, Carson et al. 1994).   
But in vivo, structural accessibility is not adequate to predict RBP binding to an 
RNA largely due to difficulty in predicting higher order structure of RNAs (Geis, Flamm 
et al. 2008). In an RNP, interactions between proteins could affect the RNA structure by 
bringing together different RNA sequences to form more stable RNP complexes or to 
influence the binding of other RBPs (Goguel and Rosbash 1993, Wu and Maniatis 1993, 
Portman and Dreyfuss 1994).  
Despite a variety of RBDs, RBPs generally bind to AU-rich or U-rich elements in 
various mRNAs with little sequence specificity. (Scherly, Kambach et al. 1991, Wang 
and Tanaka Hall 2001)  These regions can be bound by multiple ARE binding proteins 
(Brennan and Steitz 2001). Additionally, an RBP can have numerous functional targets 
(Licatalosi, Mele et al. 2008, Hafner, Landthaler et al. 2010), and its interactions with 
mRNAs are context dependent, since it has different functions in different subcellular 
compartments (Khorshid, Rodak et al. 2011). Therefore, experiments need to reliably 
detect the spatiotemporal organization (Rodriguez, Czaplinski et al. 2008, Martin and 
Ephrussi 2009) and the cellular population heterogeneity (Kaern, Elston et al. 2005) of 
RBP-mRNA interactions. 
For example, Human antigen R (HuR) is a member of the Hu/ELAV family of 
RNA binding proteins and has various functions in mRNA processing (Hinman and Lou 
2008). HuR regulates alternative splicing by binding to U-rich elements (Zhu, Hasman et 
al. 2006). In the cytoplasm, HuR can stabilize mRNAs, such as c-fos, c-myc, 
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cyclooxygenase-2, tumor necrosis factor-α (Palanisamy, Jakymiw et al. 2012),  by 
binding to AU-rich elements (AREs) in the 3' untranslated regions (3'UTRs) of mRNAs 
(Brennan and Steitz 2001, Hinman and Lou 2008). Tristetraprolin (TTP), an ELAV 
family member, binds to mRNAs via a CCCH zinc finger motif (Blackshear 2002) and 
regulates the cytoplasmic mRNAs. Unlike HuR that stabilizes mRNAs when bound to the 
3'UTR, TTP promotes degradation of mRNAs upon binding to them in the cytoplasm and 
localizing them to the exosomes (Anant and Houchen 2009). Considering these 
differences in function and localization, comparing the frequency and the location of 
HuR- and TTP-mRNA interactions in a cell may demonstrate whether the mRNAs are 
undergoing stabilization or degradation. No method exists that can describe both the 
frequency and the localization of these interactions in a single cell. 
mRNA-protein interactions can be detected using RNA imaging probes and 
proximity ligation assay 
 Multiply-labeled tetravalent RNA imaging probes (MTRIPs) (Santangelo, Lifland 
et al. 2009) and proximity ligation assay (PLA) (Soderberg, Gullberg et al. 2006) can be 
combined to detect RNA-protein interactions. MTRIPs consist of a neutravidin (NA) or 
streptavidin core to which bind fluorophore-labeled 2'O-methyl RNA-DNA chimeric 
oligonucleotides that are antisense to the mRNA target (Santangelo, Lifland et al. 2009). 
The neutravidin core of MTRIPs can be modified by conjugating high-affinity tags, like 
the flag tag, which is readily detectable via antibodies (Ab) (Jung, Lifland et al. 2013). 
Adding high-affinity tag to the neutravidin is necessary for immunodetection of the 
probe, because the specificity and variety of species for commercially available 
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antibodies against neutravidin or streptavidin are lacking compared to those against the 
high-affinity tags.  
In order to modify MTRIPs for PLA compatibility, we synthesized Cy3B-labeled 
flag-tagged MTRIPs (FMTRIPs) with a molar ratio (MR) of 1 or 2 flag, delivered them 
into live cells using SLO, and post-hybridization, fixed the cells. FMTRIPs were 
designed against specific RNA sequences near RBP binding sites. The flag peptides on 
FMTRIPs provided a partner for a PLA reaction with an RBP. Live-cell hybridization 
and subsequent fixation obviated the need for antigenicity-reducing formamide, allowing 
for efficient antibody binding. Anti-flag and anti-RBP antibodies were then added to the 
cells, followed by oligonucleotide-linked secondary antibodies against the primary 
antibodies (the proximity probes).  
If the RNA and protein interact, the oligonucleotides on the proximity probes 
came together to form a template for a circularized DNA strand by enzymatic ligation. 
Catalyzed by the phi29 DNA polymerase, one of proximity probe’s oligonucleotides 
served as a primer for rolling circle amplification (RCA), whereas three mismatched 
exonuclease-resistant 2'O-methyl RNA nucleotides at the 3' end prevented the other 
proximity probe’s oligonucleotide from acting as a primer. This reaction resulted in a 
coiled single-stranded DNA, the PLA product, complementary to the circular DNA 
strand and covalently bound to the antibody-antigen complex. The PLA product was 
detectable by hybridizing complementary Cy5 equivalent-labeled oligonucleotides 
(Soderberg, Gullberg et al. 2006). 
Probes and PLA can image and quantify mRNA-cytoskeleton interactions 
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 Using both flag-tagged multiply-labeled tetravalent RNA imaging probes 
(FMTRIP) (Santangelo, Lifland et al. 2009) and proximity ligation assay (PLA) 
(Soderberg, Gullberg et al. 2006), poly(A)+ and β-actin mRNA interactions with β-
tubulin, vimentin, and filamentous-actin (F-actin) were detected in HDFs and A549s. 
Depolymerization of these cytoskeletal structures in HDF and in A549 cells resulted in 
no PLA signal, although the mRNAs appeared near the depolymerized elements, 
suggesting that this method can accurately detect the interacting mRNA and cytoskeleton, 
not two that may be close together. Generally, in both cell types, we confirmed previous 
electron microscopy findings (Bassell, Powers et al. 1994). We also observed that 
significantly more poly(A)+ and β-actin mRNAs were bound to F-actin than the other 
cytoskeleton. And the PLA punctae were localized to the branching points of actin 
filaments. Significantly less mRNAs were bound to the intermediate filament or 
microtubules. As a negative control, probes lacking the flag tag were delivered to cells. 
No PLA signal was observed in these cells. 
Probes and PLA can image and quantify mRNA-HuR interactions 
 In order to test the specificity of proximity ligation assay (PLA) to detect 
interactions between HuR and mRNAs, HuR interactions with plasmid-derived mRNAs 
with or without HuR binding site in varying levels of HuR were studied. We used 
plasmids that encode RNAs spanning the green fluorescent protein (GFP) coding region 
and the c-Myc 3'UTR (referred to as c-Myc) with or without the HuR binding site (c-Myc 
AB and c-Myc A, respectively). The 3'UTR A segment precedes the HuR binding site in 
the B segment. (Kim, Kuwano et al. 2009) We designed RNA imaging probes to target 
three sites on the c-Myc 3'UTR A region, which are proximal to the HuR binding site in 
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the B region. The probes are not complementary to any native mRNA in Vero cells, 
which were used for all the experiments. In cells transfected with c-Myc A, the plasmid 
lacking the HuR binding site, we observed no PLA signal between c-Myc and HuR, as 
expected.  
 With the specificity of the PLA method established, we wanted to test how 
sensitive this method at detecting varying levels of HuR. We examined HuR interactions 
with poly(A)+ or β-actin mRNA in HeLa cells transfected with HuR-GFP to overexpress 
HuR. We observed increased PLA punctae frequency in cells with increased HuR levels. 
Also, when the transcription was inhibited using actinomycin D, mRNA interactions with 
HuR increased, and this increase was also observable in the number of PLA punctae. 
Post-transcriptional regulation of PDCD4 by HuR and TIA1 can be demonstrated 
using RNA probes and PLA 
 Programmed Cell Death 4 (PDCD4) is a tumor suppressor that is regulated by 
RBPs, HuR and T-cell Intracellular Antigen 1 (TIA1). The PDCD4 protein binds to and 
inhibits the activity of the eukaryotic translation initiation factor 4A (eIF4A) (Yang, 
Jansen et al. 2003). Reduction of PDCD4 protein levels, which is observed in a number 
of cancer types (Lankat-Buttgereit and Goke 2009), results in an increase in protein 
production and increased tumor promotion (Cmarik, Min et al. 1999, Yang, Jansen et al. 
2003). We extensively characterized the PDCD4 transcript as a novel target of HuR and 
TIA1 in a breast cancer cell line, MCF-7 (Soule, Vazguez et al. 1973). In addition to 
RNA-immunoprecipitation (RNA-IP) with HuR and TIA1, we employed RNA-imaging 
probes deliverable to live cells (Santangelo, Lifland et al. 2009) and PLA (Soderberg, 
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Gullberg et al. 2006) to examine the interplay between HuR and TIA1 on the PDCD4 
transcripts with single-interaction sensitivity on a per cell basis. Contrary to previous 
studies that describe a cooperative relationship between HuR and TIA1 in binding to 
RNA (Kawai, Lal et al. 2006), we demonstrated that HuR and TIA1 compete for 
interaction with the PDCD4 transcript, likely via the 3′UTR and reveal a novel 
mechanism for fine-tuning the level of PDCD4 protein.  
Conclusion 
 Various RNA-protein interactions can be imaged and quantified in a population of 
cells with high specificity and sensitivity by combining MTRIPs and PLA. We can detect 
the localization and frequency of these interactions at a single interaction level on a per 
cell basis. We achieved similar results as previous electron microscopy findings about 
mRNA-cytoskeleton interactions. We described changes in mRNA-HuR interactions in 
cells with varying levels of HuR protein. Ultimately, we uncovered a novel mechanism 
for post-transcriptional regulation of a tumor suppressor. If the binding site of two RBPs 
overlap on an mRNA, then the two proteins can compete for the binding site. Thus, an 
mRNA-stabilizing RBP can compete with a translation-inhibiting RBP as a more 
complex mechanism for regulating gene expression.  
The method presented here has shown much promise for discovering other novel 
relationships between RBPs for regulating a broad range of mRNAs. This method can be 
improved to detect interactions between a family of RBPs and mRNAs that underlie 
cellular function, such as neural plasticity or immune response, or condition, such as 
tumorigenesis or malignancy. Additionally, it can be used to elucidate intercellular 
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heterogeneity of mRNA-RBP interactions that direct the gene expression. Such an 
investigation has never been done before. In addition to cells, this method can be used to 
study tissue samples. The RNA imaging probes can be used for fluorescence in situ 
hybridization, and PLA can be easily applied to tissues. Correlating mRNA-RBP 
interactions in cells to those in tissues can allow us to discover important mechanistic 
findings for disorders, such as cancer.  
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DETECTING RNA-PROTEIN INTERACTIONS USING RNA 
IMAGING PROBES AND PROXIMITY LIGATION ASSAY 
The work presented here is an excerpt from Jung, J, Lifland, AW, Zurla, C, 
Alonas, EJ, Santangelo, PJ (2013). "Quantifying RNA-protein interactions in situ using 
modified-MTRIPs and proximity ligation." Nucleic Acids Res 41(1): e12.  
Background 
 RNA-protein interactions have been detected using biochemical assays, such as 
electrophoretic mobility shift assay (EMSA) (Wassarman 2012) and immunoprecipitation 
(IP) (Ascano, Hafner et al. 2012), and imaging methods, such as fluorescence resonance 
energy transfer (FRET) (Huranova, Jablonski et al. 2009) and fluorescence 
complementation (FC) (Yin, Zhu et al. 2013).  
EMSA is one of the earliest methods for detecting RNA-protein complexes 
(Kumar and Lindberg 1972; Spicer, Schwarzbauer et al. 1977; Fried and Crothers 1981; 
Garner and Revzin 1981). Fluorescent-, chemiluminescent-, or radioactive-labeled RNAs 
are incubated with a protein sample to form complexes, and the complexes are separated 
using polyacrylamide gel electrophoresis (Fried and Crothers 1981; Garner and Revzin 
1981). The complexes migrate to the opposite charge through a gel at varying speeds. In 
a non-denaturing gel with a buffer of near neutral pH and low ionic strength, the stable 
non-covalent bond between the protein and RNA is maintained, and the larger protein 
bound RNAs migrate slower through the gel compared to unbound RNAs. Hence, the 
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RNA-protein complexes are separated based on their size, charge, and shape. Specificity 
of the assay is tested by comparing migration of complexes formed in varying 
concentrations of labeled and unlabeled RNA and/or specific or non-specific labeled 
RNA. Antibodies against the protein can be bound to the complex to increase the size and 
the shift of the complex compared to the unlabeled control (Cheyette, Ip et al. 1992; 
Calla-Choque, Figueroa-Angulo et al. 2014). Denaturing gels can be used to examine 
dissociation of cross-linked RNA-protein complexes. Performing EMSA is simple and 
low cost and requires minimal knowledge of the RNA-protein interaction, such as 
recombinant proteins or antibodies for protein isolation and pure nucleic acids encoding 
the protein-binding RNA sequence (Buratowski and Chodosh 2001).  
RNA-IP isolates RNA-protein complexes from cell lysates using antibodies 
against the RNA-binding protein (RBP) of interest along with its associated RNA, and 
the extracted RNA can be converted to cDNA and identified via qPCR, microarrays, or 
sequencing (Setyono and Greenberg 1981; Dreyfuss, Choi et al. 1984). RBPs and RNAs 
in ribonucleoprotein (RNP) complexes may be cross-linked in vivo using ultraviolet light 
for covalently capturing close (near-covalent bond distances) association before 
immunopurification of the protein (Greenberg 1980; Wagenmakers, Reinders et al. 
1980). This technique is called cross-linking and immunoprecipitation (CLIP). The 
advantage of cross-linking is that it captures only closely associated RNAs and proteins; 
therefore, it can be highly specific. But one clear disadvantage is that it may not work for 
all RBPs or capture all the RNAs bound to a given protein, since the RNA and protein 
may not be arranged optimally for crosslinking in the complex. (Ule, Jensen et al. 2003; 
Darnell 2012) CLIP also is limited by the low efficiency of UV 254 nm RNA-protein 
15 
 
crosslinking, and the location of the crosslink is not determinable within the cross-linked 
mRNA, making it difficult to separate the cross-linked target RNA from the background 
noncross-linked RNA in the sample (Hafner, Landthaler et al. 2010).  
Incorporating 4-thiouridine (4SU) into mRNAs and identifying RBP binding sites 
by looking for thymidine (T) to cytidine (C) transitions in the sequenced cDNA (Kishore, 
Jaskiewicz et al. 2011; Ascano, Hafner et al. 2012), photoactivatable-ribonucleoside-
enhanced crosslinking and immunoprecipitation (PAR-CLIP) improves upon the CLIP 
approach. The protein binding sites on the transcripts can be mapped genome-wide using 
high-throughput sequencing of RNA isolated by CLIP (HITS-CLIP), which provides 
adequate sampling to predict potential binding sites (Licatalosi, Mele et al. 2008; Zhang 
and Darnell 2011). 
Similar to IPs, RNA pull-down assays also allow extraction of RNA-protein 
complexes from cell lysates. Conventionally, these assays use high affinity tags, such as 
biotin. RNA probes can encode the RNA sequence of interest with the affinity tag at the 
end. These probes can be added to the cell lysate, mimic the RNA of interest, and bind to 
the RBPs that usually bind to the RNA. The RNA-protein complex can be isolated using 
an antibody against the affinity tag or the protein of interest. The RNA and protein can be 
decoupled, and the RNA can be detected by RT-PCR, and the proteins can be detected by 
western blots or mass spectrometry. The pull-down assays are useful for testing whether 
an RNA can interact with an RBP. Their high sensitivity allows for detection of low 
abundant proteins.  
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Generally, these biochemical assays are excellent for initial identification of 
interactions between RNAs and proteins. However, a major disadvantage is that these 
assays require a large quantity of cells for adequate sampling (>2×106 cells). Since these 
approaches observe interactions in a large population of cells, the cell-to-cell variability 
is missed. Imaging techniques, such as FRET (Huranova, Jablonski et al. 2009; Lorenz 
2009) and FC (Rackham and Brown 2004; Yin, Zhu et al. 2013), allow for visualization 
of single cells and localization of RNA-protein complexes.  
FRET is a photophysical phenomenon in which energy is transferred between two 
fluorophores acting as a donor and acceptor. Fluorophores are attached to two proteins, 
and their proximity can be detected by the interaction and energy transfer between the 
tagged proteins. For detection, the two proteins do not need to be interacting directly. 
Two proteins in the same macromolecular complex may produce a detectable signal 
(Stanek and Neugebauer 2004; Rino, Desterro et al. 2008). In FRET methods, the RNA is 
labeled with either SytoxOrange (Lorenz 2009) or the MS2 system (Huranova, Jablonski 
et al. 2009). Although the Sytox system is bright, it lacks RNA specificity, as it targets 
nucleic acids in general. The MS2-based approach is specific but suffers from limited 
sensitivity for detecting RNA-protein interactions. Importantly, it requires expression of 
RNA containing MS2 binding sites and fluorescent RBP, which makes detecting these 
interactions at native levels impossible. The MS2 system is also used in FC experiments. 
A fluorescent protein that is split into two with one bound to the RNA of interest via MS2 
system and the other bound to the protein of interest. When these two portions are in 




In these imaging experiments, the intensity of fluorescent signal is measured and 
compared between the cells. Usually, the fluorescent signal in the cell is dispersed 
throughout the cytoplasm and difficult to localize to a subcellular structure and to 
quantify. Additionally, because the signal depends on the expression level of the MS2 
binding site containing RNA and fluorescent proteins, it is difficult to normalize it across 
the cell population for accurate comparison. These imaging methods are optimal for 
testing whether an RNA can interact with a protein inside a cell but may not be useful for 
quantifying or localizing the interactions. Hence, a new method is necessary to visualize 
and quantify RNA-protein interactions at their endogenous levels, such that their 
localization in subcellular structures can be imaged and the populational heterogeneity 
can be described. To achieve this, we modified protein-centered RNA imaging probes for 
RNA detection and combined the probes with proximity ligation assay (PLA) using 
antibodies against proteins of interest to detect RNA-protein interactions. 
Probe synthesis and delivery 
In order to image and quantify native RNA and RNA-protein interactions 
simultaneously in situ, we combined multiply-labeled tetravalent RNA imaging probes 
(MTRIPs) (Santangelo, Lifland et al. 2009) and PLA (Soderberg, Gullberg et al. 2006). 
MTRIPs consist of a neutravidin (NA) or streptavidin core to which bind fluorophore-
labeled 2'O-methyl RNA-DNA chimeric oligonucleotides that are antisense to the mRNA 
target (Santangelo, Lifland et al. 2009). NA has isoelectric point of 7 and is preferred 
over the charged streptavidin for limiting charge induced non-specific binding. The 
nucleic acid ligand may be synthesized commercially with 3-6 amino-modified 
thymidines to which fluorophores can be attached, a biotin at the 5' end for binding to the 
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neutravidin core, and a short (5-7) spacer poly(T) or poly(A) sequence to extend the 
ligand from the surface of NA. N-hydroxysuccinimide (NHS) ester-modified 
fluorophores were conjugated to the amino on thymidines. For a nucleic acid ligand that 
is 20-25 nucleotides in length, usually 3-4 thymidines would be amino-modified. Of 
these, on average, each ligand would be labeled with 2-3 fluorophores, limiting self-
quenching. The number of fluorophores may be adjusted for longer or shorter nucleic 
acid ligand; however, at least 2 fluorophores per ligand is necessary for optimal detection 
of fluorescence. The multiply labeled monovalent ligands were tetramerized via their 
binding to neutravidin, which increased probe brightness fourfold. (Santangelo, Lifland et 
al. 2009; Lifland, Zurla et al. 2011) 
MTRIPs can be delivered to cells using reversible cell membrane 
permeabilization with streptolysin O (SLO) (Santangelo, Lifland et al. 2009; Lifland, 
Zurla et al. 2011). SLO is a membrane-damaging protein toxin that is produced by most 
strains of -hemolytic group A streptococci. These water-soluble toxin molecules bind to 
cholesterol-containing target membranes to assemble into curved 7.5nm wide, 25-100nm 
long rod structures that penetrate into the apolar domain of the bilayer. (Duncan and 
Schlegel 1975; Bhakdi, Tranum-Jensen et al. 1985; Sekiya, Satoh et al. 1993) The 
embedment of the structure creates transmembrane pores with inner diameter of 24nm 
and outer diameter of 24-30nm in diameter (Sekiya, Satoh et al. 1993).  
Modification of MTRIPs with varying molar ratios of flag peptide 
 The neutravidin core of MTRIPs can be modified by conjugating high-affinity 
tags, like the flag tag, which is readily detectable via antibodies (Ab) (Jung, Lifland et al. 
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2013). Adding high-affinity tag to the neutravidin is necessary for immunodetection of 
the probe, because the specificity and variety of species for commercially available 
antibodies against neutravidin or streptavidin are lacking compared to many high-affinity 
tags. In order to modify MTRIPs for PLA compatibility, we synthesized Cy3B-labeled 
flag-tagged MTRIPs (FMTRIPs) with a molar ratio (MR) of 1 or 2 flag, delivered them 
into live cells using SLO, and post-hybridization, fixed the cells. FMTRIPs were 
designed against specific RNA sequences near RBP binding sites. The flag peptides on 
FMTRIPs provided a partner for a PLA reaction with an RBP. Live-cell hybridization 
and subsequent fixation obviated the need for antigenicity-reducing formamide, allowing 
for efficient antibody binding. Anti-flag and anti-RBP antibodies were then added to the 
cells, followed by oligonucleotide-linked secondary antibodies against the primary 
antibodies (the proximity probes). If the RNA and protein interact (<40nm apart 
(Soderberg, Gullberg et al. 2006)), the oligonucleotides on the proximity probes come 
together to form a template for a circularized DNA strand by enzymatic ligation. 
Catalyzed by the phi29 DNA polymerase, one of proximity probe’s oligonucleotides 
serve as a primer for rolling circle amplification (RCA), whereas three mismatched 
exonuclease-resistant 2'O-methyl RNA nucleotides at the 3' end prevent the other 
proximity probe’s oligonucleotide from acting as a primer. This reaction results in a 
coiled single-stranded DNA, the PLA product, complementary to the circular DNA 
strand and covalently bound to the antibody-antigen complex. The PLA product is 
detectable by hybridizing complementary Cy5 equivalent-labeled oligonucleotides 
(Soderberg, Gullberg et al. 2006). (Figure 2.1) 
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 To confirm the detection of the flag on FMTRIPs, we adsorbed FMTRIPs on 
glass and immunostained for flag. The flag immunofluorescence (IF) intensity of 
FMTRIP with a 2 molar ratio of flag (2MR-FMTRIP) was twice that of 1 MR-FMTRIP. 
IF was minimal using untagged MTRIPs. (Figure 2.1) An alternate primary anti-flag Ab 
showed similar results (Figure 2.2). Using FMTRIPs targeting the human respiratory 
syncytial virus (hRSV) genomic RNA (gRNA) in infected Vero and A549 cells, we 
characterized the FMTRIP and flag IF signals by their co-localization with a known RBP, 
the N protein. Because N binds tightly to gRNA, it was expected and confirmed that 
FMTRIP-labeled gRNA and N immunostaining colocalized (Figure 2.3). In A549 cells 
fixed 48 h post-infection (PI), the mean flag IF intensity increased with increasing flag 
MR, as observed on glass. The mean Pearson’s and Mander’s coefficients between flag 
and gRNA exceeded 0.9, indication that, when bound to gRNA, the flag on FMTRIP 
remained on the neutravidin and was accessible to its Ab. We detected no difference 
between MTRIP- and FMTRIP-labeled gRNA (Figure 2.4). Vero cells showed similar 
results. 
PLA frequency increases with increasing flag molar ratio 
 To determine the effect of flag valency, PLA was performed between flag and N 
in hRSV-infected, FMTRIP-delivered A549 cells. We assumed a PLA product, a micro-
sized fluorescent puncta, as an occurrence of interaction between N and gRNA, and that 
the volume of objects visualized by FMTRIPs correlated with the RNA copy number 
(Lifland, Zurla et al. 2011). A PLA product appeared as a puncta of consistent size and 
intensity for a variety of analytes, Ab and cell lines (Figure 2.1 and Figure 2.5), 
therefore facilitating quantification. At 12 h PI, the mean PLA frequency (number of 
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PLA punctae/FMTRIP volume) increased with more flag, whereas the mean FMTRIP 
volume remained similar (one-way ANOVA with Dunn’s method, p = 0.326). No PLA 
signal was observed using untagged-MTRIP. (Figure 2.6) Likely, not every antibody 
bound to FMTRIP participated in PLA productivity. As PLA detects interactions present 
at the time of fixation, we likely detected only a subset of gRNA and N that were bound 
at that moment. The distance between N and flag Ab may exceed the distance limit for 
proximity ligation due to their conformation or steric hinderance during virus replication. 
In the case of 2MR-FMTRIP, the second flag Ab might interfere with the probe binding 
or ligation. Indeed, for 3MR-FMTRIP, the mean flag IF intensity, as well as the mean 
PLA frequency decreased below those of 1MR, possibly due to steric hindrance by the 
additional flag and their Ab or quenching by the additional fluorophores. 
Optimal blocking is important for achieving high specificity 
For accurate RNA-protein PLA, where the RNA is in low abundance, optimal 
blocking and antibody titration are crucial. The standard Duolink II blocking solution 
(Olink Bioscience, Sweden) (std) used for PLA resulted in non-specific signal; modifying 
it (mod) eliminated the background signal (Figure 2.7). Limiting non-specific Ab 
binding through titration with untagged-MTRIPs as a negative control helped increase the 
signal-to-noise ratio. With varying N dilution, the mean PLA frequency fluctuated 
(Figure 2.8) concentrations, the specificity decreased, resulting in smaller variance but 
greater non-specific signal (Figure 2.8). For each experiment, we optimized the Ab 




Figure 2.1: Production and imaging of flag-tagged MTRIP (FMTRIP). (A) Flags 
(dark green) bind to a neutravidin (yellow) with Cy3B-conjugated (red) oligonucleotides 
to form a 1 or 2 MR-FMTRIP. (B) FMTRIPs enter cells via SLO. (C) Antibodies (Ab) 
(light blue and magenta) and proximity probes (dark blue and magenta) attach to 
FMTRIP and RBP (brown) on the mRNA (gray); probes join to synthesize a Cy5-
equivalent hybridized product (light green) via RCA. (D) Comparison of the mean flag 
immunofluorescence (IF) intensity for 0 (n=511, mean = 4, SD = 1), 1 (n=3255, mean = 
30, SD = 10) and 2 (n=4724, mean = 55, SD = 17) MR-FMTRIP. (E) Untagged MTRIP, 
as well as 1 and 2MR-FMTRIP flag IF were imaged using a widefield microscope. 
MTRIP and FMTRIP (red) and flag IF (green) are merged. Scale bar, 2 µm. a.u., arbitrary 




Figure 2.2: Quantification of the mean flag IF intensity of FMTRIPs using mouse 
anti-flag Ab. The mean flag IF intensity as the mean flag MR-FMTRIP increased from 0 
(n=882, mean=0.6, s.d.= 0.5), 1 (n=1583, mean=21, s.d.=12) and 2 (n=1559, mean=48, s.d.=19). 
***p<0.001 (one-way ANOVA with Dunn’s post-hoc method). a.u., arbitrary units. Error bars, 




Figure 2.3: Imaging and quantification of colocalization between N IF and hRSV 
gRNA in Vero and A549 cells 48 h PI. (A) MTRIP-labeled gRNA and N IF in Vero and 
A549 cells 48 h PI were imaged with scanning laser confocal microscope. Merged 
images of gRNA (red), N (green) and nucleus (blue) are shown. All planes are 
represented. Scale bar, 5 µm. (B) The mean Pearson’s (Vero: n = 25, mean=0.51, 
s.d.=0.02; A549: n = 24, mean=0.60, s.d.=0.06) and Manders’ (Vero: n = 25, mean=0.57, 
s.d.=0.05; A549: n = 24, mean=0.75, s.d.=0.10) overlap coefficients showed 




Figure 2.4: Imaging and quantification of colocalization between flag IF and hRSV 
gRNA in A549 cells 48 h PI. (A) hRSV N IF, gRNA and flag IF in A549 cells with 0, 1 
or 2MR-FMTRIP were imaged with a widefield microscope and deconvolved. All image 
planes represented. Merged images of RSV N (white), gRNA (red), flag (green) and 
nucleus (blue) are shown. Scale bar, 5 µm. (B) The mean flag IF intensity increased as 
the mean MR-FMTRIP increased from 0 (n=20, mean=0, s.d.=0), 1 (n=18, mean=391, 
s.d.=101) to 2 (n=19, mean=532, s.d.=179). Rabbit anti-flag Ab was used. ***p<0.001 
(one-way ANOVA with Dunn’s post-hoc method). a.u., arbitrary units. n.d., not detected. 
Error bars, s.d. (C) In hRSV-infected A549 cells with 1 and 2MR-MTRIP, the mean 
Pearson’s (1MR-FMTRIP: n=18, mean=0.93, s.d.=0.05; 2MR-FMTRIP: n=19, 
mean=0.97, s.d.=0.03) and Manders’ (1MR-FMTRIP: n=18, mean=0.99, s.d.=0.01; 
2MR-FMTRIP: n=19, mean=1.00, s.d.=0.00) overlap coefficients showed flag and 
FMTRIP colocalization. No difference in overlap coefficient was observed between 1 and 





Figure 2.5: The mean RCA product volume in hRSV-infected Vero and A549 cells. 
Vero (n=93, mean=0.9, s.d.=0.1) and A549 cells (n=93, mean=0.8, s.d.=0.1) were 
infected with hRSV and fixed after 6, 24 and 48 h. After fixation and blocking, they were 
immunostained with rabbit anti-flag Ab (1:500 dilution) and mouse anti-N Ab (1:500 
dilution), followed by labeling with the proximity probes. The proximity probes were 
ligated, and RCA reaction occurred for 1 h 40 min. The cells were imaged using a laser 
scanning confocal microscope. No significant difference was observed between different 
lengths of infection (two-way ANOVA Holm-Sidak post-hoc method, p>0.6). Error bars, 





Figure 2.6: Imaging and quantification of hRSV gRNA FMTRIP and PLA with 
varying flag molar ratio. (A) gRNA FMTRIP and PLA in A549 cells 12 h PI were 
imaged with a widefield microscope and deconvolved. gRNA (red), PLA (green), and 
nuclei (blue) are merged. Scale bar, 5 µm. (B) Comparison of the mean PLA frequency 
for 0 (n = 20, mean = 0, SD = 0), 1 (n = 31, mean = 1.5, SD = 0.6) and 2 (n = 32, mean = 
2.2, SD = 0.7) MR-FMTRIP in hRSV-infected A549 cells 12 h PI imaged using a 
widefield microscope. ***P < 0.001 (one-way ANOVA with Dunn’s method. n.d., not 




Figure 2.7: Optimization of blocking solution in untagged MTRIP-delivered A549 
cells 48 h PI. (A) Merged images of hRSV gRNA (red), PLA between N and gRNA 
(green) and nuclei (blue) in A549 cells blocked with the standard Duolink II blocking 
solution (std) or modified blocking solution (mod) are shown. The cells were imaged 
with a laser scanning confocal microscope. All planes are represented. Scale bar, 5 µm. 
(B) The mean PLA frequency in cells blocked with std for 1/2000 (n=14, mean=0.12, 
s.d.=0.02), 1/1000 (n=14, mean=0.12, s.d.=0.02), 1/500 (n=14, mean=0.20, s.d.=0.04), 
1/200 hRSV N Ab dilution (n=14, mean=0.16, s.d.=0.04) and mod (1/2000: n=14, m-
ean=0, s.d.=0; 1/1000: n=14, mean=0, s.d.=0; 1/500: n=14, mean=0, s.d.=0; 1/200: n=14, 
mean=0, s.d.=0). *** p<0.001 (two-way ANOVA with Holm-Sidak method). n.d., not 




Figure 2.8: Anti-N Ab titration in FMTRIP- and MTRIP-delivered A549 cells 48 h 
PI. (A) hRSV gRNA and N-gRNA PLA in A549 cells imaged with a laser scanning 
confocal microscope. Merged images of hRSV gRNA (red), PLA (green) and nuclei 
(blue) are shown. All planes are represented. Scale bar, 5 µm. (B) The mean PLA 
frequency increased as hRSV N Ab dilution increased from 1/2000 (n=14, mean=0.53, 
s.d.=0.15), 1/1000 (n=14, mean=0.40, s.d.=0.04), 1/500 (n=14, mean=0.46, s.d.=0.07), to 
1/200 (n=14, mean=0.56, s.d.=0.05) in 1MR-FMTRIP and MTRIP (1/2000: n=14, 
mean=0, s.d.=0; 1/1000: n=14, mean=0, s.d.=0; 1/500: n=14, mean=0, s.d.=0; 1/200: 
n=14, mean=0, s.d.=0) . *** p<0.001, ** 0.001<p<0.01, * 0.01<p<0.05 (two-way 
ANOVA with Holm-Sidak method). Error bars, s.d. (Jung, Lifland et al. 2013) 
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Materials and methods 
Flag-tagged neutravidin was synthesized by first conjugating flag tag-hyNic 
(Solulink) to neutravidin (Thermo) modified with 4FB (Solulink) using the 
manufacturer’s protocol. The concentration of flag tag-hyNic and 4FB-modified 
neutravidin were adjusted to produce molar ratio of 1-2 flag/neutravidin. After flag 
labeling, FMTRIPs were assembled as previously described (Santangelo, Lifland et al. 
2009). Briefly, 2'-O-methyl RNA-DNA oligonucleotide chimeras were designed with a 
5'-biotin and dT-C6-NH2 internal modifications (Biosearch Technologies). Cy3B-NHS 
ester fluorophores (GE Healthcare) were conjugated to the oligonucleotide amine groups 
using the manufacturer’s protocol. Free dye was removed using 3kD Amicon spin 
columns (Millipore). The purified, labeling oligonucleotides were then tetramerized by 
incubation for 1 h at RT with flag-tagged neutravidin at molar ratio of 5:1. The FMTRIP 
were assembled separately prior to delivery. Each neutravidin, tetramerized 
oligonucleotides that target the same sequence. For example, in order to deliver 20nM 
FMTRIP for each of three targets in an mRNA, 20 nM FMTRIP was incubated with 
100nM fluorophore-labeled oligonucleotide that encodes one of three sequnces. Free 
ligands were removed using 30 kD Amicon spin columns (Millipore). Three 20 nM 
FMTRIP, each neutravidin bound to four of the same oligonucleotide sequences, were 
combined to form a 60 nM FMTRIP mixture. 
For probe delivery, cells were washed in Dulbeco’s phosphate buffered saline 
(DPBS) without Ca2+ and Mg2+ (Lonza), and then incubated with 0.2 U/mL activated 
SLO (Sigma) in OptiMEM (Invitrogen) containing FMTRIP [30 nM, 60 nM, or 20nM 
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flag-tagged neutravidin] for 10 min at 37 °C. Delivery media were replaced with growth 
media for 15 min to restore membrane integrity before further experimentation. 
After probe delivery and cell recovery, the cells were fixed with 1% 
paraformaldehyde (Electron Microscopy Science) in PBS for 10min, permeabilized using 
0.2% Triton X-100 (Sigma) for 5 min and blocked for 1 h with the standard Duolink II 
blocking solution (Olink Bioscience) or a modified blocking solution, which consists of 
0.5% Tween-20 (CalBioChem), 0.1% Triton X-100, 0.1% gelatin (Aurion), 2% donkey 
serum (Sigma) and 1% bovine serum albumin (BSA) (EMD) in PBS. Cells were washed 
with PBS for 5 min. Then they were incubated for 30 min at 37 °C in each of two 
primary antibodies diluted in 0.25% gelatin, 0.5% Triton X-100, 0.5% donkey serum, and 
1% BSA in PBS and then corresponding oligonucleotide-labeled PLA probes (Olink 
Bioscience) diluted in 0.05% Tween-20 in PBS. They were washed with Duolink wash 
solution (Olink Bioscience) after each Ab incubation. The ligation and RCA reactions 
(Olink Bioscience) were performed as instructed in the manufacturer’s protocol. Then the 
cells were immunostained or DAPI-stained (Invitrogen) and mounted on slides using 
Prolong (Invitrogen). 
Unless specified otherwise, all the images were taken using a laser scanning 
confocal microscope, Zeiss LSM 510 Meta using 63×, numerical aperture (NA) 1.4 Plan-
Apochromat objective. Resolution was set to 1024 × 1024. Files were imported into 
Volocity (PerkinElmer) and linearly contrast enhanced for display. Widefield images 
were taken on an Axiovert 200 M microscope (Zeiss) with a 63× NA 1.4 Plan-
Apochromat objective, and an ORCA-ER AG camera (Hamamatsu). The imaging was 
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performed using the Volocity acquisition software (PerkinElmer). Image stacks were 
recorded at 200 nm intervals to adequately sample volumes for iterative deconvolution. 
Widefield images were deconvolved using Volocity’s deconvolution algorithms 
(PerkinElmer). FMTRIP and PLA signal quantification, intensity quantification, as well 
as Mander’s and Pearson’s coefficients were computed in Volocity and imported into 
Excel (Microsoft) or Sigma Plot (Systat) for further analysis and plotting. Images 
presented have been linearly contrast enhanced for clarity. All calculations were 
performed directly on raw, deconvolved widefield data or raw confocal data. 
The volume of RNA and the PLA frequency/RNA volume were measured using 
Volocity (PerkinElmer). Each cell analyzed individually as follows. Each cell was 
identified by MTRIP signal or vimentin immunostaining. The RNA volume was 
determined based on the SD intensity. The PLA signal initially was identified as PLA 
objects by their SD intensity, then separated into individual punctae using the ‘separate 
touching objects’ tool. The objects were further filtered based on size and maximum 
intensity. For each experiment, we analyzed at least 30 representative cells; experiments 
were repeated at least twice. In Sigma Plot, Mann-Whitney rank sum test was used to 
compare FMTRIP volume and the Pearson’s and Manders’ coefficients; one-way and 
two-way ANOVA statistical tests were performed to compare PLA frequency across 
various experimental groups. For one-way ANOVA test, multiple pairwise comparisons 
were performed with Dunn’s method for unequal number of samples and Tukey method 
for equal number of samples. For two-way ANOVA test, multiple pairwise comparisons 
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mRNA INTERACTIONS WITH THE CYTOSKELETON 
 The work presented here has been adapted from Jung, J, Lifland, AW, Alonas, EJ, 
Zurla, C, Santangelo, PJ (2013). “Characterization of mRNA-cytoskeleton interactions in 
situ using FMTRIP and proximity ligation.” PLoS One 8(9):e74598. 
Background 
 mRNA localization regulates gene expression spatially and temporally by 
directing transcripts to restricted subcellular compartments for translation, stabilization, 
or degradation at the appropriate time (Martin and Ephrussi 2009; Xing and Bassell 
2013). For example, during stress, mRNAs are degraded in localized foci, such as 
processing bodies and RNA exosomes (Chen, Gherzi et al. 2001; Kedersha, Stoecklin et 
al. 2005; Pillai, Bhattacharyya et al. 2007). β-actin mRNAs in fibroblasts are localized to 
the leading edge where actin polymerization promotes forward protrusions (Hill and 
Gunning 1993; Condeelis and Singer 2005; Rodriguez, Shenoy et al. 2006). Multiple labs 
have observed an association between mRNA and the cytoskeleton (Hesketh, Campbell 
et al. 1991; Sundell and Singer 1991; Hill, Schedlich et al. 1994; Glotzer, Saffrich et al. 
1997).  
Using electron microscopy (EM), poly(A)+ mRNA in human fibroblasts has been 
found in association with actin filaments mostly, while less frequently with vimentin and 
microfilaments (Bassell, Powers et al. 1994). These interactions between mRNA 
(generally, the 3'UTR), motor proteins, and cytoskeleton have been shown to drive the 
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localization of mRNAs in various model systems, such as yeast (Takizawa, Sil et al. 
1997; Beach, Salmon et al. 1999), Drosophila oogenesis (Theurkauf, Smiley et al. 1992; 
Shulman, Benton et al. 2000), and neurons (Bassell, Zhang et al. 1998; Wu, Hengst et al. 
2005). In both human dermal fibroblasts (HDF) and A549 cells, an epithelial cell line, β-
actin mRNAs exhibit processive, active transport along the microtubules using kinesin 
and dynein, while they likely are anchored on the actin filaments (Lifland, Zurla et al. 
2011), facilitating translation (Hesketh and Pryme 1991; Condeelis and Singer 2005). 
 Many experiments for detecting mRNA-cytoskeleton interactions and identifying 
the cis- and trans-acting factors have been performed using biochemical assays (Jansen 
2001; Jambhekar and Derisi 2007), such as electrophoretic mobility shift (Raju, Fukuda 
et al. 2011) and immunoprecipitation (Ling, Fahrner et al. 2004; Jonson, Vikesaa et al. 
2007; Swanger, Bassell et al. 2011), or imaging methods, such as in situ hybridization 
(Bassell, Powers et al. 1994; Swanger, Bassell et al. 2011). For RNA detection, these 
methods often use exogenously expressed RNAs with MS2, which may be imaged, 
isolated, and analyzed for binding factors (Bertrand, Chartrand et al. 1998; Zimyanin, 
Belaya et al. 2008; Slobodin and Gerst 2010).  
While these are useful in identifying RNA-binding proteins (RBP) and whether 
they bind to the RNA of interest, we describe here a new technology that can study native 
mRNAs and proteins at their endogenous levels, observe the spatial distribution of the 
interactions within the cell, and may be performed at high-throughput. Although the in 
situ hybridization EM data (Bassell, Powers et al. 1994) conclusively described the 
frequency of interactions between poly(A)+ mRNA and cytoskeletal elements, this 
approach is low-throughput, laborious, and expensive. It also may introduce sampling 
37 
 
errors due to the evaluation of thin sections of few cells. The ability to image and 
quantify interactions between mRNAs and cytoskeleton with single interaction sensitivity 
on a per cell basis will allow us to better understand the significance of these interactions 
in regulating mRNA localization and gene expression. 
Detecting mRNA-cytoskeleton interactions 
 Using both flag-tagged multiply-labeled tetravalent RNA imaging probes 
(FMTRIP) (Santangelo, Lifland et al. 2009) and proximity ligation assay (PLA) 
(Soderberg, Gullberg et al. 2006), poly(A)+ and β-actin mRNA interactions with β-
tubulin, vimentin, and filamentous-actin (F-actin) were detected in HDFs and A549s. 
Cy3B-labeled FMTRIP targeting poly(A)+ or β-actin were delivered into live cells using 
streptolysin O (SLO), and post-hybridization, the cells were fixed. Using PLA, 
interactions between the flag tag on FMTRIP-hybridized mRNA and the cytoskeletal 
elements, β-tubulin, vimentin, or F-actin, were detected in fixed cells. Each interaction 
between the probe and the cytoskeleton produced a PLA product, a Cy5-equivalent 
labeled DNA punctae, which can easily be identified and counted. (Figure 3.1) 
 Since the mRNA-cytoskeleton interactions were observed after fixation, we 
examined the effect of various fixatives. Specifically, we compared paraformaldehyde 
(PFA) diluted in PBS or in BRB80 (a tubulin retaining fixative) and methanol. Methanol 
fixation generally provided the best immunofluorescence (IF) images and maintained the 
mRNA interactions with microtubules (Figure 3.2) and intermediate filaments (Figure 
3.3). For vimentin, differences in the IF images for various fixatives were less obvious 
than in the microtubules. Still, we observed significant differences between the fixatives 
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in the percentage of FMTRIP colocalized with PLA and the frequency of PLA punctae, 
even though no difference was observed in the volume of probes in the cells, suggesting 
similar probe delivery and hybridization. (Figure 3.3) For phalloidin, PFA fixation 
proved to be optimal, confirming protocols provided by Molecular Probes (Invitrogen, 
Inc). Therefore, fixatives play an important role in imaging and detecting mRNA-
cytoskeleton interactions. One clear advantage of delivering FMTRIPs to live cells is that 
various fixatives can be used. In conventional FISH assays, probe hybridization to RNAs 
occurs post-fixation using PFA, which may affect RNA-protein interactions.  
Depolymerization of cytoskeletal elements disrupts their interactions with mRNA 
 To test whether this method accurately detects direct interactions between 
mRNAs and the cytokeleton rather than mere proximity of the two that might not be in a 
complex, we depolymerized the cytoskeleton, interrupted mRNA-cytoskeleton 
interactions, and performed PLA. Poly(A)-targeting FMTRIP were delivered into cells, 
and PLA was performed between poly(A)+ mRNA and the cytoskeletal elements, after 
depolymerizing microtubules with nocodazole, vimentin with acrylamide, or actin with 
cytochalasin D (cytoD). Depolymerization in HDF and in A549 cells resulted in no PLA 
signal, although the mRNAs appeared near the depolymerized elements. (Figure 3.4) 
Clearly, this method can accurately detect interacting mRNA and cytoskeleton, not two 
that may be close together. 
 This experiment also revealed interesting differences in mRNA dispersal post-
depolymerization of various cytoskeletal elements. Depolymerizing β-tubulin didn’t 
change the distribution of the mRNA, as they remained widely dispersed throughout the 
cytoplasm. But disrupting vimentin and actin resulted in observable differences in the 
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mRNA localization. In vimentin-depolymerized cells, the mRNA generally clustered 
around the nucleus, but in actin-depolymerized cells, it moved toward the nucleus as well 
as the top of the cell. (Figure 3.4) This difference in vertical distribution of mRNAs was 
more apparent in the HDFs than the A549s. (Figure 3.5) 
Poly(A)+ mRNAs are bound predominantly to actin in HDF and A549 cells 
 To describe how mRNAs generally interact with the cytoskeleton, we studied 
poly(A)+ mRNAs in HDF and A549 cells. Poly(A)-targeting FMTRIPs were delivered to 
cells at 60nM concentration, which is less than the concentration that provide the 
maximum probe intensity (90nM). By under-sampling the mRNA, FMTRIPs likely 
bound to the mRNA randomly. This random sampling of mRNAs facilitates imaging 
individual RNA granules and quantifying relative changes in their interactions with the 
cytoskeleton. After hybridization and fixation, the interaction of poly(A)+ mRNA with β-
tubulin, vimentin, or actin (marked by phalloidin) were imaged and quantified.  
HDFs generally were larger and more spread out with more mRNA (Figure 3.6) 
than the epithelial cells (Figure 3.7). The mean probe volume was greater in the HDFs 
than in the A549s. Despite this difference, the FMTRIP signal was well-dispersed 
throughout the cytoplasm of both cells, suggesting a broad, random sampling of the 
mRNAs. Additionally, no difference in the probe delivery and hybridization was 
observed for different experimental groups; similar volumes of probes were observed in 
different cytoskeleton groups for each cell types. 
Contrastingly, the mean percentage of FMTRIP volume colocalized with PLA 
signal (PLA-FMTRIP) as well as the mean PLA frequency significantly differed between 
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mRNA interactions with various cytoskeletal elements. Although the poly(A)+ mRNA 
and β-tubulin IF appeared colocalized, their interactions were less than 5% for both HDF 
and A549 cells. In the HDF, on average, 2.3% FMTRIP volume colocalized with PLA 
signal between the mRNA and β-tubulin (Figure 3.6). This was consistent in A549 cells 
(Figure 3.7). Similarly, the mean PLA frequency normalized by the cell’s mRNA 
volume was minimal for the HDF and the A549 cells. The minimal percentage of mRNA 
bound to β-tubulin was due to the minimal number of interactions as detected by PLA, 
rather than smaller aggregates of mRNA bound to β-tubulin. Interactions between the 
mRNA and vimentin were more frequent in comparison. The mean percentage of PLA-
FMTRIP was 11.5% in HDFs. This was similar in A549s (n=28). The mean PLA 
frequency also was greater in HDFs and A549s.  
 As previously observed by Bassell et al using EM (Bassell, Powers et al. 1994), 
we also observed significantly more poly(A)+ mRNA (53.7%) was bound to F-actin in 
HDF. The mean poly(A)+ mRNA and F-actin PLA frequency was consistently the 
greatest. (Figure 3.6) However, for A549, there was no significant difference (p>0.05) 
between vimentin and F-actin. In A549 cells, less mRNA colocalized with PLA between 
mRNA and F-actin compared to HDFs. The mean PLA frequency also was less. (Figure 
3.7) Generally, the PLA punctae were localized to the branching points of actin filaments 
(Figure 3.6 and 3.7), as previously observed with EM (Bassell, Powers et al. 1994). 
As a negative control, probes lacking the flag tag were delivered to HDF (Figure 
3.8) and A549 cells (Figure 3.9). The delivery and hybridization of flag-less probes were 
similar to the flagged ones. Only a few interactions, likely due to non-specific 
interactions, were observed between the mRNA and cytoskeleton. In HDFs, the mean 
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percentage of PLA-MTRIP was minimal (<0.2%). (Figure 3.8) The mean PLA frequency 
also was insignificant. This was consistent in A549 cells. The mean percentage of PLA-
MTRIP was <0.05%, and the mean PLA was minimal. (Figure 3.9) 
β-actin mRNAs also are bound predominantly to actin 
Since we observed that poly(A)+ mRNAs predominantly bind to actin and 
minimally to microtubules, we wanted to see if this was also the case with β-actin 
mRNA. We delivered 50nM FMTRIP targeting β-actin mRNA (Jung, Lifland et al. 
2013). As previously observed (Santangelo, Lifland et al. 2009; Lifland, Zurla et al. 
2011), FMTRIP-bound β-actin mRNA was mostly localized in the perinuclear region and 
the leading edges of the cell. The range of FMTRIP volume was similar in both HDFs 
and A549s. No difference in the delivery and binding of FMTRIP was observed between 
the experimental groups. Similar to poly(A)+ mRNAs, most mRNAs interacted with F-
actin than the other cytoskeletal elements. (Figure 3.10 and 3.11) In HDFs, on average, 
3.9% of β-actin FMTRIP interacted with β-tubulin, 12.7% with vimentin, and 71.5% with 
F-actin. The mean frequency of PLA was consistent with the percentage of PLA-
FMTRIP. (Figure 3.10) In A549 cells, 2.6% β-actin FMTRIP interacted with β-tubulin, 
11.8% with vimentin, and 31.3% with F-actin. The mean PLA frequency also was 
consistent with the percentage of mRNA interacting with the cytoskeleton. (Figure 3.11) 
As with poly(A)+ mRNA, β-actin mRNAs were predominantly bound to F-actin. 
 As a negative control, we again delivered flag-less probes targeting β-actin. There 
was no difference in the probe delivery or hybridization between the probes with and 
without the flag tag (Figure 3.12 and 3.13). Minimal interaction was observed (Figure 
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3.12 and 3.13). As additional negative controls, we used PLA to detect β-actin mRNA 
interactions with nuclear proteins, nucleolin and histone H1. Since the nuclear proteins 
are predominantly within the nucleus, they generally do not interact with the cytoplasmic 
β-actin mRNA. The probes only target the cytoplasmic mRNAs; therefore, we detected 
no PLA signal between β-actin mRNAs and the nuclear proteins (Figure 3.14). 
Depolymerization of F-actin increases mRNA binding to the microtubules 
 Once we determined that depolymerization altered mRNA interactions with the 
depolymerized element and that we can accurately detect mRNA-cytoskeleton 
interactions, we asked whether depolymerization of one cytoskeleton altered mRNA 
interactions with the other, intact, cytoskeletal elements. When F-actin is depolymerized, 
the cell morphology was noticeably affected. The cytoplasm was reduced significantly 
with retracted edges, and the mRNA localized in the perinuclear region. Generally, the 
detected mRNA volume also decreased. However, when the interactions with F-actin 
were eliminated, the mean percentage of poly(A) + mRNA interacting with β-tubulin 
increased, while interactions with vimentin decreased. Consistently, the mean PLA 
frequency for interactions with β-tubulin increased, while interactions with vimentin 
decreased. Hence, changes in the percentage of mRNA interacting with β-tubulin or 
vimentin were due to changes in the number of PLA, rather than larger mRNA granules 
colocalizing with PLA. Considering the dramatic changes in the cell morphology, F-actin 
depolymerization might have also disrupted other cytoskeletal components, such as 
microtubules and intermediate filaments. However, since poly(A) + mRNA interactions 
with β-tubulin and vimentin resulted in PLA products, β-tubulin and vimentin likely were 
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not disrupted significantly by cytoD, since their depolymerization would have decreased 
the PLA signal to undetectable levels. (Figure 3.4) 
The increase in poly(A)+ mRNA binding to β-tubulin and decrease in the binding 
to vimentin suggest that as mRNA granules separate from F-actin, due to its 
depolymerization, and likely bind to microtubules. Microtubules have been observed to 
transport mRNA granules (Lifland, Zurla et al. 2011; Zurla, Lifland et al. 2011), while F-
actin has been thought to anchor and translate the mRNA. Moving mRNA granules are 
unlikely to undergo translation; hence, once the mRNAs separate from F-actin and 
vimentin, they may bind to microtubules to be transported elsewhere. This will be 
explored in future experiments. From these experiments, it is clear that depolymerization 
of F-actin leads to altered mRNA localization, specifically to the microtubules. 
Arsenite-induced oxidative stress decreased mRNA binding to F-actin and increased 
binding to microtubules 
In order to further investigate the relationship between mRNA binding to various 
cytoskeletal components, we examined interactions between poly(A)+ mRNA and the 
cytoskeletal elements at various time points during arsenite-induced oxidative stress. 
Arsenite is known to induce stress granule formation and alter mRNA localization and 
translational potential; therefore, a relevant perturbation to the cell. After 5-10 min of 
arsenite exposure, the poly(A) + mRNA interactions with β-tubulin increased 
significantly. Interactions significantly decreased at 20 min and remained minimal until 
40 min. Contrastingly, interactions with F-actin decreased significantly at 5 min and 
remained low throughout the experiment. Changes in the interactions with vimentin were 
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not as dramatic. Generally, they remained similar until 40 min, when the percentage 
mRNAs interacting with vimentin reached their minimum. (Figure 3.15) 
Zurla et al observed that 15 min after arsenite exposure, the β-actin mRNA 
granules began to accumulate near the nucleus and microtubule-organizing center 
(MTOC). After 30 min, the cells’ morphology changed dramatically with their edges 
retracted toward the nucleus. They also found that depolymerizing microtubules using 
nocodazole prevented β-actin mRNA from localizing to the MTOC. The increase in the 
poly(A)+ mRNA interactions with β-tubulin and the decrease in the interactions with F-
actin within the first 10 min of exposure are consistent with previous findings. mRNA 
granules anchored to F-actin likely separate and bind to microtubules for transport to the 
perinuclear region and MTOC.  
Zurla et al found that within 10 min, the mRNA granules at the cell periphery 
were not recruited toward the MTOC possibly because they remained bound to the 
cytoskeleton. (Jung, Lifland et al. 2013) At 10 min after exposure, we also observed PLA 
signals around the periphery (Figure 3.15), which eventually disappeared with extended 
exposure. By 40 minutes, interactions with β-tubulin, vimentin, and F-actin all decreased 
to minimal levels. This was likely due to arsenite-induced cytoskeleton instability. 
Exposure to arsenite led to cell retraction and loss of actin filaments; at higher doses, loss 
of microtubules and intermediate filaments was observed as well as inhibition of 
cytoskeletal protein synthesis (Chou 1989; Li and Chou 1992). In these experiments, we 
found that arsenite altered mRNA localization with the cytoskeleton, promoting 




Figure 3.1: Detection of interactions between FMTRIP-hybridized mRNA and 
cytoskeletal elements using proximity ligation assay (PLA). (A) Flag (dark green) 
bound to a neutravidin (yellow) with Cy3B-conjugated (red) oligonucleotides (red dash) 
formed an FMTRIP. (B) Streptolysin O created entrance for FMTRIP in the cell 
membrane, allowing access to the mRNA (gray) bound to the β-tubulin (blue), vimentin 
(magenta), and F-actin (green), via RNA-binding proteins (RBP, brown). (C) Antibodies 
against the flag (light blue) and the cytoskeletal element (light magenta) in addition to the 
proximity probes against the antibodies (dark blue and magenta) attached to the 
FMTRIP-bound mRNA (gray) and the cytoskeleton (green); the oligonucleotides (black 
dash) on the proximity probes join to synthesize a Cy5-equivalent hybridized DNA 




Figure 3.2: Interactions between poly(A)+ mRNA and α-tubulin in A549 cells fixed 
with methanol, 1% paraformaldehyde (PFA) in PBS, and 1% PFA in BRB80. α-
tubulin immunofluorescence (IF), poly(A)+ mRNA, and proximity ligation assay (PLA) 
product between poly(A)+ mRNA and α-tubulin were imaged with a laser-scanning 
confocal microscope. Merged images of α-tubulin (white), poly(A)+ mRNA (red), PLA 
(green), and nuclei (blue) are shown. Single image plane is represented. Scale bar, 10µm. 




Figure 3.3: Interactions between poly(A)+ mRNA and vimentin in A549 cells fixed 
with methanol, 1% PFA in PBS, and 1% PFA in BRB80. (A) Vimentin IF, poly(A)+ 
mRNA, and PLA product between poly(A)+ mRNA and vimentin were imaged with a 
laser-scanning confocal microscope. Merged images of Vimentin (white), poly(A)+ 
mRNA (red), PLA (green), and nuclei (blue) are shown. Single image plane is 
represented. Scale bar, 10 µm. (B) The mean FMTRIP volume was similar (Kruskal-
Wallis One Way ANOVA on Ranks, p=0.5) in all fixatives, methanol (n=20), 1% PFA in 
PBS (n=20), and 1% PFA in BRB80 (n=21). (C) The mean percentage of FMTRIP 
colocalized with PLA (PLA-FMTRIP) in cells fixed with methanol (n=20) was greater 
(Kruskal-Wallis One Way ANOVA on Ranks with Dunn’s method, ***, p<0.001) than 
those fixed with 1% PFA in PBS (n=20) or 1% PFA in BRB80 (n=21). (D) The mean 
PLA frequency was greater (Kruskal-Wallis One Way ANOVA on Ranks with Dunn’s 
method, *, p<0.02) in methanol fixation (n=20) than in 1% PFA in PBS (n=20) or 1% 




Figure 3.4: Interactions between poly(A)+ mRNA and cytoskeletal elements in HDF 
post-depolymerization of microtubules using nocodazole, intermediate filaments 
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using acrylamide, and actin using cytochalasin D. (A) β-tubulin, vimentin, and 
phalloidin immunofluorescence (IF), poly(A)+ mRNA, and PLA between poly(A)+ 
mRNA and the cytoskeletal elements in HDF were imaged with a laser-scanning confocal 
microscope. Merged images of the cytoskeleton (white), poly(A)+ mRNA (red), PLA 
(green) and nuclei (blue) are shown. Single image plane is represented. Scale bar, 10 µm. 
(B) The mean FMTRIP volume decreased after 90 min exposure to cytochalasin D 
(Mann-Whitney rank sum test, β-tubulin, p<0.01; vimentin, p<0.01) in experiments 
quantifying interactions with β-tubulin (n=21, mean=254µm3, s.d.=110µm3) and 
vimentin (n=16, mean=253µm3, s.d.=188µm3). (C) The mean percentage of FMTRIP 
(PLA-FMTRIP) bound to β-tubulin increased after depolymerization (Mann-Whitney 
rank sum test, p<0.001; n=21, mean=16.3%, s.d.=9.5%) but decreased for vimentin 
(Mann-Whitney rank sum test, p<0.001; n=16, mean=1.5%, s.d.=1.9%). (D) The mean 
PLA frequency detecting interactions with β-tubulin also increased (Mann-Whitney rank 
sum test, p=0.015; n=21, mean=0.03µm-3, s.d.=0.02µm-3) and decreased for vimentin 
(Mann-Whitney rank sum test, p<0.001; n=16, mean=0.01µm-3, s.d.=0.01µm-3). Error 





Figure 3.5: Interactions between poly(A)+ mRNA and cytoskeletal elements in A549 
cells post-depolymerization of microtubules using nocodazole, intermediate 
filaments using acrylamide, and actin using cytochalasin D. β-tubulin, vimentin, and 
phalloidin immunofluorescence (IF), poly(A)+ mRNA, and PLA between poly(A)+ 
mRNA and the cytoskeletal elements in HDF were imaged with a laser-scanning confocal 
microscope. Merged images of the cytoskeleton (white), poly(A)+ mRNA (red), PLA 
(green) and nuclei (blue) are shown. Single image plane is represented. Scale bar, 10 µm. 
(Jung, Lifland et al. 2013) 
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Figure 3.6: Interactions between poly(A)+ mRNA and cytoskeletal elements in HDF. 
(A) β-tubulin, vimentin and phalloidin IF, poly(A)+ mRNA, and PLA between poly(A)+ 
mRNA and the cytoskeletal elements in HDF were imaged with a laser-scanning confocal 
microscope. Merged images of the cytoskeleton (white), poly(A)+ mRNA (red), PLA 
(green) and nuclei (blue) are shown. Single image plane is represented. Inset, images of 
boxed regions. Scale bar, 10 µm (2 µm in insets). (B) The mean FMTRIP volume was 
similar (Kruskal-Wallis One Way ANOVA on Ranks, p=0.5) in cells, where the 
interactions between poly(A)+ mRNA and β-tubulin (n=25, mean=706µm3, 
s.d.=427µm3), vimentin (n=33, mean=780µm3, s.d.=405µm3), or phalloidin (n=23, 
mean=916µm3, s.d.=346µm3) were quantified. (C) The mean percentage of FMTRIP 
colocalized with PLA (PLA-FMTRIP) was significantly different between interactions of 
poly(A)+ mRNA with β-tubulin (n=25, mean=2.3%, s.d.=1.5%), vimentin (n=33, 
mean=11.5%, s.d.=9.7%), and phalloidin (n=23, mean=53.7%, s.d.=19.9%). (Table 3.1) 
(D) The mean PLA frequency was significantly different between the interactions of 
poly(A)+ mRNA with β-tubulin (n=25, mean=0.010µm-3, s.d.=0.007µm-3), vimentin 
(n=33, mean=0.019µm-3, s.d.=0.016µm-3), or phalloidin (n=23, mean=0.069µm-3, 
s.d.=0.039µm-3). (Table 3.2) Error bars, s.d. (Jung, Lifland et al. 2013) 
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Table 3.1: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) in human dermal fibroblasts (HDF). Interactions between poly(A)+ 
mRNA and β-tubulin (n=25, mean=2.3%, SD=1.5%), vimentin (n=33, mean=11.5%, 
SD=9.7%), or phalloidin (n=23, mean=53.7%, SD=19.9%) were compared using 
Kruskal-Wallis one-way ANOVA on ranks with Dunn’s method for multiple comparison 






Table 3.2: Comparisons of the mean PLA frequency in HDF. Interactions between 
poly(A)+ mRNA and β-tubulin (n=25, mean=0.010µm-3, s.d.=0.007µm-3), vimentin 
(n=33, mean=0.019µm-3, s.d.=0.016µm-3), or phalloidin (n=23, mean=0.069µm-3, 
s.d.=0.039µm-3) were compared using Kruskal-Wallis one-way ANOVA on ranks with 






Figure 3.7: Interactions between poly(A)+ mRNA and cytoskeletal elements in A549 
cells. (A) β-tubulin, vimentin and phalloidin IF, poly(A)+ mRNA, and PLA between 
poly(A)+ mRNA and the cytoskeletal elements in A549 cells were imaged with a laser-
scanning confocal microscope. Merged images of the cytoskeleton (white), poly(A)+ 
mRNA (red), PLA (green) and nuclei (blue) are shown. Single image plane is 
represented. Inset, images of boxed regions. Scale bar, 10 µm (2 µm in insets). (B) The 
mean FMTRIP volume was similar (One Way ANOVA with normal distribution, p=0.7) 
in cells, where the interactions between poly(A)+ mRNA and β-tubulin (n=26, 
mean=146µm3, s.d.=42µm3), vimentin (n=28, mean=160µm3, s.d.=43µm3), or phalloidin 
(n=24, mean=177µm3, s.d.=51µm3) were quantified. (C) The mean percentage of 
FMTRIP colocalized with PLA (PLA-FMTRIP) was different between the interactions of 
poly(A)+ mRNA with β-tubulin (n=26, mean=2.1%, s.d.=1.4%), vimentin (n=28, 
mean=10.5%, s.d.=6.1%), and phalloidin (n=24, mean=22.9%, s.d.=18.6%). (Table 3.3) 
(D) The mean PLA frequency was significantly different between the interactions of 
poly(A)+ mRNA with β-tubulin (n=26, mean=0.063µm-3, s.d.=0.023µm-3), vimentin 
(n=28, mean=0.15µm-3, s.d.=0.07µm-3), or phalloidin (n=24, mean=0.13µm-3, 
s.d.=0.09µm-3). (Table 3.4) Error bars, s.d. (Jung, Lifland et al. 2013) 
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Table 3.3: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) in A549 cells. Interactions between poly(A)+ mRNA and β-tubulin 
(n=26, mean=2.1%, s.d.=1.4%), vimentin (n=28, mean=10.5%, s.d.=6.1%), or phalloidin 
(n=24, mean=22.9%, s.d.=18.6%) were compared using Kruskal-Wallis one-way 
ANOVA on ranks with Dunn’s method for multiple comparison (p < 0.001). (Jung, 





Table 3.4: Comparisons of the mean PLA frequency in A549 cells. Interactions 
between poly(A)+ mRNA and β-tubulin (n=26, mean=0.063µm-3, s.d.=0.023µm-3), 
vimentin (n=28, mean=0.15µm-3, s.d.=0.07µm-3), or phalloidin (n=24, mean=0.13µm-3, 
s.d.=0.09µm-3) were compared using Kruskal-Wallis one-way ANOVA on ranks with 







Figure 3.8: Interactions between poly(A)+ mRNA bound to MTRIP lacking flag tag 
and cytoskeletal elements in human dermal fibroblasts (HDF). (A) β-tubulin, 
vimentin and phalloidin IF, poly(A)+ mRNA, and PLA between poly(A)+ mRNA, and 
the cytoskeletal elements in HDF were imaged with a laser-scanning confocal 
microscope. Merged images of the cytoskeleton (white), poly(A)+ mRNA (red), PLA 
(green), and nuclei (blue) are shown. Single image plane is represented. Scale bar, 10 µm. 
(B) The mean MTRIP volume was similar (Kruskal-Wallis One Way ANOVA on Ranks, 
p=0.08) in cells, where the interactions between β-actin mRNA and β-tubulin (n=18, 
mean=404µm3, s.d.=317µm3), vimentin (n=19, mean=518µm3, s.d.=362µm3), or 
phalloidin (n=15, mean=653µm3, s.d.=211µm3) were quantified. (C) The mean 
percentage of MTRIP colocalized with PLA (PLA-MTRIP) was similarly minimal 
(Kruskal-Wallis One Way ANOVA on Ranks, p=0.15) in β-tubulin (n=18, mean=0.01%, 
s.d.=0.03%), vimentin (n=19, mean=0.04%, s.d.=0.1%), or phalloidin (n=15, 
mean=0.20%, s.d.=0.41%). (D) The mean PLA frequency was also minimal (Kruskal-
Wallis One Way ANOVA on Ranks, p=0.23) in β-tubulin (n=18, mean=0.0004µm-3, 
s.d.=0.001µm-3), vimentin (n=19, mean=0.0008µm-3, s.d.=0.0001µm-3), or phalloidin 
(n=15, mean=0.001µm-3, s.d.=0.002µm-3). Error bars, s.d. (Jung, Lifland et al. 2013) 
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Figure 3.9: Interactions between poly(A)+ mRNA bound to MTRIP lacking flag tag 
and cytoskeletal elements in A549 cells. (A) β-tubulin, vimentin and phalloidin IF, 
poly(A)+ mRNA, and PLA between poly(A)+ mRNA and the cytoskeletal elements in 
HDF were imaged with a laser-scanning confocal microscope. Merged images of the 
cytoskeleton (white), poly(A)+ mRNA (red), PLA (green) and nuclei (blue) are shown. 
Single image plane is represented. Scale bar, 10 µm. (B) The mean MTRIP volume was 
similar (Kruskal-Wallis One Way ANOVA on Ranks, p=0.08) in cells, where the 
interactions between β-actin mRNA and β-tubulin (n=18, mean=404µm3, s.d.=317µm3), 
vimentin (n=19, mean=518µm3, s.d.=362µm3), or phalloidin (n=15, mean=653µm3, 
s.d.=211µm3) were quantified. (C) The mean percentage of MTRIP colocalized with PLA 
(PLA-MTRIP) was similarly minimal (Kruskal-Wallis One Way ANOVA on Ranks, 
p=0.15) in β-tubulin (n=18, mean=0.01%, s.d.=0.03%), vimentin (n=19, mean=0.04%, 
s.d.=0.1%), or phalloidin (n=15, mean=0.20%, s.d.=0.41%). (D) The mean PLA 
frequency was also minimal (Kruskal-Wallis One Way ANOVA on Ranks, p=0.23) in β-
tubulin (n=18, mean=0.0004µm-3, s.d.=0.001µm-3), vimentin (n=19, mean=0.0008µm-3, 
s.d.=0.0001µm-3), or phalloidin (n=15, mean=0.001µm-3, s.d.=0.002µm-3). Error bars, s.d. 





Figure 3.10: Interactions between β-actin mRNA and cytoskeletal elements in HDF. 
(A) β-tubulin, vimentin and phalloidin IF, β-actin mRNA, and PLA between β-actin 
mRNA and the cytoskeletal elements in HDF were imaged with a laser-scanning confocal 
microscope. Merged images of the cytoskeleton (white), β-actin mRNA (red), PLA 
(green), and nuclei (blue) are shown. Single image plane is represented. Inset, images of 
boxed regions. Scale bar, 10 µm (2 µm in insets). (B) The mean FMTRIP volume was 
similar (Kruskal-Wallis One Way ANOVA on Ranks, p=0.5) in cells, where the 
interactions between β-actin mRNA and β-tubulin (n=40, mean=567µm3, s.d.=355µm3), 
vimentin (n=36, mean=607µm3, s.d.=385µm3), or phalloidin (n=30, mean=660µm3, 
s.d.=389µm3) were quantified. (C) The mean percentage of FMTRIP colocalized with 
PLA (PLA-FMTRIP) was significantly different (Table 3.5) between the interactions of 
β-actin mRNA with β-tubulin (n=40, mean=3.9%, s.d.=3.2%), vimentin (n=36, 
mean=12.7%, s.d.=7.9%), or phalloidin (n=30, mean=71.5%, s.d.=20.1%). (D) The mean 
PLA frequency was significantly different (Table 3.6) between the interactions of β-actin 
mRNA with β-tubulin (n=40, mean=0.012µm-3, s.d.=0.011µm-3), vimentin (n=36, 
mean=0.027µm-3, s.d.=0.023µm-3), or phalloidin (n=30, mean=0.33µm-3, s.d.=0.17µm-3). 
Error bars, s.d. (Jung, Lifland et al. 2013) 
60 
 
Table 3.5: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) in HDF. Interactions between β-actin mRNA and β-tubulin (n=40, 
mean=3.9%, s.d.=3.2%), vimentin (n=36, mean=12.7%, s.d.=7.9%), or phalloidin (n=30, 
mean=71.5%, s.d.=20.1%) were compared using Kruskal-Wallis one-way ANOVA on 





Table 3.6: Comparisons of the mean PLA frequency in HDF. Interactions between β-
actin mRNA and β-tubulin (n=40, mean=0.012µm-3, s.d.=0.011µm-3), vimentin (n=36, 
mean=0.027µm-3, s.d.=0.023µm-3), or phalloidin (n=30, mean=0.33µm-3, s.d.=0.17µm-3) 
were compared using Kruskal -Wallis one-way ANOVA on ranks with Dunn’s method 





Figure 3.11: Interactions between β-actin mRNA and cytoskeletal elements in A549 
cells. (A) β-tubulin, vimentin and phalloidin IF, β-actin mRNA, and PLA between β-
actin mRNA and the cytoskeletal elements in A549 cells were imaged with a laser-
scanning confocal microscope. Merged images of the cytoskeleton (white), β-actin 
mRNA (red), PLA (green) and nuclei (blue) are shown. Single image plane is 
represented. Inset, images of boxed regions. Scale bar, 10 µm (2 µm in insets). (B) The 
mean FMTRIP volume was similar (One Way ANOVA with normal distribution, p=0.08) 
in cells, where the interactions between β-actin mRNA and β-tubulin (n=31, 
mean=281µm3, s.d.=104µm3), vimentin (n=19, mean=336µm3, s.d.=114µm3), or 
phalloidin (n=20, mean=263µm3, s.d.=96µm3) were quantified. (C) The mean percentage 
of FMTRIP colocalized with PLA (PLA-FMTRIP) was significantly different (Table 
3.7) between the interactions of β-actin mRNA with β-tubulin (n=31, mean=2.6%, 
s.d.=1.7%), vimentin (n=19, mean=11.8%, s.d.=5.7%), or phalloidin (n=20, 
mean=31.3%, s.d.=19.6%). (D) The mean PLA frequency for interactions between β-
actin mRNA and phalloidin (n=20, mean=0.14µm-3, s.d.=0.08µm-3) was significantly 
greater (Table 3.8) than the interactions between β-actin mRNA and β-tubulin (n=31, 
mean=0.030µm-3, s.d.=0.016µm-3) or vimentin (n=19, mean=0.04µm-3, s.d.=0.03µm-3). 
Error bars, s.d. (Jung, Lifland et al. 2013) 
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Table 3.7: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) in A549 cells. Interactions between β-actin mRNA and β-tubulin 
(n=31, mean=2.6%, s.d.=1.7%), vimentin (n=19, mean=11.8%, s.d.=5.7%), or phalloidin 
(n=20, mean=31.3%, s.d.=19.6%) were compared using Kruskal-Wallis one-way 
ANOVA on ranks with Dunn’s method for multiple comparison (p < 0.001). (Jung, 




Table 3.8: Comparisons of the mean PLA frequency in A549 cells. Interactions 
between β-actin mRNA and β-tubulin (n=31, mean=0.030µm-3, s.d.=0.016µm-3), 
vimentin (n=19, mean=0.04µm-3, s.d.=0.03µm-3), or phalloidin (n=20, mean=0.14µm-3, 
s.d.=0.08µm-3) were compared using Kruskal-Wallis one-way ANOVA on ranks with 






Figure 3.12: Interactions between β-actin mRNA bound to MTRIP lacking flag tags 
and cytoskeletal elements in human dermal fibroblasts (HDF). (A) β-tubulin, 
vimentin, and phalloidin IF, β-actin mRNA, and PLA between β-actin mRNA and the 
cytoskeletal elements in HDF were imaged with a laser-scanning confocal microscope. 
Merged images of the cytoskeleton (white), β-actin mRNA (red), PLA (green), and 
nuclei (blue) are shown. Single image plane is represented. Scale bar, 10µm. (B) The 
mean MTRIP volume was similar (Kruskal-Wallis One Way ANOVA on Ranks, p=0.12) 
in cells, where the interactions between β-actin mRNA and β-tubulin (n=25, 
mean=750µm3, s.d.=460µm3), vimentin (n=22, mean=980µm3, s.d.=470µm3), or 
phalloidin (n=17, mean=710µm3, s.d.=340µm3) were quantified. (C) The mean 
percentage of MTRIP colocalized with PLA (PLA-MTRIP) was similarly minimal 
(Kruskal-Wallis One Way ANOVA on Ranks, p>0.05) in β-tubulin (n=25, mean=0.2%, 
s.d.=0.9%), vimentin (n=22, mean=0.1%, s.d.=0.4%), or phalloidin (n=17, mean=0.04%, 
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s.d.=0.08%). (D) The mean PLA frequency was also minimal (Kruskal-Wallis One Way 
ANOVA on Ranks, p>0.05) in β-tubulin (n=25, mean=0.0001µm-3, 0.0003µm-3), 
vimentin (n=22, mean=0.0002µm-3, 0.0004µm-3), or phalloidin (n=17, mean=0.001µm-3, 





Figure 3.13: Interactions between β-actin mRNA bound to MTRIP lacking flag tags 
and cytoskeletal elements in A549 cells. (A) β-tubulin, vimentin, and phalloidin IF, β-
actin mRNA, and PLA between β-actin mRNA and the cytoskeletal elements in A549 
cells were imaged with a laser-scanning confocal microscope. Merged images of the 
cytoskeleton (white), β-actin mRNA (red), PLA (green), and nuclei (blue) are shown. 
Single image plane is represented. Scale bar, 10µm. (B) The mean MTRIP volume was 
similar (Kruskal-Wallis One Way ANOVA on Ranks, p=0.08) in cells, where the 
interactions between β-actin mRNA and β-tubulin (n=15, mean=289µm3, s.d.=68µm3), 
vimentin (n=11, mean=299µm3, s.d.=71µm3), or phalloidin (n=13, mean=243µm3, 
s.d.=53µm3) were quantified. (C) The mean percentage of MTRIP colocalized with PLA 
(PLA-MTRIP) was similarly minimal (Kruskal-Wallis One Way ANOVA on Ranks, 
p>0.05) in β-tubulin (n=15, mean=0.0%, s.d.=0.0%), vimentin (n=11, mean=0.07%, 
s.d.=0.14%), or phalloidin (n=13, mean=0.003%, s.d.=0.009%). (D) The mean PLA 
frequency was also minimal (Kruskal-Wallis One Way ANOVA on Ranks, p>0.05) in β-
tubulin (n=15, mean=0.00µm-3, s.d.=0.00µm-3), vimentin (n=11, mean=0.001µm-3, 
s.d.=0.002µm-3), or phalloidin (n=13, mean=0.0003µm-3, s.d.=0.0011µm-3). Error bars, 




Figure 3.14: Interactions between β-actin mRNA and nuclear proteins in A549 cells. 
Nucleolin (C23) and Histone H1 IF, β-actin mRNA, and PLA between β-actin mRNA 
and the nuclear proteins in A549 cells were imaged with a laser-scanning confocal 
microscope. Merged images of the nuclear protein (white), β-actin mRNA (red), PLA 
(green), and nuclei (blue) are shown. All image planes are represented. Scale bar, 10µm. 




In contrast to the 48 hours required to image and quantify interactions between 
poly(A)+ mRNA and cytoskeleton in five to ten cells using EM (Bassell, Powers et al. 
1994), using the combined FMTRIP and PLA method, this was achievable for two 
different mRNAs in 15-40 cells within eight hours using a widefield fluorescent 
microscope. Since single interactions lead to the production of single fluorescent puncta 
(Soderberg, Gullberg et al. 2006), mRNA-cytoskeleton interactions were easily identified 
and quantified on a per cell basis. With the mRNAs also hybridized to fluorescent probes 
that reflect their quantity (Zurla, Lifland et al. 2011; Jung, Lifland et al. 2013), the 
interactions were normalized by the mRNA signal, allowing quantification that can be 
compared between cells. Because probes were hybridized to the mRNA in live cells 
before fixation, they targeted mRNAs that were undistorted by fixatives. The ability to 
detect these interactions quantitatively using multiple fixatives post-probe delivery, 
allowed us to utilize the optimal fixative for each cytoskeletal element, ensuring 
accuracy; this was not possible with other methods.  
In addition to these methodological advantages, our findings were consistent with 
the EM data (Bassell, Powers et al. 1994), both poly(A)+ and β-actin mRNA were bound 
predominantly to actin, compared to microtubules and vimentin, in both A549 cells and 
HDF. In human diploid fibroblasts, Bassell et al. observed 72% poly(A)+ mRNA was 
localized within 5nm of F-actin filaments (n=5); 29% with vimentin filaments (n=5); and 
less than 10% with microtubules (n=5) (Bassell, Powers et al. 1994). In human dermal 
fibroblasts, on average, we observed 54% poly(A)+ mRNA interacting with F-actin 
(n=23); 12% with vimentin (n=33); and 2% with β-tubulin (n=25). For β-actin mRNA, 
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72% interacted with F-actin (n=30), 13% with vimentin (n=36), and 4% with β-tubulin 
(n=40).  
The lower mean percentage of poly(A)+ mRNA interaction using PLA compared 
to EM is likely because we under-labeled mRNA. Instead of using 90nM probes that 
produces the maximum intensity (Santangelo, Lifland et al. 2009; Lifland, Zurla et al. 
2011), 60nM concentrations of probes were delivered in order to label a random portion 
of the mRNA population and to facilitate the imaging of individual mRNA granules and 
quantification of relative differences in their interactions with the cytoskeleton. In 
addition, the PLA reaction depends on the antibodies bound to the cytoskeleton and 
FMTRIP. Antibody concentrations that were less than that for maximal coverage were 
utilized, in order to sample a random portion of the protein population and to limit the 
detection of non-specific interactions. This is acceptable because the main purpose of 
using PLA for detection mRNA-protein interactions is to quantify and compare the 
relative change in the interactions, rather than to determine the absolute number of 
interactions. Slight differences between the EM data and our findings might be due to our 
larger sample size, methodological differences in data acquisition and analysis, and 
differences in the cell types used. 
This work supports the idea that mRNAs are bound predominantly to actin, 
compared to microtubules and vimentin. mRNAs are likely anchored to actin (Condeelis 
and Singer 2005) and transported to specific areas in the cell by microtubules associated 
with motors (Lifland, Zurla et al. 2011). Similar to actin, vimentin likely serves to anchor 
the mRNA rather than to direct its motion. Vimentin depolymerization dramatically 
changed the mRNA localization for both mRNAs in both cell types, similar to actin 
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depolymerization. Contrastingly, microtubule depolymerization had little effect on the 
mRNA distribution. 
On average, a greater percentage of mRNA was bound to F-actin in the HDFs 
compared to A549 cells, even though the percentage of mRNA bound to β-tubulin and 
vimentin was similar in both cell types. During epithelial to mesenchymal transition 
(EMT) in various cell types, translation of actin and vimentin increases along with actin 
rearrangement (Kalluri and Neilson 2003). One hypothesis may be that since A549 cells 
are an adenocarcinoma cell line and likely exhibit increased mesenchymal characteristics 
than normal epithelial cells, such as greater production of vimentin and actin (Mathias 
and Simpson 2009; Oyanagi, Ogawa et al. 2012). Still, since EMT can be induced in 
A549 cells using TGF-β (Pirozzi, Tirino et al. 2011), they likely express less actin than 
fibroblasts, which explains less F-actin interactions than HDFs. Additionally, considering 
their smaller size compared to the HDF, mRNA localization away from the nucleus and 
actin-anchoring may not be as crucial as in the HDF. 
Using PLA, we detected changes in the poly(A)+ mRNA interactions with the 
cytoskeleton after F-actin depolymerization and arsenite-induced oxidative stress. We 
observed increased poly(A)+ mRNA binding to β-tubulin after F-actin depolymerization. 
Consistently, exposure to arsenite resulted in decreased poly(A)+ mRNA binding to F-
actin and increased binding to β-tubulin within the first ten minutes. Interestingly, in both 
cytoD and arsenite exposure experiments, a complementary relationship between F-actin 
and β-tubulin was observed. When the mRNA granules separated from F-actin, their 
binding to microtubules increased. To date, a dynamic relationship between mRNA and 
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cytoskeletal components has not been reported. The mechanism for the similarity of these 
responses is unknown. Similar to cytoD, arsenite also disrupts actin filament formation 
(Chou 1989; Li and Chou 1992), but in a less direct and intense manner. With the arsenite 
exposure, mRNAs do not fall off of the F-actin, as with cytoD exposure, instead they may 
be moved onto microtubules predominantly and intermediate filaments to a lesser degree. 
This implies that the dynamic relationship between mRNA localization to F-actin and 
microtubules is likely a conserved response in both cytoD and arsenite exposure 
experiments, and not specific to F-actin depolymerization. The mechanism of this event 
will be explored in future publications. 
In addition, these observations elicit a number of questions regarding mRNA 
control. The trans-acting factors controlling the mRNA localization to F-actin versus 
microtubules remain to be identified. The significance of mRNA binding to cytoskeleton 
in directing its function and fate toward translation or degradation also needs to be 
elucidated. Are the mRNAs switching from F-actin to microtubules so that they can be 
degraded? Or are they simply binding to microtubules randomly, because they are no 
longer bound to F-actin? Future studies, using the method discussed in this paper in 
conjunction with other methods, such as crosslinking and immunoprecipitation, should 
allow us to answer these questions. 
Here, we present a powerful tool for imaging and quantifying mRNA-
cytoskeleton interactions. It has shown to provide similar accuracy as EM but is easier to 
perform and is less labor-intensive. Unlike other methods, this technique can quantify the 
spatiotemporal asymmetry within an individual and population of cells as well as cell-to-
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cell variations, which are valuable in numerous studies, such as viral infection (Heinlein, 
Epel et al. 1995; Bukrinskaya, Brichacek et al. 1998; Nemerow and Stewart 1999), stem 
cell differentiation (Suon, Jin et al. 2004; Ratti, Fallini et al. 2006; Hailesellasse Sene, 
Porter et al. 2007), and cancer pathophysiology (Zimber, Nguyen et al. 2004; Escuin, 
Kline et al. 2005; Greijer, van der Groep et al. 2005). This method, in future studies, will 
assist in improving our understanding of the effects of intracellular and extracellular 
signaling events on mRNA trafficking, localization, and translation via alterations in the 
interactions between the mRNA, RBPs, motor proteins, and cytoskeleton. Multiplexing 
this assay to detect multiple RNA-cytoskeleton and RNA-RBP interactions, 
simultaneously, will provide a more complete understanding of how these interactions are 
altered during infections, oxidative stress, or during the application of external forces. By 
combining this method with other assays, such as immunoprecipitation, that can identify 
RBPs that regulate mRNA-cytoskeleton interactions, we can elucidate the underlying 






Figure 3.15: Arsenite-induced oxidative stress reduced poly(A)+ mRNA binding to 
F-actin and vimentin, while increasing interactions with β-tubulin. (A) β-tubulin, 
vimentin and phalloidin IF, poly(A)+ mRNA, and PLA between poly(A)+ mRNA and the 
cytoskeletal elements in HDF were imaged at 0 min (or no) and 10 min exposure to 
arsenite with a laser-scanning confocal microscope. Merged images of the cytoskeleton 
(white), poly(A)+ mRNA (red), PLA (green), and nuclei (blue) are shown. All image 
planes are represented. Scale bar, 10 µm. (B) The mean percentage of FMTRIP (PLA-
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FMTRIP) bound to β-tubulin increased significantly from 0 min exposure (n=28, 
mean=2.5%, s.d.=1.6%) to 5 min exposure (Kruskal-Wallis One Way ANOVA on Ranks, 
p<0.001; n=31, mean=12.8%,s.d.=14.6%); remained high for 10 min exposure (n=26, 
mean=11.3%, s.d.=9.1%); and decreased to the pre-exposure level at 20 (Kruskal-Wallis 
One Way ANOVA on Ranks, p<0.05; n=22, mean=2.6%, s.d.=3.8%) and 40 min (n=20, 
mean=2.2%, s.d.=3.0%) (Table 3.9). (C) The mean percentage of FMTRIP (PLA-
FMTRIP) bound to vimentin remained similar to 0 min exposure (n=42, mean=11.1%, 
s.d.=8.8%) for 5 (n=23, mean=13.9%,s.d.=6.5%),10 (n=19, mean=18.7%, s.d.=7.5%), 
and 20 min (n=13, mean=13.3%, s.d.=7.1%) exposure; it decreased at 40 min (n=17, 
mean=5.9%, s.d.=4.4%) (Table 3.10). (D) The mean percentage of FMTRIP (PLA-
FMTRIP) bound to F-actin decreased significantly from 0 min exposure (n=38, 
mean=49.3%, s.d.=19.4%) to 5 min exposure (Kruskal-Wallis One Way ANOVA on 
Ranks, p<0.001; n=25, mean=6.0%,s.d.=5.2%); remained low for 10 (n=21, mean=9.6%, 
s.d.=6.4%), 20 (n=19, mean=15.4%, s.d.=9.4%), and 40 min (n=16, mean=6.8%, 




Table 3.9: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) for poly(A)+ mRNA interactions with β-tubulin in HDF cells 
exposed to arsenite. At 0 (n=28, mean=2.5%, s.d.=1.6%), 5 (n=31, 
mean=12.8%,s.d.=14.6%), 10 (n=26, mean=11.3%, s.d.=9.1%), 20 (n=22, mean=2.6%, 
s.d.=3.8%), and 40 min (n=20, mean=2.2%, s.d.=3.0%), PLA-FMTRIP were compared 
using Kruskal-Wallis one-way ANOVA on ranks with Dunn’s method for multiple 





Table 3.10: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) for poly(A)+ mRNA interactions with vimentin in HDF cells 
exposed to arsenite. At 0 (n=42, mean=11.1%, s.d.=8.8%), 5 (n=23, 
mean=13.9%,s.d.=6.5%), 10 (n=19, mean=18.7%, s.d.=7.5%), 20 (n=13, mean=13.3%, 
s.d.=7.1%), and 40 min (n=17, mean=5.9%, s.d.=4.4%), PLA-FMTRIP were compared 
using Kruskal-Wallis one-way ANOVA on ranks with Dunn’s method for multiple 





Table 3.11: Comparisons of the mean percentage of FMTRIP colocalized with PLA 
(PLA-FMTRIP) for poly(A)+ mRNA interactions with F-actin in HDF cells exposed 
to arsenite. At 0 (n=38, mean=49.3%, s.d.=19.4%), 5 (n=25, mean=6.0%,s.d.=5.2%), 10 
(n=21, mean=9.6%, s.d.=6.4%), 20 (n=19, mean=15.4%, s.d.=9.4%), and 40 min (n=16, 
mean=6.8%, s.d.=4.4%), PLA-FMTRIP were compared using Kruskal-Wallis one-way 
ANOVA on ranks with Dunn’s method for multiple comparison (p<0.001). (Jung, 





Materials and methods 
Flag-tagged neutravidin was synthesized by first conjugating flag tag-hyNic 
(Solulink) to neutravidin (Thermo) modified with 4FB (Solulink) using the 
manufacturer’s protocol. The concentration of flag tag-hyNic and 4FB-modified 
neutravidin were adjusted to produce a molar ratio of two flags per neutravidin. After flag 
labeling, FMTRIPs were assembled as previously described (Santangelo, Lifland et al. 
2009). Briefly, 2′-O-methyl RNA-DNA oligonucleotide chimeras were designed with a 
5′-biotin and dT-C6-NH2 internal modifications (Biosearch Technologies). Cy3B-NHS 
ester fluorophores (GE Healthcare) were conjugated to the oligonucleotide amine groups 
using the manufacturer’s protocol. Free dye was removed using 3 kDa Amicon spin 
columns (Millipore). The purified, labeled oligonucleotides were then tetramerized by 
incubation for 1 h at RT with flag-tagged neutravidin at molar ratio of 5:1. Free ligands 
were removed using 30 kDa Amicon spin columns (Millipore). The FMTRIP targeting 
different mRNA sequences (Table 3.12) were assembled separately prior to delivery. 
Neutravidin lacking the flag tag was used to assemble MTRIPs for a negative control. 
 Primary human dermal fibroblasts (Lonza, Basel, Switzerland) and A549 lung 
carcinoma cells (ATCC CCL-185) were maintained in High Glucose DMEM (Lonza) 
with 10% FBS (Hyclone), 100 U/ml penicillin (Invitrogen), and 100 µg/ml streptomycin 
(Invitrogen). Cells were plated on No. 1.5 glass coverslips (Ted Pella) one day prior to 
infection, transfection or imaging. 
 For probe delivery, cells were washed in Dulbecco’s Phosphate Buffered Saline 
(DPBS) without Ca2+ and Mg2+ (Lonza), and then incubated with 0.2 U/ml activated 
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streptolysin O (Sigma) in OptiMEM (Invitrogen) containing FMTRIP (60 nM poly(A) or 
10 nM each of 5 β-actin-targeting probes) for 10 min at 37°C. Delivery media were 
replaced with growth media for 15 min to restore membrane integrity before fixation. 
 After probe delivery and recovery, cells were fixed with either methanol or 1% 
paraformaldehyde (Electron Microscopy Science) in PBS, unless noted otherwise, for 10 
min; permeabilized using acetone for 2 min (post-methanol fixation) or 0.2% triton X-
100 (Sigma) for 5 min (post-PFA fixation); and blocked for 45 min with a modified 
blocking solution, which consists of 0.5% Tween 20 (CalBioChem), 0.1% Triton X-100, 
0.1% gelatin (Aurion), 2% donkey serum (VWR) and 1% bovine serum albumin (BSA) 
(EMD) in PBS. Cells were washed with PBS for 5 min. Then they were incubated for 30 
min at 37°C in each of two primary antibodies (Ab) diluted in 0.25% gelatin, 0.5% Triton 
X-100, 0.5% donkey serum and 1% BSA in PBS, and then corresponding 
oligonucleotide-labeled PLA probes (Olink Bioscience) diluted in 0.05% Tween-20 in 
PBS. They were washed with Duolink wash solution (Olink Bioscience) after each Ab 
incubation. The ligation and RCA reactions (Olink Bioscience) were performed as 
instructed in the manufacturer’s protocol. Then the cells were immunostained or DAPI-
stained (Invitrogen) and mounted on slides using Prolong (Invitrogen). 
 Primary Ab were mouse monoclonal anti-flag (1:500 for IF, 1:1000 for PLA, 
Sigma), rabbit polyclonal anti-flag (1:500 for IF, 1:1000 for PLA, Sigma), mouse 
monoclonal anti-β-tubulin (1:100 for IF, 1:1000 for PLA, Developmental Studies 
Hybridoma Bank), rabbit polyclonal anti-α-tubulin (1:200 for IF, 1:1500 for PLA, 
Abcam), mouse monoclonal anti-vimentin (1:50 for IF, 1:1000 for PLA, Developmental 
Studies Hybridoma Bank), rabbit anti-alexa fluor 488 (1:100 for IF, 1:2000 for PLA, 
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Molecular Probes). Rabbit polyclonal anti-flag Ab was used with mouse anti-β-tubulin 
and mouse anti-vimentin Ab. Mouse monoclonal anti-flag Ab was used with rabbit anti-
alexa fluor 488 Ab. Alexa fluor 488 Phalloidin (Molecular Probes) was used to stain actin 
fibers, which were then targeted with rabbit anti-alexa fluor 488 Ab for PLA. Goat 
polyclonal anti-nucleolin antibody (1:200 for IF, 1:500 for PLA, Santa Cruz) and mouse 
monoclonal anti-histone H1 antibody (1:200 for IF, 1:500 for PLA, Santa Cruz) were 
used as negative controls. 
 After probe delivery, cells were incubated for 90 min at 37°C in glucose free 
DMEM (Invitrogen) containing 1µM cytochalasin D (Sigma) for actin depolymerization, 
for 90 min with 4µM nocodazole (Sigma) for microtubule depolymerization, and for 4 hr 
with 6mM acrylamide (Sigma) for vimentin depolymerization (Sager 1989). For 
oxidative stress, cells were incubated for 5, 10, 20, and 40 min at 37°C in 0.5mM sodium 
arsenite. The cells were fixed after incubation. 
 Unless specified otherwise, all the images were taken using a laser scanning 
confocal microscope, Zeiss LSM 700 using a 63×, NA 1.4 Plan-Apochromat objective. 
Resolution was set to 1036 × 1036. Files were imported into Volocity and linearly 
contrast enhanced for display. Widefield images were taken on an Axiovert 200M 
microscope (Zeiss) with a 63× numerical aperture (NA) 1.4 Plan-Apochromat objective, 
and an ORCA-ER AG camera (Hamamatsu). The imaging was performed using the 
Volocity acquisition software (PerkinElmer). Image stacks were recorded at 200 nm 
intervals to adequately sample volumes for iterative deconvolution. 
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 Widefield images were deconvolved using Volocity’s deconvolution algorithms. 
Probe and PLA signal quantification were computed in Volocity and imported into Excel 
(Microsoft) or Sigma Plot (Systat) for further analysis and plotting. Images presented 
have been linearly contrast enhanced for clarity. All calculations were performed directly 
on raw, deconvolved widefield data. 
 The volume of RNA, volume of PLA-colocalized RNA, and PLA frequency/RNA 
volume were measured using Volocity. Each cell was analyzed individually as follows. 
Each cell was identified by cytoskeletal immunostaining. The RNA volume was 
determined based on the SD intensity. The PLA signal initially was identified as PLA 
objects by their SD intensity then separated into individual punctae using the “separate 
touching objects” tool. The objects were further filtered based on size and maximum 
intensity. The RNA volume colocalized with PLA signal was determined selecting the 
RNA volume with PLA fluorescence intensity greater than the minimum intensity or one 
SD intensity below the average intensity of the PLA objects detected in the cell, 
whichever value was greater. For each experiment, we analyzed at least 30 representative 
cells; experiments were repeated at least twice. In Sigma Plot, Kruskal-Wallis one-way 
ANOVA was used to compare the mean probe volume, the mean percentage of probe 
colocalized with PLA, and the mean PLA frequency. Multiple pairwise comparisons 







Table 3.12: Poly(A)+ and β-actin mRNA targeting probe sequences and 
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DETECTING HuR-mRNA INTERACTIONS USING PLA 
 The work presented here is an excerpt from Jung, J, Lifland, AW, Zurla, C, 
Alonas, EJ, Santangelo, PJ (2013). "Quantifying RNA-protein interactions in situ using 
modified-MTRIPs and proximity ligation." Nucleic Acids Res 41(1): e12. 
Background 
  Post-transcriptional processes are critical to ensure the proper gene expression in 
a cell. A myriad of RNA binding proteins and noncoding RNAs, such as micro RNAs 
(miRNAs), mediate these post-transcriptional events and are, therefore, key factors in 
modulating gene expression (Keene 2007; Cech and Steitz 2014). Highlighting the 
importance of these events, there are a growing number of examples in which the 
dysregulation of RNA binding proteins or miRNAs and, in turn, the post-transcriptional 
processing events they mediate are associated with various types of cancer (Lukong, 
Chang et al. 2008; Srikantan and Gorospe 2012; Blackinton and Keene 2014; Chan, 
Hieter et al. 2014).  
The 3′ untranslated region (UTR) of an mRNA transcript is the site of binding and 
regulation for many post-transcriptional factors. The AU-Rich Element Binding Proteins 
represent one class of RNA binding proteins that mediate their post-transcriptional 
function by binding to AU- or U-rich RNA elements (AREs) located primarily within the 
3′UTRs of target mRNAs. This protein family which includes the mRNA stability factor, 
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Human antigen R (HuR), plays a role in the post-transcriptional regulation of a number of 
biologically important mRNAs (Abdelmohsen and Gorospe 2010; Khabar 2010). 
 HuR is the ubiquitously expressed member of the embryonic lethal abnormal 
vision (ELAV) family of RNA binding proteins (Ma, Cheng et al. 1996). Two N-terminal 
RNA Recognition Motifs (RRMs) within HuR mediate recognition of AREs located 
primarily within the 3′UTR of target mRNA transcripts (Uren, Burns et al. 2011; Wang, 
Zeng et al. 2013). A third RRM in the C-terminus of HuR has affinity for polyadenosine 
RNA and is thought to bind to the poly(A) tail of target mRNAs (Abe, Sakashita et al. 
1996; Ma, Chung et al. 1997). HuR localizes to the nucleus at steady-state but can shuttle 
out of the nucleus when the cell experiences stress such as oxidative stress (Anderson and 
Kedersha 2002) or transcriptional inhibition (Fan and Steitz 1998). For the majority of 
HuR target transcripts, association with HuR in the cytoplasm leads to increased stability 
of the HuR-bound target mRNA, ultimately resulting in an increase in steady-state 
protein level (Brennan and Steitz 2001). In addition to this conventional role of HuR in 
stabilizing RNA, recent work has revealed that HuR can increase the expression of target 
transcripts without affecting their stability (Mazan-Mamczarz, Galban et al. 2003; Lal, 
Kawai et al. 2005). 
 Recent transcriptome-wide analyses of HuR binding reveal a large number of 
candidate mRNA targets that could be bound and regulated by these RNA binding 
proteins. These studies suggest HuR binding to approximately 10% of the transcriptome, 
specifically within the 3′UTRs and introns of these candidate target transcripts. Further 
analyses of these sequencing studies reveal a robust preference of HuR for U-rich 
sequences, which challenges the previously held belief that HuR is an exclusively AU-
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rich RNA binding protein. (Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 2011; 
Uren, Burns et al. 2011) Secondary structural predictions of the candidate HuR binding 
sites suggest a preference for single-stranded RNA for binding to HuR, specifically 
within the context of a loop (Lopez de Silanes, Zhan et al. 2004; Uren, Burns et al. 2011).  
 HuR is an important stabilizing RNA-binding protein that usually binds to the 
3'UTR. Its localization in the cytoplasm is important in its function and binding to the 
mRNA. It is difficult to visualize HuR-mRNA interactions and the location of these 
interactions in situ in cells using conventional biochemical assays. Here, we used flag-
tagged multiply labeled tetravalent RNA imaging probes (FMTRIPs) and proximity 
ligation assay (PLA) to image interactions between HuR and mRNAs. We examined 
poly(A)+ and β-actin mRNAs under varying levels of HuR and actinomycin D (actD) 
induced transcription inhibition. PLA successfully detected HuR-mRNA complexes with 
good specificity and sensitivity. Exogenous RNAs with and without the HuR binding site 
were used to test for the specificity of this method in detecting HuR RNA interactions in 
situ. Changes in the interactions under different levels of HuR and actD exposure 
demonstrated the sensitivity.  
HuR-mRNA interactions can be imaged and quantified by PLA 
 In order to test the specificity of proximity ligation assay (PLA) to detect 
interactions between HuR and mRNAs, HuR interactions with plasmid-derived mRNAs 
with and without HuR binding site in varying levels of HuR were studied. We used 
plasmids that encode RNAs spanning the green fluorescent protein (GFP) coding region 
and the c-Myc 3'UTR (referred to as c-Myc) with and without the HuR binding site (c-
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Myc AB and c-Myc A, respectively). The 3'UTR A segment precedes the HuR binding 
site in the B segment. (Kim, Kuwano et al. 2009) We designed RNA imaging probes to 
target three sites on the c-Myc 3'UTR A region, which are proximal to the HuR binding 
site in the B region. The probes are not complementary to any native mRNA in Vero 
cells, which were used for all the experiments. 
 In cells transfected with c-Myc A, the plasmid lacking the HuR binding site, we 
observed no PLA signal between c-Myc and HuR, as expected (Figure 4.1). To further 
test the specificity, we increased HuR by transfecting Vero cells with both c-Myc A and 
HuR-GFP. With this increased HuR, there was a small increase in the mean PLA 
frequency, likely due to increased random interactions between c-Myc and HuR. In 
contrast, c-Myc AB transfection resulted in PLA signal between c-Myc and HuR (Figure 
4.1). The difference in the mean PLA frequency between cells expressing c-Myc A or c-
Myc AB was statistically significant (p<0.001). In cells expressing both c-Myc AB and 
increased HuR via HuR-GFP co-transfection, the frequency of interactions also 
increased, similar to the increase observed in cells expressing both c-Myc A and HuR-
GFP. But the difference in the frequency of interactions between cells expressing c-Myc 
A or c-Myc AB was statistically significant (p=0.028), still. Again, the increase is 
probably due to increased non-specific interactions with increased levels of HuR. Clearly, 
PLA can accurately detect HuR interactions only with the RNA containing the HuR 
binding site. 
HuR-mRNA interactions increase with HuR overexpression and actD exposure 
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With the specificity of the PLA method established, we wanted to test how 
sensitive this method is at detecting varying levels of HuR. We examined HuR 
interactions with poly(A)+ or β-actin mRNA in HeLa cells transfected with HuR-GFP to 
overexpress HuR. After 36 hours of transfection, the cells were delivered RNA imaging 
probes and fixed after 15 minutes of recovery. Considering that different number of 
probes may bind to each mRNA, we tested whether the number of probes bound per 
mRNA affected the number of PLA punctae per mRNA. We delivered three probes 
targeting the coding region of β-actin, three targeting the 3'-UTR, or all six (Figure 4.2). 
Hence, PLA detected the occurrence of single interaction between HuR and the closest 
probe bound to β-actin mRNA; therefore, the presence of additional probes on the mRNA 
did not increase the number of detected interactions. 
In addition to the variability in transfection efficiency, which contributed to 
varying amounts of HuR, we observed cell-to-cell variability in mRNA amounts and 
HuR-mRNA interactions as measured by PLA punctae (Figure 4.3). It is important to 
note that because the difference between the nuclear and cytoplasmic concentrations of 
HuR is beyond the imageable dynamic range using immunofluorescence ((Fan and Steitz 
1998; Peng, Chen et al. 1998), the cytoplasmic HuR fraction could not be imaged without 
saturating the nuclear signal. Hence, even though HuR may not be observable in the 
photomicrographs, PLA occurred in the cytoplasm where HuR and mRNA interact due to 
the greater sensitivity of PLA.  
In order to produce meaningful statistical data, for each transfection condition, we 
analyzed only the cells expressing similar levels of nuclear HuR as measured using the 
mean IF intensity (600–1000 a.u.). It should also be noted that the concentration of 
92 
 
poly(A) FMTRIPs used (60 nM) was less than the concentration that resulted in the 
maximum intensity (90 nM). By under-sampling, we were able to label a random portion 
of the mRNA population, which facilitated the imaging of individual granules and 
detection of relative changes in HuR interactions. β-actin FMTRIPs were delivered at a 
concentration (20nM for each of three FMTRIPs) such that they bind to >80% of the β-
actin mRNA (Lifland, Zurla et al. 2011). 
First, we quantified how the mRNA signal varied under our experimental 
conditions. Under normal growth conditions, cytoplasmic mRNAs, as detected using 
poly(A) FMTRIPs, were found to be more abundant in untransfected HeLa cells than in 
the transfected ones (Figure 4.4 and Table 4.3). The large, observed standard deviation 
was likely due to the heterogeneity in the population. Whereas HuR overexpression did 
not increase the overall cytoplasmic mRNA amount, we found that it dramatically slowed 
the effect of actD in reducing mRNA number, after 30 min of exposure. (Figure 4.4; 
Table 4.3 and 4.4) ActD treatment on HuR-transfected cells had more dramatic effects 
on β-actin mRNA, both as detected by using 3'-UTR FMTRIPs and analyzed by qRT–
PCR. HuR overexpression stabilized the β-actin mRNA and increased its quantity in the 
cytoplasm, consistent with the findings by Dormoy-Raclet et al. (Dormoy-Raclet, Menard 
et al. 2007) (Figure 4.4). With 60 min exposure to actD, the β-actin mRNA decreased to 
similar levels in transfected and untransfected cells. 
In order to demonstrate the specificity and sensitivity of PLA, we compared PLA 
signal in cells containing untargeted or targeted FMTIRPs and with varying levels of 
HuR (Figure 4.5). In cells with untargeted probes, the PLA signal was minimal (Figure 
4.5). However, in HuR-GFP transfected cells with increased levels of HuR, the mean 
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PLA frequency increased to a level similar to the untransfected cells with poly(A) 
FMTRIPs, but significantly less than the HuR-GFP transfected cells delivered poly(A) 
FMTRIPs (Figure 4.5). This was likely due to increased random interactions between 
FMTRIP and HuR with a greater amount of HuR in the cytoplasm. When the HuR level 
was decreased using HuR siRNA, the PLA signal fell to a minimal level, similar to the 
untransfected cells containing untargeted probes (Figure 4.5). In contrast, in cells 
transfected with a control siRNA that had no effect on HuR, the mean PLA frequency 
was similar to that of the untransfected cells delivered poly(A) FMTRIPs (Figure 4.5). 
Here, we showed that PLA specifically detected interactions between the poly(A)+ 
mRNA and HuR. The mean PLA frequency quantifiably demonstrated changes in the 
frequency of interactions between mRNA and HuR, as the amount of HuR decreased and 
increased. 
Next, given that actD exposure has been shown to increase HuR binding to 
mRNA in the cytoplasm (Peng, Chen et al. 1998), we quantified the HuR–mRNA 
interactions via PLA but selected cells with a similar range of FMTRIP signal volume 
(poly(A), 60 ± 40 µm3; β-actin, 160 ± 90 µm3). The mean PLA frequency increased with 
HuR overexpression and longer exposure to actD (Figure 4.5). Specifically, in 
transfected cells and in the absence of actD, the frequency of HuR interactions increased 
99% with poly(A)+ mRNA (Figure 4.5) and 255% with β-actin mRNA (Figure 4.6) 
greater than in untransfected cells. In transfected cells and in the presence of actD, the 
frequency of HuR interactions increased 184% with poly(A)+ mRNA (Figure 4.5) and 
250% with β-actin mRNA (Figure 4.6). No PLA was observed in transfected, MTRIP-
delivered (no flag tag) cells (Figure 4.5). Although these changes in mRNA stability and 
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interactions resulting from changes in HuR localization may seem less than those 
reported using UV-cross-linking (Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 
2011) and gel shift assay (Peng, Chen et al. 1998), our findings show changes in 
individual cells, not in cell lysates.  
Conclusion 
 We imaged and quantified interactions between poly(A)+ mRNA (Zurla, Lifland 
et al. 2011) or β-actin mRNA (Lifland, Zurla et al. 2011) and an RBP, HuR, whose 
interactions with mRNAs have been implicated in tumorigenesis (Yeap, Voon et al. 2002; 
Mazan-Mamczarz, Galban et al. 2003; Lal, Kawai et al. 2005). HuR binds to the poly(A) 
tail (Ma, Chung et al. 1997) and the 3'UTR of many genes, including β-actin (Misquitta, 
Iyer et al. 2001; Dormoy-Raclet, Menard et al. 2007; Lopez de Silanes, Quesada et al. 
2007). Although predominately within the nucleus, HuR has been shown to shuttle 
between the nucleus and the cytoplasm through its nucleocytoplasmic shuttling domain, 
when cells are exposed to specific stimuli, such as actD (Fan and Steitz 1998). Although 
we observed cell-to-cell variability in the amount of HuR and mRNA, as well as in the 
frequency of their interactions, HuR–mRNA interactions generally increased as the 
amount of HuR increased in the cytoplasm, whereas the amount of mRNA decreased 
with actD exposure. One clear advantage of this methodology is that it allowed us to 
quantify the cell-to-cell variability in RNA expression and interactions simultaneously, 
which is challenging with other methods, such as biochemical assays and imaging 
methods. 
 With normal HuR regulation of mRNAs disrupted in various cancer types 
(Mazan-Mamczarz, Galban et al. 2003; Abdelmohsen and Gorospe 2010; Blackinton and 
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Keene 2014), applying this method to investigate changes in HuR interactions in 
cancerous cells and tissues may offer numerous advantages. For example, a deeper 
understanding of gene expression can be gained from examining changes in RBP and 
mRNA interactions in both space and time on a per cell basis (Pelkmans 2012). 
Addressing this challenge can be difficult with conventional biochemical methods and 
imaging tools (Welch, Elliott et al. 2011). Although an averaged view of the interaction 
network may provide valuable information, the spatiotemporal and cell-to-cell variation 
of RNA–protein interactions are important for investigating their role in a variety of 
cellular events, such as identifying oncogenic, aberrant RNA–protein interactions that 
precede the synthesis of cancer-causing proteins among a heterogeneous population of 
cancerous and healthy cells.  
The FMTRIP-based PLA method is a powerful tool that meets this challenge. It 
provides accurate, easily detectable, quantifiable spatiotemporal information from which 
causal inference and hypothesis-driven statistics can be derived about the post-
transcriptional regulation of RNA. This technique allows collection of large, high-
throughput data that are necessary for mapping the RNA–protein interactome in situ and 
for rapid identification of interactions between a series of RNA sequences and their 
potential RBPs. It has potential to serve as a valuable diagnostic tool for disorders 







Figure 4.1: Imaging and quantification of PLA between HuR and c-Myc 3′-UTR 
mRNA containing the HuR-binding site (c-Myc AB) or lacking it (c-Myc A) in Vero 
cells with varying levels of HuR. (A) GFP IF, c-Myc 3′-UTR mRNA, PLA between c-
Myc 3′-UTR and HuR were imaged in untransfected and HuR-GFP transfected Vero cells 
co-transfected with either GFP-c-Myc A or GFP-c-Myc AB. Merged images of GFP IF 
(blue), c-Myc 3′-UTR mRNA (red) and PLA (green) are shown. All the images were 
deconvolved, except for GFP and PLA. All image planes are represented. Scale bar: 5 
µm. (B) The mean PLA frequency was minimal in cells transfected with c-Myc A, 
lacking the HuR-binding site. It was significantly greater in the presence of HuR-binding 
site with c-Myc AB transfection. (Table 4.1 for two-way ANOVA with Holm–Sidak 
method and Table 4.2 for Kruskal–Wallis one-way ANOVA with Dunn’s method for 
multiple comparisons) Error bars, SD. (Jung, Lifland et al. 2013) 
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Table 4.1: Comparisons of the mean PLA frequency detecting interactions between 
c-Myc and HuR in Vero cells with varying HuR levels using two-way ANOVA with 
Holm-Sidak method. There was no significant interaction between HuR and c-Myc 
transfection (p=0.210). (HuR-GFP Untransfected: c-Myc A, n = 15, mean = 0.00, s.d. = 
0.00; c-Myc AB, n = 19, mean = 0.39, s.d. = 0.21; HuR-GFP Transfected: c-Myc A, n = 
12, mean = 0.04, s.d. = 0.04; c-Myc AB, n = 15, mean = 0.53, s.d. = 0.20). (Jung, Lifland 
et al. 2013) 
Comparison P P<0.05 
c-Myc A vs c-Myc AB <0.001 Yes 







Table 4.2: Comparisons of the mean PLA frequency detecting interactions between 
c-Myc and HuR in Vero cells with varying HuR levels using Kruskal-Wallis one-way 
ANOVA with Dunn’s method for multiple comparisons. (HuR-GFP Untransfected: c-
Myc A, n = 15, mean = 0.00, s.d. = 0.00; c-Myc AB, n = 19, mean = 0.39, s.d. = 0.21; 
HuR-GFP Transfected: c-Myc A, n = 12, mean = 0.04, s.d. = 0.04; c-Myc AB, n = 15, 
mean = 0.53, s.d. = 0.20) (Jung, Lifland et al. 2013) 
Comparison Diff of Ranks Q P<0.05 
c-Myc A vs c-Myc AB 30.2 3.6 Yes 
HuR-GFP, c-Myc A vs HuR-GFP c-Myc 
AB 
30.9 4.5 Yes 
c-Myc A vs HuR-GFP, c-Myc A 6.8 1.0 No 
c-Myc A vs HuR-GFP, c-Myc AB 37.7 5.8 Yes 
c-Myc AB vs HuR-GFP, c-Myc A 23.5 3.6 Yes 






Figure 4.2: Quantification of the mean HuR-βactin PLA frequency in cells delivered 
FMTRIPs targeting the coding region of β-actin, its 3′UTR or both. Three FMTRIPs 
targeting the coding regions and three targeting 3′UTR were used. All six were used to 
detect both. No significant difference was observed with varying number of FMTRIPs 
(p=0.3, Kruskal-Wallis one-way ANOVA on ranks) (Coding region+3’UTR: n=14, 
mean=0.03, s.d.= 0.01; Coding region: n=12, mean=0.04, s.d.=0.03; 3′UTR: n=14, 




Figure 4.3: Imaging and quantification of cell-to-cell variability in HuR interactions 
with poly(A). HuR IF, poly(A)+ mRNA, PLA between poly(A) and HuR were imaged 
in transfected HeLa cells with the mean HuR IF intensity and volume within 1 s.d. 
after 0 and 60 min Actinomycin D (actD) exposure. Those with the minimum (min), 
mean and maximum (max) PLA frequency imaged using a widefield microscope are 
shown. Merged images of vimentin IF (white), poly(A)+ mRNA (red), PLA (green) and 
HuR IF (blue) are shown. All the images were deconvolved, except for HuR and 






Figure 4.4: Imaging and quantification of cell-to-cell variability in poly(A)+ and β-
actin mRNA. (A) HuR IF, poly(A)+ mRNA, PLA between poly(A) and HuR were 
imaged in transfected HeLa cells with the mean HuR IF intensity and volume within 1 
SD after 0 and 60 min actD exposure. Those with the minimum (min), mean and 
maximum (max) mRNA volume and PLA frequency imaged using a widefield 
microscope are shown. Merged images of vimentin IF (white), poly(A)+ mRNA (red), 
PLA (green) and HuR IF (blue) are shown. All the images were deconvolved, except for 
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HuR and vimentin IF. All image planes are represented. Scale bar, 5 µm. (B) Comparison 
of the mean normalized poly(A) FMTRIP volume in HuR-GFP transfected and 
untransfected HeLa cells exposed to actD for 0–60 min. The values were normalized to 
the mean of untransfected cells with 0 min actD exposure. FMTRIP volume decreased 
with longer actD (5 µg/ml) exposure. (Table 4.3-4.5 for two-way ANOVA with Holm–
Sidak method) (C) Comparison of the mean normalized β-actin 3′-UTR FMTRIP volume 
in HuR-GFP transfected and untransfected HeLa cells exposed to actD for 0 and 60 min. 
The values were normalized to the mean of untransfected cells with 0 min actD exposure. 
Generally, FMTRIP volume decreased with longer actD exposure. Without actD, the 
mean FMTRIP volume in transfected cells was significantly greater than that of 
untransfected cells. (Tables 4.6-4.8 for two-way ANOVA with Holm–Sidak method) (D) 
Comparison of the RQ of β-actin cytoplasmic mRNA determined using qRT–PCR of 
RNA collected from HuR-GFP transfected and untransfected HeLa cells exposed to actD 
for 0 and 60 min. (Tables 4.9-4.11 for two-way ANOVA with Bonferroni post-hoc 




Table 4.3: Comparisons of the mean normalized poly(A) FMTRIP volume between 
untransfected and transfected HeLa cells at each actD exposure time from 0 to 60 
min using two-way ANOVA Holm-Sidak method (Untransfected: 0 min, n = 36, mean 
= 1.0, s.d. = 0.6; 0.5 min, n = 33, mean = 0.8, s.d. = 0.2; 30 min, n = 35, mean = 0.4, s.d. 
= 0.2; 60 min, n = 33, mean = 0.4, s.d. = 0.2; Transfected: 0 min, n = 70, mean = 0.6, s.d. 
= 0.3; 0.5 min, n = 70, mean = 0.7, s.d. = 0.3; 30 min, n = 29, mean = 0.5, s.d. = 0.3; 60 
min, n = 41, mean = 0.3, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Actinomycin D 
Exposure (min) 
Comparison P P<0.05 
0 Untransfected vs Transfected <0.001 Yes 
0.5 Untransfected vs Transfected 0.056 No 
30 Untransfected vs Transfected 0.027 Yes 





Table 4.4: Comparisons of the mean normalized poly(A) FMTRIP volume in 
untransfected HeLa cells between different actD exposure times from 0 to 60 min 
using two-way ANOVA Holm-Sidak method (Untransfected: 0 min, n = 36, mean = 
1.0, s.d. = 0.6; 0.5 min, n = 33, mean = 0.8, s.d. = 0.2; 30 min, n = 35, mean = 0.4, s.d. = 
0.2; 60 min, n = 33, mean = 0.4, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 
60 min vs 0 min <0.001 Yes 
60 min vs 0.5 min <0.001 Yes 
60 min vs 30 min 0.864 No 
30 min vs 0.5 min <0.001 Yes 
30 min vs 0 min <0.001 Yes 





Table 4.5: Comparisons of the mean normalized poly(A) FMTRIP volume in 
transfected HeLa cells between different actD exposure times from 0 to 60 min using 
two-way ANOVA Holm-Sidak method (Transfected: 0 min, n = 70, mean = 0.6, s.d. = 
0.3; 0.5 min, n = 70, mean = 0.7, s.d. = 0.3; 30 min, n = 29, mean = 0.5, s.d. = 0.3; 60 
min, n = 41, mean = 0.3, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 
60 min vs 0 min <0.001 Yes 
60 min vs 0.5 min <0.001 Yes 
60 min vs 30 min 0.010 Yes 
30 min vs 0.5 min 0.243 No 
30 min vs 0 min 0.576 No 





Table 4.6: Comparisons of the mean β-actin 3′UTR FMTRIP volume between 
untransfected and transfected HeLa cells at 0 and 60 min actD exposure using two-
way ANOVA Holm-Sidak method (Untransfected: 0 min, n = 24, mean = 1.0, s.d. = 
1.3; 60 min, n = 33, mean = 0.4, s.d. = 0.2; Transfected: 0 min, n = 19, mean = 14.4, s.d. 
= 14.4; 60 min, n = 25, mean = 0.3, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Actinomycin D 
Exposure (min) 
Comparison P P<0.05 
0 Untransfected vs Transfected <0.001 Yes 





Table 4.7: Comparisons of the mean β-actin 3′UTR FMTRIP volume in 
untransfected HeLa cells between 0 and 60 min actD exposure using two-way 
ANOVA Holm-Sidak method (Untransfected: 0 min, n = 24, mean = 1.0, s.d. = 1.3; 60 
min, n = 33, mean = 0.4, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 





Table 4.8: Comparisons of the mean β-actin 3′UTR FMTRIP volume in transfected 
HeLa cells between 0 and 60 min actD exposure using two-way ANOVA Holm-
Sidak method (Transfected: 0 min, n = 19, mean = 14.4, s.d. = 14.4; 60 min, n = 25, 
mean = 0.3, s.d. = 0.2). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 





Table 4.9: Comparisons of the mean normalized β-actin cytoplasmic mRNA 
threshold cycle (ΔCT) between untransfected and transfected HeLa cells at 0 and 60 
min actD exposure using two-way ANOVA with Bonferroni post-hoc test. (Jung, 
Lifland et al. 2013) 
Actinomycin D 
Exposure (min) 
Comparison P P<0.05 
0 Untransfected vs Transfected 0.1107 No 





Table 4.10: Comparisons of the mean normalized β-actin cytoplasmic mRNA 
threshold cycle (ΔCT) in untransfected HeLa cells between 0 and 60 min actD 
exposure using two-way ANOVA with Bonferroni post-hoc test. (Jung, Lifland et al. 
2013) 
Comparison P P<0.05 





Table 4.11: Comparisons of the mean normalized β-actin cytoplasmic mRNA ΔCT in 
transfected HeLa cells between 0 and 60 min actD exposure using two-way ANOVA 
with Bonferroni post-hoc test. (Jung, Lifland et al. 2013) 
Comparison P P<0.05 






Figure 4.5: Imaging and quantification of interactions between HuR and poly(A)+ 
mRNA in HuR-GFP transfected and untransfected HeLa cells exposed to actD for 
0–60 min. (A) HuR IF, poly(A)+ mRNA, PLA between Poly(A) and HuR were imaged 
in untransfected and transfected HeLa cells exposed to actD for 0 and 60 min, using a 
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laser-scanning confocal microscope. Untagged-MTRIP delivered transfected cells after 
60 min actD exposure are shown as a negative control. Merged images of vimentin IF 
(white), poly(A)+ mRNA (red), PLA (green) and HuR IF (blue) are shown. All image 
planes are represented. Scale bar, 5 µm. (B) The mean HuR-poly(A) PLA frequency in 
HeLa cells transfected with 200 nM HuR siRNA (Transfection = HuR siRNA, MTRIP = 
PA) was minimal, whereas it was similar in cells transfected with 200 nM control siRNA 
(Transfection = control siRNA, MTRIP = PA) and the untransfected cells (Transfection = 
No, MTRIP = PA). In cell-delivered untargeted MTRIPs (UT), the mean HuR-UT PLA 
frequency (Transfection = No, MTRIP = UT) was minimal. With HuR-GFP transfection 
(Transfection = HuR-GFP, MTRIP = UT), it increased but remained less than the mean 
HuR-poly(A) PLA frequency of untransfected (Transfection = No, MTRIP = PA) and 
transfected (Transfection = HuR-GFP, MTRIP = PA) cells. (Tables 4.12-4.16) (C) The 
mean HuR-poly(A) PLA frequency increased with longer exposure to actD (5 µg/ml) in 
untransfected and transfected HeLa cells. (Tables 4.17-4.19 for two-way ANOVA with 




Table 4.12: Comparison between the mean HuR-poly(A) and HuR-untargeted 
FMTRIP PLA frequency in untransfected and transfected HeLa cells using two-way 
ANOVA Holm-Sidak method. (Jung, Lifland et al. 2013) 
Transfection Comparison P P<0.05 
Untransfected HuR-poly(A) vs HuR-untargeted 0.02 Yes 





Table 4.13: Comparison of the mean HuR-poly(A) or HuR-untargeted FMTRIP 
PLA frequency between untransfected and HuR-GFP transfected HeLa cells using 
two-way ANOVA Holm-Sidak method. (Jung, Lifland et al. 2013) 
PLA Comparison P P<0.05 
HuR-poly(A) Untransfected vs HuR-GFP 
Transfected 
<0.001 Yes 







Table 4.14: Comparison of the mean HuR-poly(A) or HuR-untargeted FMTRIP 
PLA frequency between untransfected and HuR-GFP transfected HeLa cells using 
Kruskal-Wallis one-way ANOVA on ranks with Dunn’s method for multiple 
comparisons. (Jung, Lifland et al. 2013) 
Comparison Diff of 
Ranks 
Q P<0.05 
HuR-GFP, poly(A) vs Untransfected, untargeted 45.5 6.4 Yes 
HuR-GFP, poly(A) vs HuR-GFP, untargeted 38.4 5.4 Yes 
HuR-GFP, poly(A) vs Untransfected, poly(A) 22.5 3.8 Yes 
Untransfected, poly(A) vs Untransfected, untargeted 23.0 3.3 Yes 
Untransfected, poly(A) vs HuR-GFP, untargeted 15.9 2.3 No 
Transfected, untargeted vs Untransfected, 
untargeted 





Table 4.15: Comparisons of the mean HuR-poly(A) PLA frequency at varying HuR 
levels in HeLa cells using Kruskal-Wallis one-way ANOVA on ranks with Dunn’s 
method for multiple comparisons. (Jung, Lifland et al. 2013) 
Comparison Diff of 
Ranks 
Q P<0.05 
HuR-GFP (↑ HuR) vs HuR siRNA (↓ HuR) 61.6 8.1 Yes 
HuR-GFP (↑ HuR) vs Untransfected 34.3 4.7 Yes 
HuR-GFP (↑ HuR) vs Control siRNA 24.0 3.1 Yes 
Untransfected vs HuR siRNA (↓ HuR) 27.3 3.6 Yes 
Control siRNA vs HuR siRNA (↓ HuR) 37.7 4.9 Yes 





Table 4.16: Comparisons of the mean HuR-poly(A) or HuR-untargeted FMTRIP 
PLA frequency at varying HuR levels in HeLa cells using two-way ANOVA Holm-
Sidak method. (Jung, Lifland et al. 2013) 
Comparison P P<0.05 
HuR-poly(A) vs HuR-untargeted <0.001 Yes 
HuR-GFP (↑ HuR) vs HuR siRNA (↓ HuR) <0.001 Yes 
HuR-GFP (↑ HuR) vs Untransfected <0.001 Yes 
HuR-GFP (↑ HuR) vs Control siRNA <0.001 Yes 
Untransfected vs HuR siRNA (↓ HuR) <0.001 Yes 
Control siRNA vs HuR siRNA (↓ HuR) 0.001 Yes 





Table 4.17: Comparisons of the mean HuR-poly(A) PLA frequency between 
untransfected and transfected HeLa cells at each actD exposure time from 0 to 60 
min using two-way ANOVA Holm-Sidak method (Untransfected: 0 min, n=23, 
mean=0.05, s.d.=0.04, 0.5 min, n=22, mean=0.05, s.d.=0.03, 30 min, n=21, mean=0.08, 
s.d.=0.05, 60 min, n=20, mean=0.50, s.d.=0.19; Transfected:  0 min, n=23, mean=0.21, 
s.d.=0.09, 0.5 min, n=26, mean=0.58, s.d.=0.09, 30 min, n=21, mean=1.66, s.d.=1.0, 60 
min, n=32, mean=2.06, s.d.=0.81). (Jung, Lifland et al. 2013) 
Actinomycin D 
Exposure (min) 
Comparison P P<0.05 
0 Untransfected vs Transfected 0.275 No 
0.5 Untransfected vs Transfected <0.001 Yes 
30 Untransfected vs Transfected <0.001 Yes 





Table 4.18: Comparisons of the mean HuR-poly(A) PLA frequency in untransfected 
HeLa cells between 0, 0.5, 30 and 60 min actD exposure using two-way ANOVA 
Holm-Sidak method (Untransfected: 0 min, n=23, mean=0.05, s.d.=0.04, 0.5 min, n=22, 
mean=0.05, s.d.=0.03, 30 min, n=21, mean=0.08, s.d.=0.05, 60 min, n=20, mean=0.50, 
s.d.=0.19). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 
60 min vs 0 min 0.031 Yes 
60 min vs 0.5 min 0.028 Yes 
60 min vs 30 min 0.039 Yes 
30 min vs 0.5 min 0.998 No 
30 min vs 0 min 0.983 No 





Table 4.19: Comparisons of the mean HuR-poly(A) PLA frequency in transfected 
HeLa cells between 0, 0.5, 30 and 60 min actD exposure using two-way ANOVA 
Holm-Sidak method (Transfected:  0 min, n=23, mean=0.21, s.d.=0.09, 0.5 min, n=26, 
mean=0.58, s.d.=0.09, 30 min, n=21, mean=1.66, s.d.=1.0, 60 min, n=32, mean=2.06, 
s.d.=0.81). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 
60 min vs 0 min <0.001 Yes 
60 min vs 0.5 min <0.001 Yes 
60 min vs 30 min <0.001 Yes 
30 min vs 0.5 min <0.001 Yes 
30 min vs 0 min 0.007 Yes 






Figure 4.6: Imaging and quantification of interactions between HuR and β-actin 3′-
UTR in HuR-GFP transfected and untransfected HeLa cells exposed to actD for 0 
and 60 min. (A) HuR IF, β-actin mRNA and PLA between β-actin 3′-UTR and HuR 
were imaged in untransfected and transfected HeLa cells exposed to actD for 0 and 60 
min, using a widefield microscope. Merged images of vimentin IF (white), β-actin 
mRNA (red), PLA (green) and HuR IF (blue) are shown. The images have been 
deconvolved, except for HuR and vimentin IF. Scale bar, 5 μm. (B) The mean HuR-β-
actin 3′-UTR PLA frequency increased with longer exposure to actD in untransfected and 
transfected HeLa cells (Tables 4.20-4.22 for two-way ANOVA test with Holm–Sidak 
method) Error bars, SD. (Jung, Lifland et al. 2013) 
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Table 4.20: Comparisons of the mean HuR-β-actin 3′UTR PLA frequency between 
untransfected and transfected HeLa cells at 0 and 60 min actD exposure using two-
way ANOVA Holm-Sidak method (Untransfected: 0 min, n=24, mean=0.008, 
s.d.=0.018, 60 min, n=27, mean=0.100, s.d.=0.052; Transfected:  0 min, n=19, 




Comparison P P<0.05 
0 Untransfected vs Transfected 0.858 No 





Table 4.21: Comparisons of the mean HuR-β-actin 3′UTR PLA frequency in 
untransfected HeLa cells between 0 and 60 min actD exposure using two-way 
ANOVA Holm-Sidak method (Untransfected: 0 min, n=24, mean=0.008, s.d.=0.018, 60 
min, n=27, mean=0.100, s.d.=0.052). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 





Table 4.22: Comparisons of the mean HuR-β-actin 3′UTR PLA frequency in 
untransfected HeLa cells between 0 and 60 min actD exposure using two-way 
ANOVA Holm-Sidak method (Transfected:  0 min, n=19, mean=0.017, s.d.=0.020, 60 
min, n=23, mean=0.755, s.d.=0.308). (Jung, Lifland et al. 2013) 
Comparison P P<0.05 


















Materials and methods 
Flag-tagged neutravidin was synthesized by first conjugating flag tag-hyNic 
(Solulink) to neutravidin (Thermo) modified with 4FB (Solulink) using the 
manufacturer’s protocol. The concentration of flag tag-hyNic and 4FB-modified 
neutravidin were adjusted to produce molar ratio (MR) of 1-2 flag/neutravidin. After flag 
labelling, FMTRIPs were assembled as previously described (Santangelo, Lifland et al. 
2009). Briefly, 2′-O-methyl RNA–DNA oligonucleotide chimeras were designed with a 
5′-biotin and dT-C6-NH2 internal modifications (Biosearch Technologies). Cy3B-NHS 
ester fluorophores (GE Healthcare) were conjugated to the oligonucleotide amine groups 
using the manufacturer’s protocol. Free dye was removed using 3 kD Amicon spin 
columns (Millipore). The purified, labelled oligonucleotides were then tetramerized by 
incubation for 1 h at RT with flag-tagged neutravidin at molar ratio of 5:1. The FMTRIP 
targeting different mRNA sequences (Table 4.23) were assembled separately prior to 
delivery. Each neutravidin, tetramerized oligonucleotides that target the same sequence. 
For example, in order to deliver 20 nM FMTRIP for each of three targets in β-actin 3′-
UTR, 20 nM FMTRIP was incubated with 100 nM fluorophore-labelled oligonucleotide 
that encodes one of three sequences. Free ligands were removed using 30 kD Amicon 
spin columns (Millipore). Three 20 nM FMTRIP, each neutravidin bound to four of the 
same oligonucleotide sequences, were combined to form a 60 nM FMTRIP mixture. 
HeLa cells (ATCC CCL-2) were maintained in High Glucose Dulbecco’s 
modified Eagle’s medium (DMEM) (Lonza) with 10% FBS (Hyclone), 100 U/ml 
penicillin (Invitrogen) and 100 µg/ml streptomycin (Invitrogen). Cells were plated on No 
1.5 glass coverslips (Ted Pella) 1 day prior to infection, transfection or imaging. 
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Cells were transfected using Lipofectamine 2000 Transfection Reagent 
(Invitrogen) according to the manufacturer’s protocol. For each well in a 24-well plate, 
Vero cells were transfected with 1.0 µg of N-GFP plasmid (a gift from Dr James E. 
Crowe Jr, Vanderbilt Univ.) and 2 µl Lipofectamine 2000. After 36 h of transfection, 
FMTRIPs were delivered into cells. For experiments using c-Myc 3′-UTR plasmids, Vero 
cells were transfected with 0.8 µg GFP-c-Myc plasmid and 1.6 µl Lipofectamine 2000, 
and 0.4 µg of HuR-GFP plasmid and 0.8 µl Lipofectamine 2000 (the plasmids were gifts 
from Dr Myriam Gorospe, NIH/NIA). After 48 h of transfection, FMTRIPs were 
delivered into cells. HeLa cells were transfected with 0.4 µg of HuR-GFP plasmid (a gift 
from Dr Myriam Gorospe, NIH/NIA) and 0.8 µl Lipofectamine 2000. After 36 h of 
transfection, FMTRIPs were delivered into cells. For siRNA transfections, HeLa cells 
were transfected with 200 nM On-TARGETplus Non-targeting siRNA #1 or On-
TARGET SMARTpool HuR siRNA (Thermo Scientific Dharmacon) and 1 µl 
Lipofectamine 2000. After 48 h of transfection, FMTRIPs were delivered into cells. 
For probe delivery, cells were washed in Dulbecco’s phosphate buffered saline 
(DPBS) without Ca2+and Mg2+ (Lonza), and then incubated with 0.2 U/ml activated SLO 
(Sigma) in OptiMEM (Invitrogen) containing FMTRIP [30nM, 60 nM or 20nM flag-
tagged neutravidin targeted to hRSV, poly(A) or each of 3 β-actin 3′-UTR, respectively] 
for 10 min at 37°C. Delivery media were replaced with growth media for 15 min to 
restore membrane integrity before actD exposure or fixation. For studying hRSV 
infection, FMTRIPs with a 1 flag MR were used, unless otherwise specified. For 
experiments investigating HuR–mRNA interactions in HeLa cells, FMTRIPs with a 2 
MR were used to maximize the signal. 
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Cells were incubated for 0.5, 30 and 60 min at 37°C with 5 µg/ml actD (Sigma) in 
growth medium and fixed at the end of exposure. 
After probe delivery and recovery, cells were fixed with 1% paraformaldehyde 
(Electron Microscopy Science) in PBS for 10 min, permeabilized using 0.2% Triton X-
100 (Sigma) for 5 min and blocked for 1 h with the standard Duolink II blocking solution 
(Olink Bioscience) or a modified blocking solution, which consists of 0.5% Tween-20 
(CalBioChem), 0.1% Triton X-100, 0.1% gelatin (Aurion), 2% donkey serum (VWR) and 
1% bovine serum albumin (BSA) (EMD) in PBS. Cells were washed with PBS for 5 min. 
Then they were incubated for 30 min at 37°C in each of two primary antibodies (Ab) 
diluted in 0.25% gelatin, 0.5% Triton X-100, 0.5% donkey serum and 1% BSA in PBS 
and then corresponding oligonucleotide-labelled PLA probes (Olink Bioscience) diluted 
in 0.05% Tween-20 in PBS. They were washed with Duolink wash solution (Olink 
Bioscience) after each Ab incubation. The ligation and RCA reactions (Olink Bioscience) 
were performed as instructed in the manufacturer’s protocol. Then the cells were 
immunostained or DAPI-stained (Invitrogen) and mounted on slides using Prolong 
(Invitrogen). 
Primary antibodies used were mouse monoclonal anti-flag (1:500 for 
immunofluorescence (IF), 1:1000 for PLA, Sigma), rabbit polyclonal anti-flag (1:500 for 
IF, 1:1000 for PLA, Sigma), mouse monoclonal anti-HuR 3A2 (1:6000 for PLA, Santa 
Cruz), mouse monoclonal anti-HuR 19F12 (1:200 for IF, Santa Cruz) and mouse 
monoclonal anti-vimentin (1:50 for IF, Developmental Studies Hybridoma Bank). Rabbit 
polyclonal anti-flag Ab (Sigma) was used unless otherwise specified. 
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Unless specified otherwise, all the images were taken using a laser scanning 
confocal microscope, Zeiss LSM 510 Meta using a 63×, NA 1.4 Plan-Apochromat 
objective. Resolution was set to 1024 × 1024. Files were imported into Volocity and 
linearly contrast enhanced for display. Widefield images were taken on an Axiovert 200 
M microscope (Zeiss) with a 63× numerical aperture (NA) 1.4 Plan-Apochromat 
objective, and an ORCA-ER AG camera (Hamamatsu). The imaging was performed 
using the Volocity acquisition software (PerkinElmer). Image stacks were recorded at 
200 nm intervals to adequately sample volumes for iterative deconvolution. 
Widefield images were deconvolved using Volocity’s deconvolution algorithms. 
FMTRIP and PLA signal quantification, intensity quantification, as well as Mander’s and 
Pearson’s coefficients were computed in Volocity and imported into Excel (Microsoft) or 
Sigma Plot (Systat) for further analysis and plotting. Images presented have been linearly 
contrast enhanced for clarity. All calculations were performed directly on raw, 
deconvolved widefield data or raw confocal data. 
The volume of RNA and the PLA frequency/RNA volume were measured using 
Volocity. Each cell was analysed individually as follows. Each cell was identified by 
MTRIP signal or vimentin immunostaining. The RNA volume was determined based on 
the SD intensity. The PLA signal initially was identified as PLA objects by their SD 
intensity, then separated into individual punctae using the ‘separate touching objects’ 
tool. The objects were further filtered based on size and maximum intensity. For each 
experiment, we analysed at least 30 representative cells; experiments were repeated at 
least twice. In Sigma Plot, Mann–Whitney rank sum test was used to compare FMTRIP 
volume and the Pearson’s and Manders’ coefficients; one-way and two-way ANOVA 
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statistical tests were performed to compare PLA frequency. For one-way ANOVA test, 
multiple pairwise comparisons were performed with Dunn’s method for unequal number 
of samples and Tukey method for equal number of samples. For two-way ANOVA test, 
multiple pairwise comparisons were performed with Holm–Sidak. 
HeLa cells were grown on six-well plates and transfected as described with 2 µg 
of HuR-GFP plasmid per well. After 36 h post-transfection, they were exposed to actD. 
At the end of the exposure, total RNA was extracted at the indicated time points using the 
PARIS kit (Ambion). Total RNA was quantified via UV-VIS spectroscopy. A quantity of 
1 µg total RNA was used for cDNA synthesis using the RT2 first strand kit (SA 
biosciences) according to the manufacturer’s instructions. About 1 µl of the product then 
was used for Quantitative reverse transcriptase polymerase chain reaction (qRT–PCR) 
using the Real-time RT2 qPCR primer assay (SYBR green) in the presence of gene-
specific primers for ACTB and 18S rRNA (SA Biosciences). qRT–PCR was performed 
with three replicates using ABI StepOnePlus real-time PCR system (Applied 
Biosciences). The relative quantification (RQ) of gene expression and comparative 
threshold cycle (CT) values were obtained using an ABI StepOnePlus real-time PCR 
system. The values were compared with the untransfected cells with no actD exposure. 
Here, 18S rRNA was used as the internal control (Student’s t-test: P = 0.0995). These 
values and their summary statistics were used to compare the effects of actD exposure in 
the transfected and untransfected groups (Schmittgen and Livak 2008). Two-way 
ANOVA test was performed using the summary statistics provided, and the Bonferroni 




Table 4.23: FMTRIP sequences and modifications. (Jung, Lifland et al. 2013) 
Target Ligand Location within 
transcript 































 Boldface: 2′-O-Methyl RNA; X: dT-C6-NH2; all 
others are DNA;  
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POST-TRANSCRIPTIONAL REGULATION OF PDCD4 mRNA BY 
HuR AND TIA1 
 This work has been adapted from Wigington, CP*, Jung, J*, Rye, EA, Belauret, 
SL, Philpot, AM, Santangelo, PJ, Corbett, AH (2014). “Post-transcriptional regulation of 
programmed cell death 4 (PDCD4) mRNA by the RNA binding proteins human antigen 
R (HuR) and T-cell intracellular antigen 1 (TIA1).” J Biol Chem, Under revision. *These 
authors contributed equally to this work. 
Background 
 The 3′ untranslated region (3'UTR) of an mRNA transcript is the site of binding 
and regulation for many post-transcriptional factors. The AU-Rich Element Binding 
Proteins are RNA binding proteins (RBP) that bind to the AU- or U-rich RNA elements 
(AREs) in the 3′UTRs of target mRNAs and regulate them. This family of proteins 
include human antigen R (HuR), and T-cell Intracellular Antigen 1 (TIA1) and regulate 
the expression of numerous mRNAs (Dixon, Balch et al. 2003; Abdelmohsen and 
Gorospe 2010; Subramaniam, Ooi et al. 2010).  
 mRNAs bound to HuR in the cytoplasm usually have greater stability and 
increased translation (Brennan and Steitz 2001). However, HuR can also increase the 
expression of target transcripts without affecting their stability (Mazan-Mamczarz, 
Galban et al. 2003; Lal, Kawai et al. 2005) possibly via coordinating with translational 
repressors, such as TIA1 (Kawai, Lal et al. 2006). TIA1 generally inhibits the translation 
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(Forch and Valcarcel 2001). TIA1 contains three tandem RRMs at the N-terminus of the 
protein followed by a glutamine-rich C-terminal domain (Kawakami, Tian et al. 1992). 
RRM2 of TIA1 has specificity for U-rich RNA and allows for high affinity binding to the 
intronic and 3′UTR regions (Dember, Kim et al. 1996; Wang, Kayikci et al. 2010). TIA1 
is present in both the nucleus and the cytoplasm and can shuttle between the two 
compartments (Kedersha, Cho et al. 2000; Zhang, Delestienne et al. 2005). Similar to 
HuR, TIA1 localization shifts toward the cytoplasm upon oxidative stress and 
transcriptional inhibition (Zhang, Delestienne et al. 2005). During oxidative stress, TIA1 
binding to the 3′UTR of target mRNAs promotes the compartmentalization of 
translationally incompetent preinitiation complexes into stress granules, resulting in 
translational repression (Anderson and Kedersha 2002).  
Transcriptome-wide analyses of both HuR and TIA1 binding reveal a variety of 
mRNAs that can bind to these RBPs (Wang, Kayikci et al. 2010; Kishore, Jaskiewicz et 
al. 2011; Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 2011; Uren, Burns et al. 
2011). HuR may potentially bind to approximately 10% of the transcriptome, specifically 
within the 3′UTR and introns. These analyses show HuR binding to the U-rich sequences 
with a greater affinity than the AU-rich regions, contradicting the conventional 
assumption about HuR binding (Kishore, Jaskiewicz et al. 2011; Lebedeva, Jens et al. 
2011; Mukherjee, Corcoran et al. 2011; Uren, Burns et al. 2011). Secondary structural 
predictions of HuR binding sites suggest a preference for single-stranded RNA for 
binding to HuR, specifically within a loop (Lopez de Silanes, Zhan et al. 2004; Uren, 
Burns et al. 2011). A recent TIA1 iCLIP study reveals a high degree of TIA1 binding to 
U-rich regions found within the 3′UTR (Wang, Kayikci et al. 2010). With the U-rich 
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regions as potential targets for both HuR and TIA1, they may compete if an mRNA has 
limited U-rich regions in the 3'UTR or potentially cooperate if otherwise. 
 These transcriptome-wide studies validate the binding sites of many well-
characterized HuR targets, including the cell cycle regulators, cyclin A, B1, D1 and E1 
(Wang, Caldwell et al. 2000; Lal, Mazan-Mamczarz et al. 2004; Guo and Hartley 2006), 
p53 (Mazan-Mamczarz, Galban et al. 2003; Pryzbylkowski, Obajimi et al. 2008), and 
Estrogen Receptor α (ERα) (Pryzbylkowski, Obajimi et al. 2008). Additionally, HuR has 
been found to regulate many apoptotic factors, such as Prothymosin α (Lal, Kawai et al. 
2005), cytochrome c (Kawai, Lal et al. 2006), Bcl-2 and Mcl-1 (Abdelmohsen and 
Gorospe 2010). Similarly, TIA1 also regulates apoptotic mRNAs, including the Tumor 
Necrosis Factor α mRNA (TNF-α) (Piecyk, Wax et al. 2000; Forch and Valcarcel 2001). 
These studies suggest a potential role for HuR and TIA1 in coordinating the apoptotic 
program (Abdelmohsen and Gorospe 2010). 
 HuR and TIA1 regulate several cancer-relevant targets. Programmed Cell Death 4 
(PDCD4) is a tumor suppressor that was identified in transcriptome-wide analyses. The 
PDCD4 protein inhibits the activity of the eukaryotic translation initiation factor 4A 
(eIF4A) (Yang, Jansen et al. 2003), which is an RNA helicase responsible for unwinding 
the secondary structure in the 5′UTRs of translating mRNAs (Rogers, Richter et al. 
1999). Decreased PDCD4 protein levels, observed in a number of cancer types (Lankat-
Buttgereit and Goke 2009), increases protein production and tumor promotion (Cmarik, 
Min et al. 1999; Yang, Jansen et al. 2003). PDCD4 may be a key regulator of global 
translational levels and likely regulated by multiple factors.  
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The oncomiR, miR-21, which is overexpressed in almost all cancer types studied 
(Pan, Wang et al. 2010), regulates PDCD4 by binding to its 3′UTR and reducing its 
protein levels (Asangani, Rasheed et al. 2008; Frankel, Christoffersen et al. 2008). 
PDCD4 expression also is regulated at the transcriptional (Leupold, Asangani et al. 2012; 
Vikhreva, Shepelev et al. 2014) and post-translational levels (Dorrello, Peschiaroli et al. 
2006; Lankat-Buttgereit and Goke 2009; Powers, Fay et al. 2011). The transcriptome-
wide sequencing analyses of HuR and TIA1 suggest that they may bind to PDCD4 
mRNAs. These RBPs may serve as additional post-transcriptional regulators of PDCD4 
expression. 
 In this study, we extensively demonstrated the PDCD4 mRNA as a novel target of 
HuR and TIA1 in a breast cancer cell line, MCF-7 (Soule, Vazguez et al. 1973). In 
addition to RNA-immunoprecipitation (RNA-IP) with HuR and TIA1, we employed 
RNA-imaging probes deliverable to live cells (Santangelo, Lifland et al. 2009) and 
proximity ligation assay (PLA) (Soderberg, Gullberg et al. 2006; Jung, Lifland et al. 
2013) to examine the interplay between HuR and TIA1 on the PDCD4 transcripts with 
single-interaction sensitivity on a per cell basis. Contrary to previous studies that describe 
a cooperative relationship between HuR and TIA1 in binding to cytochrome C mRNA 
(Kawai, Lal et al. 2006), we demonstrate that HuR and TIA1 compete for interaction with 
PDCD4 transcripts, likely via shared binding sites in the 3′UTR. This competitive 
interplay between the two RBPs may be a novel mechanism for fine-tuning the level of 
PDCD4 protein. 
PDCD4 mRNA is a candidate target of HuR 
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 Many transcriptome-wide PAR-CLIP studies in HeLa and HEK293 cells reveal 
novel functions and potential targets of HuR (Kishore, Jaskiewicz et al. 2011; Lebedeva, 
Jens et al. 2011; Mukherjee, Corcoran et al. 2011; Uren, Burns et al. 2011), including 
potential tumorigenic targets. One such candidate transcript is PDCD4, which encodes a 
tumor suppressor that inhibits neoplastic transformation by interfering with the helicase 
activity of eIF4A (Yang, Jansen et al. 2003). The PDCD4 mRNA contains multiple 
predicted AREs (Gruber, Fallmann et al. 2011) within the 3′UTR as well as CLIP-Seq 
tags from HuR-CLIP studies, suggesting that it is a candidate target of HuR. 
 To assess whether HuR binds to PDCD4 mRNA in MCF-7 breast cancer cells, CP 
Wigington performed RNA immunoprecipitation (RNA-IP) with endogenous HuR 
protein. As expected, HuR protein was detected in the bound fraction when purified with 
HuR antibody but not with IgG control antibody (Figure 5.1A). The input and bound 
fractions were then analyzed for the presence of bound PDCD4 transcript using qRT-
PCR. As shown in Figure 5.1B, the PDCD4 transcript was robustly enriched with HuR. 
As controls, she also examined a known HuR target, Estrogen Receptor α (ERα) 
(Pryzbylkowski, Obajimi et al. 2008), as well as GAPDH, which is not bound by HuR 
(Lopez de Silanes, Zhan et al. 2004). As expected, the GAPDH transcript showed no 
enrichment with HuR; however, the previously defined HuR target, ERα (Pryzbylkowski, 
Obajimi et al. 2008), showed enrichment. These results provide evidence that HuR binds 
to PDCD4 mRNA in MCF-7 cells.  
HuR RRMs 1 and 2 are required for PDCD4 binding 
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 CP Wigington identified that the HuR protein contains three RRMs (Figure 
5.2A). The two N-terminal RRMs are critical for ARE recognition while the third RRM 
is thought to recognize polyadenosine sequences (Abe, Sakashita et al. 1996; Ma, Chung 
et al. 1997). The crystal structure of RRMs 1 and 2 (residues 18-186) of HuR in complex 
with an AUUUUUUAUUUU RNA oligomer (PDB # 4ED5) (Wang, Zeng et al. 2013) is 
shown in Figure 5.2A. While RRM1 is the primary ARE recognition domain within 
HuR, the conformational change that takes place upon RNA binding leads to additional 
interactions between RRM2 and the target mRNA, ultimately increasing RNA binding 
affinity (Wang, Zeng et al. 2013). This structure, along with other studies examining the 
structural basis of HuR-RNA interactions (Wang, Li et al. 2011), illustrates important key 
residues that are predicted to be crucial for high affinity RNA-binding by HuR (Wang, Li 
et al. 2011; Wang, Zeng et al. 2013). 
To define specific residues within RRM1 and 2 that are critical for HuR binding 
to target RNA, we focused on three of the residues (asparagine 21 [N21], tyrosine 109 
[Y109] and arginine 147 [R147]) shown in vitro to be critical for RNA binding (Wang, Li 
et al. 2011). CP Wiginton changed each of these residues to alanine in an N-terminally 
FLAG-tagged HuR expression vector to create a FLAG-HuR binding mutant, which she 
term FLAG-HuR(BM). To ensure that FLAG-HuR(BM) is expressed at comparable 
levels to the wild type FLAG-HuR, she transfected MCF-7 cells with the FLAG-HuR and 
-HuR(BM) constructs and analyzed expression by immunoblotting for HuR (Figure 
5.2B). HuR antibody detects both endogenous HuR (lower band) and FLAG-tagged HuR 
protein (upper band). The steady-state level of FLAG-HuR protein is comparable for 
HuR and HuR(BM), demonstrating that the amino acid changes within the RRM do not 
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significantly impact the steady-state level of HuR protein. Importantly, the localization of 
HuR(BM) is also indistinguishable from HuR(WT) as assessed by indirect 
immunofluorescence (Figure 5.1C).  
 To test whether the residues altered in HuR(BM) are critical for HuR binding to 
target mRNA, she expressed FLAG-HuR and -HuR(BM) in MCF-7 cells and subjected 
these cell lysates to RNA-IP analysis. To ensure specific purification of FLAG-tagged 
HuR, she performed the RNA-IP with FLAG antibody-conjugated protein A beads. As 
shown in Figure 5.2C, CP Wigington achieved robust purification of both FLAG-HuR 
and -HuR(BM) with no purification of the untagged, endogenous HuR protein. To 
identify RNA transcripts that co-purify with the FLAG-tagged HuR proteins, qRT-PCR 
analysis was performed (Figure 5.2D). As expected, the well-studied HuR target, ERα 
(Pryzbylkowski, Obajimi et al. 2008), was robustly enriched upon purification of FLAG-
HuR. Significantly reduced enrichment of the ERα transcript was detected with FLAG-
HuR(BM) as compared to WT FLAG-HuR, providing the first evidence that these key 
residues within HuR RRM1 and RRM2 are important for interaction with HuR target 
RNA in cells and demonstrating the utility of this mutant for validating ARE-containing 
HuR target RNAs. As expected, the negative control transcript, RPLP0, did not enrich 
with either FLAG-HuR or -HuR(BM).  
CP Wiginton next exploited the HuR(BM) to assess whether PDCD4 binding 
depends on HuR RRMs 1 and 2, as established for the ARE-containing ERα transcript. 
She analyzed PDCD4 mRNA enrichment with both FLAG-HuR and -HuR(BM). 
Consistent with the results from the endogenous HuR RNA-IP, she observed robust 
enrichment of the PDCD4 transcript upon purification of wild type HuR. In contrast, no 
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significant enrichment of PDCD4 was detected in the HuR binding mutant sample. The 
loss of enrichment of the ERα and PDCD4 transcripts with FLAG-HuR(BM) demonstrate 
that PDCD4 binding to HuR is similar to that of the classical ARE-containing target, 
ERα.   
HuR binds to two distinct regions within the PDCD4 3'UTR 
 Previous CLIP-Seq studies examining HuR binding across the transcriptome 
reveal that HuR binds primarily within the 3′UTRs and introns of mRNAs. Additional 
preliminary data from these CLIP-Seq studies show that the 3′UTR of the PDCD4 
transcript contains multiple AU- and U-rich stretches that could be bound by HuR. 
(Kishore, Jaskiewicz et al. 2011; Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 
2011; Uren, Burns et al. 2011) The UCSC Genome Browser defines the PDCD4 3′UTR 
as being 1,918 nt long; however, data from poly(A)-Seq analyses in various human 
tissues suggest that an evolutionarily conserved upstream polyadenylation site may be 
used for 3′ end processing of the PDCD4 transcript, resulting in a 3′UTR of 
approximately 672 nt. To determine the precise length of the PDCD4 3′UTR in MCF-7 
cells, CP Wigington performed 3′ RACE analysis using primers specific to the PDCD4 
3′UTR. The GAPDH 3′UTR was used as a control. To define the size of the PDCD4 
3′UTR in two other human cancer cell lines, she also performed 3′ RACE analyses using 
cDNA from HeLa (cervical adenocarcinoma; ATCC CCL-2) and MDA-MB-231 
(mammary adenocarcinoma; ATCC HTB-26) cells. As shown in Figure 5.3A and 
verified by sequence analysis, the 3′UTR of PDCD4 is 672 nucleotides in all cell types 
analyzed. These results focus our analysis of post-transcriptional regulation of PDCD4 on 




FIGURE 5.1: HuR RNA-IP in MCF-7 cells enriches for PDCD4 mRNA. Endogenous 
HuR protein was immunoprecipitated from MCF-7 cells using either HuR antibody-
coated protein A beads or isotype control Mouse IgG-coated beads. (A) Proteins from the 
Input, unbound (UB) and Bound fractions were resolved on an SDS-PAGE gel and 
subjected to immunoblotting with HuR antibody. HuR was detected in the HuR bound 
fraction but not the IgG bound fraction. (B) RNA isolated from the HuR RNA-IP was 
subjected to qRT-PCR analyses with GAPDH, ER Alpha and PDCD4 primers. mRNA 
levels in HuR bound fractions were normalized to input levels and then compared by 
fold-enrichment over IgG control. Significant enrichment of ERα and PDCD4 transcripts 
was observed with HuR IP. Values represent the mean ± SEM for n=3 independent 




FIGURE 5.2: Key residues in HuR RRMs 1 and 2 are required for binding to ARE-
containing target mRNAs, including PDCD4. (A) The HuR protein contains three 
RRMs (RRM1, RRM2 and RRM3) and a HuR Nucleocytoplasmic Shuttling sequence 
(HNS), which mediates bidirectional transport of HuR between the nucleus and 
cytoplasm. The two N-terminal RRMs (green) are responsible for ARE recognition while 
the C-terminal RRM (blue) is thought to bind to the poly(A) tail of mRNA transcripts. 
Shown below the linearized map of HuR is a recently solved co-crystal structure (PDB # 
4ED5) of HuR RRMs 1 and 2 (green) in complex with an AUUUUUUAUUUU RNA 
oligomer (yellow). Residues shown to be important for RNA recognition in in vitro 
binding studies are highlighted in red (N21, Y109 and R147). A putative HuR RNA 
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binding mutant (BM) was generated by changing these residues to alanine in a FLAG-
tagged HuR expression construct. (B) MCF-7 cells were transfected with vector control, 
FLAG-HuR(WT) or -HuR(BM) plasmids and subjected to immunoblotting with HuR and 
Tubulin antibodies. FLAG-HuR proteins were detected only in FLAG-transfected cells 
and levels of BM are comparable to WT. (C) Transfected MCF-7 cells were analyzed by 
indirect immunofluorescence with FLAG antibody to detect FLAG-HuR(WT) or (BM). 
Colocalization with DAPI reveals steady-state nuclear localization of both FLAG-HuR 
proteins (WT and BM). (D) Cells expressing vector control or FLAG-HuR proteins were 
subjected to RNA-IP using FLAG antibody-conjugated beads. Immunoblot analysis of IP 
samples demonstrates specific enrichment of FLAG-HuR proteins in bound fractions. (E) 
RNA that co-precipitated with FLAG-HuR proteins was subjected to qRT-PCR analyses 
with RPLP0, ER Alpha and PDCD4 primers to detect bound transcripts. ER Alpha and 
PDCD4 transcripts were significant enriched upon wildtype HuR purification; however, a 
significant decrease in enrichment was observed upon purification of HuR binding 
mutant. mRNA levels in FLAG-HuR-bound fractions were normalized to input levels and 
then compared by fold-enrichment over vector control samples. Values represent the 




 To determine whether HuR binds to the 3′UTR of PDCD4, she generated a 
biotinylated RNA probe that corresponds to the 672 nt region of the PDCD4 3′UTR. As 
controls, she employed the c-Myc 3′UTR, which is a well-defined target of HuR (Ma, 
Cheng et al. 1996) and the GAPDH 3′UTR, which is not a HuR target (Figure 5.3B). The 
biotinylated probes were incubated with MCF-7 cell lysates, precipitated by neutravidin-
coated beads, and then subjected to immunoblot analysis with HuR antibody to detect 
HuR bound to the probes. As shown in Figure 3C, HuR protein was readily detected in 
the input fractions, verifying the presence of HuR protein in these cell lysates. She 
detected robust HuR binding to the full-length PDCD4 3′UTR probe, suggesting that 
HuR binds to the 3′UTR of PDCD4. As expected, she detected HuR protein bound to the 
c-Myc 3′UTR probe but not samples without a probe or with the negative control GAPDH 
3'UTR probe. These results confirm that HuR binds to the 3′UTR of PDCD4 mRNA. 
To define specific regions of the PDCD4 3′UTR that allow HuR binding, CP 
Wigington generated a set of biotinylated probes that correspond to the first 290 and final 
382 nucleotides of the PDCD4 3′UTR (5′290 and Δ290 probes, respectively; Figure 
5.3B). As shown in Figure 5.3C, she detected robust HuR binding to the 5′290 probe. 
But we did not detect HuR binding to the Δ290 probe, suggesting that HuR binds 
specifically to the 5′290 nucleotides of the PDCD4 3′UTR. Interestingly, the 5′290 
nucleotides of the PDCD4 3′UTR contain multiple AU- and U-rich stretches to which 
HuR can bind (Gruber, Fallmann et al. 2011). To determine whether HuR binds to one or 
more of these stretches, she generated additional biotinylated probes that correspond to 
100 or 90 nucleotide regions of the PDCD4 5′290 3′UTR region (Figure 5.3B; Probes A, 
B and C). She detected robust binding of HuR to the first two 100 nucleotide regions of 
146 
 
the PDCD4 3′UTR, but not to the third 90 nucleotides (Figure 5.3C). These results show 
two distinct HuR binding sites within the first 200 nucleotides of the PDCD4 3′UTR. 
RNA imaging probes can be used to visualize PDCD4 mRNA in live cells 
Recent studies demonstrate the ability to accurately visualize RNA granules and 
RNA-protein interactions at a single molecule level in live cells (Santangelo, Lifland et 
al. 2009; Jung, Lifland et al. 2013). To detect HuR-PDCD4 interactions in MCF-7 cells, 
we designed four imaging probes that target four different sequences in the PDCD4 3′ 
UTR, avoiding the defined HuR binding sites (HuR BS) (Figure 5.4A). To determine 
probe specificity, we delivered each probe, labeled with Cy3b fluorophores, along with 
the other three probes labeled with Dylight 650 fluorophores. For example, in order to 
examine the specificity of probe 1, probe 1 was labeled with Cy3b while probes 2, 3, and 
4 were labeled with Dylight 650 (Figure 5.4B). Therefore, colocalization of probe 1 with 
the other three probes would suggest specificity of probe 1 in targeting the PDCD4 
3′UTR.  
For each probe, three images were obtained for analysis and colocalization was 
quantified by Mander’s coefficient. The mean Mander’s coefficients for probes 1-3 were 
greater than 0.8 and were not statistically different from one another (p>0.9), suggesting 
good colocalization. Probes 1-3 overlapped well with the other probes, as shown in the 
intensity profile of the representative mRNA punctae (Figure 5.4B). However, the mean 
Mander’s coefficient for probe 4 was 0.6 and was significantly less than the other three 
probes (p<0.009). Generally, probe 4 did not overlap well with the other probes as shown 
in the intensity profile (Figure 5.4B). Where the probe signal was bright, the signal of the 
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other probes was dim or vice versa. Thus, probe 4 was deemed non-specific and was not 
used for further analysis and probes 1-3 were employed in all experiments. These results 
suggest that probes 1-3 specifically recognize the PDCD4 3′UTR and allow us to 
visualize PDCD4 RNA granules in MCF-7 cells. 
Proximity ligation assay can detect HuR-PDCD4 mRNA interactions 
To visualize HuR protein-PDCD4 mRNA interactions in MCF-7 cells, we 
performed proximity ligation assay (PLA) between HuR and the FLAG peptides on the 
PDCD4 RNA probes. As schematized in Figure 5.4C, primary antibodies of different 
species bind to HuR and the FLAG tag (mouse and rabbit, respectively), which can then 
be detected by species-specific PLA probes with oligonucleotides. The oligonucleotides 
attached to the PLA probe form a circularized DNA strand by enzymatic ligation, one of 
which can serve as a primer for rolling circle amplification. This amplification ultimately 
results in a coiled single-stranded DNA, or the PLA product, which is complementary to 
the circular DNA strand. The PLA product is then detected by hybridizing 
complementary fluorophore labeled oligonucleotides (Figure 5.4C) (Soderberg, Gullberg 
et al. 2006; Jung, Lifland et al. 2013). As shown in Figure 5.4D, we observe endogenous 
HuR-PDCD4 interactions by PLA in untransfected and untreated cells (top row; 
quantified in Figure 5.4F), which supports the HuR-PDCD4 binding data obtained from 
both RNA-IP (Figures 5.1 and 5.2) and biotin pulldown analyses (Figure 5.3). As 
expected, we observed no PLA signal in cells treated with negative control probes 





FIGURE 5.3: HuR binds to sites within the PDCD4 3′UTR. (A) Total RNA isolated 
from HeLa, MB-231 and MCF-7 cells was subjected to 3′RACE analysis using PDCD4 
and GAPDH 3′UTR-specific primers as described in Materials and Methods. PCR 
products were resolved on a 2% agarose gel and represent the 3′UTR plus the length of 
the primers used for amplification. The PDCD4 3′UTR is 672 nt and was verified by 
sequencing. The GAPDH 3′UTR is shown as a control. Molecular weight markers in base 
pairs (MW bp) are shown to the left of the gel. (B) Biotinylated probes corresponding to 
the 3′UTRs of the c-Myc, GAPDH and PDCD4 transcripts were generated and used for 
biotin pulldown experiments in MCF-7 cells. The red asterisk denotes the well-defined 
miR-21 seed region in the PDCD4 3’UTR. The PDCD4 3’UTR was also dissected to 
generate various biotin probes that represent different regions of the transcript. (C) 
Proteins that co-precipitated with the avidin-bound biotinylated probes, as shown in (B), 
were subjected to immunoblotting with HuR antibody. HuR protein co-precipitates with a 
probe corresponding to the c-Myc 3′UTR as well as the first two 100 nt regions of the 
PDCD4 3′UTR. Images are representative of n=3 independent experiments. (Wigington, 





To validate the interaction of HuR with the PDCD4 transcript, we also modulated 
both HuR levels and localization and assessed the impact on PLA signal. These 
experiments were carried out either in cells expressing endogenous HuR or where total 
levels of HuR were increased by expression of HuR-GFP. For both of these conditions, 
cells were also treated with the transcriptional inhibitor, Actinomycin D (ActD), which 
increases the cytoplasmic localization of HuR (Peng, Chen et al. 1998). To assess 
changes in the frequency of HuR-PDCD4 mRNA interactions, we counted the number of 
HuR-PDCD4 PLA punctae and normalized to the amount of mRNA in each cell, which 
was quantified by measuring the volume of probe signal for each cell. The probe volume 
was the same in both untransfected and HuR-GFP transfected cells with (p=0.16) and 
without (p=0.26) ActD (Figure 5.4E). This analysis confirms that the probe delivery and 
binding as well as the amount of RNA granules are not significantly affected by 
transfection. In contrast, as expected for treatment with a transcriptional inhibitor, 
incubation of cells with ActD reduced the total volume of PDCD4 mRNA by 
approximately 40% (p<0.001; quantified in Figure 5.4E). 
Treatment with ActD resulted in significantly more HuR-PDCD4 PLA punctae 
than untreated cells due to increased cytoplasmic HuR in both untransfected (p<0.02) and 
HuR-GFP transfected cells (p<0.001; quantified in Figure 5.4F). As experiments 
employed a low amount of HuR-GFP plasmid (0.8 µg) for transfection, HuR-GFP 
transfected cells untreated with ActD showed only a slight increase in PLA frequency 
compared to the untransfected samples (p=0.046). Without ActD, HuR was 
predominately in the nucleus, unavailable to interact with cytoplasmic PDCD4 mRNA. 
Addition of ActD caused HuR to localize to the cytoplasm and resulted in a greater 
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increase in HuR-PDCD4 interactions in the HuR-GFP transfected cells than in 
untransfected cells (p<0.001). These results demonstrate individual HuR-PDCD4 
interactions in MCF-7 cells and further validate the interaction between HuR and 
PDCD4. 
HuR alters PDCD4 protein levels without affecting transcript stability 
 These immunoprecipitation, immunoblotting, and PLA data clearly demonstrate 
binding of HuR to the 3′UTR of the PDCD4 transcript and raise the important question of 
whether HuR modulates the expression of PDCD4. The canonical role for HuR in the 
post-transcriptional regulation of target mRNA transcripts is as a positive regulator of 
mRNA stability  (Brennan and Steitz 2001), however, some studies also suggest HuR 
modulating mRNA translation (Mazan-Mamczarz, Galban et al. 2003; Lal, Kawai et al. 
2005; Kawai, Lal et al. 2006). To determine whether transient modulation of HuR levels 
has an impact on PDCD4 steady-state protein or mRNA levels, we performed siRNA-
mediated knockdown of HuR in MCF-7 cells. As shown in Figure 5A, immunoblotting 
revealed a robust knockdown of HuR with HuR siRNA but not with scramble control 
siRNA. Probing these same samples with PDCD4 antibody reveals a decrease in PDCD4 
protein upon HuR knockdown, but no change in a control protein, tubulin. Performed by 
CP Wigington, quantification of PDCD4 steady-state protein levels upon HuR 
knockdown confirmed a significant decrease in PDCD4 protein levels (Figure 5.5B). In 
contrast, qRT-PCR analyses performed with RNA from these samples revealed no 
significant change in PDCD4 steady-state mRNA levels upon HuR knockdown (Figure 




As mentioned above, generally, HuR binding to target mRNAs increases 
transcript stability. In fact, many HuR target mRNAs are inherently labile and responsive 
to cellular stimuli (Dani, Blanchard et al. 1984; von Roretz, Macri et al. 2011). As shown 
in Figure 5.5C, knockdown of HuR in MCF-7 cells does not impact steady-state PDCD4 
mRNA levels; however, this result does not technically preclude the possibility that HuR 
could modulate stability of the PDCD4 transcript with some concomitant change in rates 
of PDCD4 transcription. To determine the half-life of the PDCD4 transcript in MCF-7 
cells, CP Wigington treated cells with the potent transcriptional inhibitor, ActD (Hurwitz, 
Furth et al. 1962), and collected cells at 0, 3, 6 and 9 hours after drug addition. She 
performed qRT-PCR analysis with PDCD4 primers to determine the percent mRNA 
remaining over time following ActD treatment (Figure 5.5D). For controls, she also 
analyzed the c-Myc transcript, which has a short half-life (Dani, Blanchard et al. 1984) as 
well as the very stable RPLP0 transcript (Tani, Mizutani et al. 2012). As shown in Figure 
5.5D, the PDCD4 transcript showed significant decay over the course of the experiment, 
with a calculated half-life of 5.5 hours, which is less than the average mRNA half-life of 
9 hours  (Schwanhausser, Busse et al. 2011). These results suggest that the PDCD4 
transcript is labile. As expected, the c-Myc transcript levels decreased dramatically after 
ActD treatment with a calculated half-life of 1.5 hours, which is comparable to 
previously determined c-Myc mRNA half-life values (Dani, Blanchard et al. 1984). The 
RPLP0 transcript did not decay over the time course examined as expected for a highly 
stable transcript.  
 To determine whether HuR modulates the stability of the PDCD4 transcript, CP 
Wigington transfected MCF-7 cells with scrambled and HuR specific siRNA followed by 
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treatment with ActD. Cells collected at 0, 2, 3, 4, 5 and 6 hours after ActD treatment were 
analyzed by qRT-PCR to detect PDCD4 transcript. As shown in Figure 5.5A and 5.5F, 
she achieved a robust knockdown of HuR; however, no significant difference in the half-
life of PDCD4 mRNA between siScramble and siHuR-treated cells (Figure 5.5E) was 
detected, revealing that HuR does not modulate PDCD4 mRNA stability.  
Although the rate of decay of the PDCD4 transcript was not altered, steady-state 
PDCD4 protein decreased rapidly over the time course of the ActD experiment. As 
shown in Figure 5.5F, immunoblot analysis of siScramble and siHuR-treated ActD 
samples with PDCD4 antibody revealed a sharp decrease in PDCD4 steady-state protein 
levels upon ActD treatment. Notably, the samples depleted of HuR displayed a greater 
initial decrease in PDCD4 protein upon ActD treatment (quantified in Figure 5.5G), 
again suggesting that HuR may play a role in influencing the translation of PDCD4. 
The U-rich element RNA binding protein, TIA1, binds to PDCD4 mRNA in MCF-7 
cells 
 Several studies describe HuR as a positive regulator of target mRNA translation 
(Mazan-Mamczarz, Galban et al. 2003; Lal, Kawai et al. 2005; Kawai, Lal et al. 2006). 
Consistently, our results suggest that HuR may positively regulate the translation of the 
PDCD4 transcript. Often such regulation occurs when a balance or competition exists 
between positive and negative regulators of translation. Interestingly, a previous study 
has defined a cooperative relationship between HuR and TIA1 in regulating the 
translation of specific target RNAs (Kawai, Lal et al. 2006). As shown in Figure 5.6A, 
alignment of iCLIP-Seq tags from a recent transcriptome-wide TIA1 iCLIP study in 
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HeLa cells (Wang, Kayikci et al. 2010) reveals two predicted TIA1 binding sites that 
overlap with the HuR binding site in 3'UTR (Figure 5.3C). These observations suggest 
that HuR and TIA1 could bind to similar or overlapping regions in the PDCD4 3′UTR.  
 To assess whether TIA1 binds to PDCD4 mRNA in MCF-7 cells, CP Wigington 
performed RNA-IP with endogenous TIA1 protein. As shown in Figure 5.6B, TIA1 
protein was detected in the bound fraction when purified with TIA1 antibody but not with 
IgG control antibody. The input and bound fractions were then analyzed for PDCD4 
transcript using qRT-PCR. As shown in Figure 5.6C, the PDCD4 transcript was robustly 
enriched with TIA1. As controls, she also examined known TIA1 targets, Cytochrome c 
(CYCS) (Kawai, Lal et al. 2006) and Prothymosin α (PTMA) (Lal, Kawai et al. 2005), as 
well as GAPDH, which is not bound by TIA1. As expected, the GAPDH transcript 
showed no enrichment with TIA1, however, the previously defined TIA1 targets, CYCS 
and PTMA, showed enrichment. These results suggest that PDCD4 mRNA is a target of 
TIA1 in MCF-7 cells. 
To further validate the interaction between TIA1 and PDCD4 mRNA, we 
performed PLA between TIA1 and FLAG-tagged probes on PDCD4 mRNA in MCF-7 
cells with and without TIA1-GFP transfection (Figure 5.6D). As shown in Figure 5.6E, 
we observed no significant difference in the amount of mRNA probes under any of the 
experimental conditions employed (p=0.855), suggesting that probe delivery and binding 
was not affected by TIA1-GFP transfection. TIA1-PDCD4 mRNA interactions were 
observed by PLA with endogenous TIA1 levels and, as expected, a significant increase in 
TIA1-PDCD4 interactions was observed by PLA upon TIA1-GFP transfection (p<0.001), 
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which demonstrates specific interaction between TIA1 and PDCD4 mRNA in these cells 
(Figure 5.6F).  
HuR and TIA1 compete for binding to PDCD4 mRNA 
To assess whether HuR and TIA1 cooperate or compete for binding to the 
PDCD4 transcript, we modulated levels of TIA1 or HuR in MCF-7 cells and analyzed 
HuR-PDCD4 interactions using PLA (Figure 5.7A-C). No difference in the probe 
volume was observed between treatment groups (p=0.12), demonstrating that probe 
delivery and binding as well as the level of PDCD4 mRNA were not affected by 
transfection. As expected, upon reduction of HuR, HuR-PDCD4 interactions decreased 
significantly (p<0.001; quantified in Figure 5.7C). A similar decrease in HuR-PDCD4 
interactions was observed upon overexpression of TIA1 through transfection of TIA1-
GFP (p<0.001). In contrast, knockdown of TIA1 resulted in increased HuR-PDCD4 
interactions comparable to HuR-GFP transfected cells (p=0.76). These results suggest 
that increasing TIA1 may prevent HuR from binding to the PDCD4 3′UTR, while 
decreasing TIA1 facilitates HuR-PDCD4 interactions (Figure 5.7A-C), which suggests a 
competitive relationship between HuR and TIA1 for binding to the PDCD4 3′UTR.  
To determine whether changing HuR levels affects TIA1-PDCD4 interactions, we 
modulated HuR by siRNA or HuR-GFP transfection and assessed TIA1-PDCD4 PLA 
values. Again, we found no difference in probe volume between different transfection 
groups (p=0.21), indicating that probe delivery and binding as well as the level of 
PDCD4 mRNA were not affected by transfection. As expected, knockdown and 
overexpression of TIA1 resulted in decreased and increased, respectively, TIA1-PDCD4 
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PLA interactions (Figure 5.7D and 5.7F). Consistent with our model where HuR and 
TIA1 compete for binding to PDCD4, upon reduction of HuR, we observed an increase 
in TIA1 binding to PDCD4 mRNA (p<0.001; Figure 5.7D and 5.7F). In contrast, 
overexpression of HuR did not have a significant effect on TIA1 binding to PDCD4 
(p=0.21), but the level of HuR overexpression was quite modest (Figure 5.7D-F). These 
results suggest that the PDCD4 transcript is competitively bound and regulated by HuR 
and TIA1 and therefore is regulated in a different manner than a previously described 
target mRNA that is cooperatively regulated by HuR and TIA1 (Kawai, Lal et al. 2006).  
Conclusion 
In this study, we identified the PDCD4 mRNA transcript as a novel target of HuR. 
Our results show that HuR binds to the PDCD4 transcript via at least two distinct binding 
sites within the 3′UTR that overlap with predicted TIA1 binding sites. We demonstrate 
binding of TIA1 to the PDCD4 mRNA and also show that modulation of TIA1 levels 
regulates HuR-PDCD4 interactions in MCF-7 cells, suggesting a competitive interaction 
between HuR and TIA1 on the PDCD4 transcript. This work as well as recent studies 
implicating HuR and TIA1 as dynamic and coordinate regulators of target mRNA 
expression (Kawai, Lal et al. 2006; Pullmann, Kim et al. 2007) suggests a model for 
regulation of PDCD4 by HuR and TIA1 (Figure 5.8) and yields mechanistic insight into 
the post-transcriptional regulation of U-rich-containing mRNAs, such as PDCD4. 
Recent transcriptome-wide CLIP-Seq studies on HuR demonstrate a preference 
for U-rich sequences (Kishore, Jaskiewicz et al. 2011; Lebedeva, Jens et al. 2011; 
Mukherjee, Corcoran et al. 2011; Uren, Burns et al. 2011). A few of these studies 
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performed RNA secondary structure prediction analyses on their target motifs, revealing 
a putative secondary structural motif for HuR binding (Lebedeva, Jens et al. 2011; Uren, 
Burns et al. 2011). An over-representation of U-rich motifs predicted to be located within 
variably sized hairpin loops was detected in one study (Uren, Burns et al. 2011). Another 
study reported a U-rich preference for HuR binding within 3′UTRs; however, 
computational folding predictions suggested single-stranded U-rich motifs with no 
indication of hairpins (Lebedeva, Jens et al. 2011). Our results show that HuR binds to 
two independent regions within the first 200 nt of the PDCD4 3′UTR. The PDCD4 
3′UTR is considerably AU- or U-rich (68% and 37%, respectively) and contains two 
striking U-rich stretches within the 5′290 nt region of the 3′UTR. Indeed, these two U-
rich regions are found within the first 200 nt of the 3′UTR and are consistent with the 
mapped HuR binding sites (Figure 5.3). Preliminary secondary structure prediction 
analyses of the 672 nt 3′UTR of PDCD4 predict two single-stranded U-rich motifs within 
the first 200 nt, suggesting that these are the motifs bound by HuR (Zuker 2003). The 
predicted binding sites of TIA1 on the PDCD4 3′UTR overlap with the HuR binding sites 
and, due to the U-rich preference of TIA1, may represent U-rich regions that are 
competitively bound by HuR and TIA1 (Figure 5.8A,B).   
Previous studies demonstrate that competition between HuR and TIA1 for binding 
to 5′ splice sites regulates alternative splicing in numerous cell types (Zhu, Hasman et al. 
2006; Izquierdo 2008; Zhu, Hinman et al. 2008). However, there is no precedent for 
competition between HuR and TIA1 that influences mRNA stability and/or translation. 
Employing RNA imaging probes and PLA, we detected and quantified individual 
interactions between native PDCD4 mRNA and either endogenous HuR or TIA1 in 
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single cells in situ. These PLA studies (Figure 5.7) provide evidence that HuR and TIA1 
compete for binding to the PDCD4 3′UTR. Overexpression of TIA1 reduced interactions 
between HuR and PDCD4, while knockdown of TIA1 increased HuR-PDCD4 
interactions (Figure 5.7). Similarly, knockdown of HuR increased TIA1 interactions with 
PDCD4 (Figure 5.7). This competition between HuR and TIA1 could regulate the 
translation of PDCD4, as suggested by the significant reduction of PDCD4 protein, but 
not mRNA, observed upon HuR knockdown (Figure 5.5 and 5.8B).  
Other transcripts may be subject to coordinated regulation by HuR and TIA1. For 
example, the β-actin mRNA is bound by HuR via a U-rich region in its 3′UTR (1300-
1339 nt) and this binding is associated with increased stability and translation of the 
mRNA (Dormoy-Raclet, Menard et al. 2007). TIA1 may bind to the same region as well 
as another U-rich region more distal from the coding region (Carrascoso, Sanchez-
Jimenez et al. 2014). Interestingly, knockdown of HuR in HeLa cells led to a decrease in 
both β-actin protein and mRNA. Depletion of TIA1 did not affect β-actin mRNA levels 
but did increase protein levels. Such competition for binding sites need not be limited to 
HuR and TIA1. HuR and CUG triplet repeat RNA binding protein 2 (CUGBP2) have 
been reported to compete for binding to the 3′UTR of cyclooxygenase-2 (COX2) mRNA 
to regulate translation. However, the binding sites of these RNA binding proteins have 
not been defined (Sureban, Murmu et al. 2007). Taken together, these studies support a 
general model where HuR and other RNA binding proteins, such as TIA1, compete for 
binding to target transcripts to modulate gene expression.  
While the data presented in this study suggest a model where HuR and TIA1 
compete for binding to overlapping cis-acting sequences, other RNAs may be regulated 
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through a mechanism where these RNA binding proteins cooperate with one another. For 
example, post-transcriptional regulation of the cytochrome c gene, which is a key 
regulator of apoptosis (Kulikov, Shilov et al. 2012), occurs through HuR and TIA1 
binding to non-overlapping binding sites in the AU-rich regions within the 3′UTR 
(Kawai, Lal et al. 2006). Consistent with our finding, this study observed that HuR 
binding promotes the translation the cytochrome c mRNA without affecting mRNA 
levels while TIA1 binding inhibits translation (Kawai, Lal et al. 2006). In contrast to the 
observed competition between HuR and TIA1 reported here, the study of the cytochrome 
c transcript reported that HuR and TIA1 bind cooperatively to the cytochrome c 3′UTR 
such that increasing TIA1 levels increased HuR binding; however, increasing HuR levels 
had no detectable effect on TIA1 binding (Kawai, Lal et al. 2006). The caveat of this 
study, as the authors noted, is that the analysis of cytochrome c employed recombinant, 
exogenous proteins. In direct binding assays that employed RNA electrophoretic mobility 
shift assays, the authors did not observe simultaneous binding of HuR and TIA1 (Kawai, 
Lal et al. 2006). These results indicate that coordinate regulation by RNA binding 
proteins needs to be individually defined for each transcript.  
In addition to competing or cooperating for binding sites on mRNAs, HuR and 
TIA1 bind to one another’s 3′UTR and have the potential to co-regulate one another. 
TIA1 mRNA stability and translation are controlled by HuR binding to its 3′UTR. In 
contrast, modulation of TIA1 does not affect HuR expression (Kawai, Lal et al. 2006; 
Pullmann, Kim et al. 2007). Hence, HuR appears to be a strong regulator of TIA1, but the 
reverse may not be true, suggesting a possible negative feedback mechanism for general 
regulation of gene expression. Understanding the interplay between HuR and TIA1 is 
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critical to further understand the post-transcriptional regulation of all HuR/TIA1 target 
mRNAs, including PDCD4. 
The PDCD4 protein is an inhibitor of the eIF4A helicase, which unwinds 
secondary structural elements located within the 5′UTR of mRNA transcripts to facilitate 
translation (Yang, Jansen et al. 2003). PDCD4 expression is upregulated after the 
initiation of programmed cell death (or apoptosis) (Shibahara, Asano et al. 1995) and a 
reduction in PDCD4 protein levels leads to neoplastic transformation (Yang, Jansen et al. 
2001). Because of the critical role for PDCD4 as a global regulator of protein synthesis 
and as a tumor suppressor, PDCD4 expression is regulated at multiple levels (Lankat-
Buttgereit and Goke 2009). PDCD4 is regulated at the transcriptional level by the 
transcription factor, v-Myb (Schlichter, Burk et al. 2001) as well as by epigenetic 
regulation through DNA methylation (Fan, Zhao et al. 2007). With regard to post-
transcriptional regulation of PDCD4, the only study beyond the extensive analysis of 
miR-21 (Asangani, Rasheed et al. 2008; Frankel, Christoffersen et al. 2008), examines the 
regulation of the PDCD4 transcript by the splicing factor, SRSF3 (Kim, Park et al. 2014). 
SRSF3 binds to the 5′UTR of the PDCD4 transcript and modulates splicing and 
translational efficiency (Kim, Park et al. 2014) (Figure 5.8C). Post-translational 
regulation of PDCD4 includes phosphorylation of PDCD4 at serine 67 by Akt or S6K1, 
which leads to significantly decreased PDCD4 protein levels via increased proteasomal 
degradation (Dorrello, Peschiaroli et al. 2006; Schmid, Jansen et al. 2008) and 
methylation of PDCD4 at an N-terminal arginine residue that accelerates tumor growth 
(Powers, Fay et al. 2011) and promotes tumor cell viability during nutrient deprivation 
(Fay, Clegg et al. 2014). Our observation that reduction of HuR levels results in reduced 
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PDCD4 protein levels (Figure 5.5), as well as the fact that modulation of TIA1 levels 
inversely correlates with interactions between HuR and PDCD4 (Figure 5.7), suggests 
that HuR and TIA1 compete to modulate the PDCD4 mRNA and therefore represents an 
additional point of regulation for PDCD4 expression (Figure 5.8). 
Analysis of RNA regulons and the cooperation and/or competition of multiple 
RNA binding proteins on target mRNAs suggest a complex and dynamic post-
transcriptional regulatory program (Keene 2007). The observation that RBPs such as 
HuR interface with miRNA machinery (Srikantan, Tominaga et al. 2012) adds additional 
complexity to the regulation of target mRNAs. In fact, numerous studies demonstrate a 
competitive relationship between HuR and miRNA machinery at both the individual 
transcript (Bhattacharyya, Habermacher et al. 2006; Epis, Barker et al. 2011; Srikantan, 
Abdelmohsen et al. 2011; Tominaga, Srikantan et al. 2011; Young, Moore et al. 2012) 
and transcriptome-wide (Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 2011) 
levels. The transcriptome-wide PAR-CLIP analyses that examined interplay between 
HuR and miRNAs suggest that transcripts with non-overlapping HuR/miRNA binding 
sites (such as PDCD4) are likely regulated by the miRNA instead of HuR (Lebedeva, 
Jens et al. 2011; Mukherjee, Corcoran et al. 2011). Our results demonstrate that 
modulation of HuR impacts the steady-state protein, but not mRNA, level of PDCD4 and 
suggest a model where HuR regulates the translation of PDCD4. The mechanism by 
which HuR modulates translation is not well understood; however, recent studies 
demonstrate that direct competition between HuR and miRNAs can influence translation 
(Bhattacharyya, Habermacher et al. 2006). Alternatively, HuR binding could influence 
the secondary structure of the 3′UTR to modulate miRNA binding/accessibility 
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(Srikantan, Tominaga et al. 2012). This type of coordination is challenging to study and 
is therefore less understood than direct competition.  
As mentioned previously, the PDCD4 3'UTR is a well-studied target of the 
oncomiR, miR-21 (Asangani, Rasheed et al. 2008; Frankel, Christoffersen et al. 2008), 
which is overexpressed in many cancer types (Pan, Wang et al. 2010) and targets the 
PDCD4 transcript via a well-studied seed region within the 3′UTR (Asangani, Rasheed et 
al. 2008). The miR-21 seed region lies within the 290 nt region of the PDCD4 3′UTR that 
was identified in a HuR iCLIP study (Uren, Burns et al. 2011). However, the miR-21 seed 
region does not overlap with the HuR binding sites identified here (Figure 5.3) and is 
instead located more distal to the coding region (miRNA seed region designated by red 
asterisk in Figure 5.3B). If miR-21 is involved in HuR-mediated regulation of PDCD4 
translation, the location of the miR-21 binding site is more consistent with a model where 
HuR impacts the local RNA structure to modulate miRNA binding than direct 
competition.  
In addition to possible modulation of miR-21 binding, growing evidence shows 
that HuR binds to and regulates the processing of primary miRNA (pri-miR) transcripts 
(Lebedeva, Jens et al. 2011; Mukherjee, Corcoran et al. 2011; Young, Moore et al. 2012). 
A recent study demonstrated HuR binding to and destabilizing miR-7 (Lebedeva, Jens et 
al. 2011), suggesting that this may represent another mode of regulation by HuR in post-
transcriptional processing. Interestingly, another study identified HuR binding to the pri-
miR-21 transcript (Mukherjee, Corcoran et al. 2011), which could indicate direct 
regulation of the miR-21 transcript by HuR. These results suggest that knocking down 
HuR could result in elevated miR-21 levels, leading to reduced PDCD4 protein levels, as 
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reported in this study. Like HuR, TIA1 also may play a role in modulating gene 
expression via interactions with miRNA machinery. 
Further study is required to understand how direct interactions and feedback 
mechanisms between miR-21, as well as other miRNAs predicted to bind the PDCD4 
3′UTR, and RBPs, such as HuR and TIA1, function coordinately to control post-









FIGURE 5.4: Visualization of HuR-PDCD4 interactions in situ using FLAG-tagged 
probes. (A) The 672 nt PDCD4 3′UTR contains two HuR binding sites (HuR BS) within 
the first 200 nt. Four mRNA probes (1, 2, 3 and 4) were designed to target distinct 
positions within the PDCD4 3′UTR (shown in red). (B) Each of four PDCD4 3′UTR 
probes labeled with Cy3B fluorophores was delivered to MCF-7 cells along with the 
other three probes labeled with Dylight 650 fluorophores. Merge images of Cy3B-labeled 
probe (red), Dylight 650-labeled probe (green), and DAPI-stained nuclei (blue) are also 
shown. All image planes are represented. Magnified, merge images of overlapping probes 
in the boxed region are shown with profile plot of the fluorescence intensity of Cy3B 
(red) and Dylight 650 (green) along an intersection of the probes (white line). Scale bar, 
10 µm. The mean Mander’s coefficient of Cy3B and Dylight 650 probe colocalization is 
shown. (C) A schematic of the proximity ligation assay (PLA), which measures the 
interaction between HuR and probes specific to the PDCD4 3’UTR is shown. As 
described in Experimental Procedures, PLA was performed between HuR and FLAG-
tagged (dark green lines) probes with four Cy3b-labeled (red) oligonucleotides (red dash 
lines) and a neutravidin core (yellow) in nucleotides 296-549 of the PDCD4 3′UTR. 
Anti-HuR mouse primary antibody (light blue) and anti-mouse PLA probe (dark blue) 
bind to HuR, while anti-FLAG rabbit primary antibody (light magenta) and anti-rabbit 
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PLA probe (dark magenta) bind to FLAG. Once they are in proximity, the 
oligonucleotides (black dash lines) attached to the PLA probe come together via ligation 
to form a template for DNA polymerase, which resulted in a coiled DNA product that can 
be labeled with Cy5-equivalent fluorophore (light green) bound complementary DNA 
strands (black dash lines). (D) HuR, PDCD4 mRNA and PLA between HuR and PDCD4 
mRNA were imaged in untransfected and HuR-GFP transfected MCF-7 cells exposed to 
(+ActD) or unexposed to (-ActD) actinomycin D. MCF-7 cells transfected with HuR-
GFP and exposed to ActD received PDCD4 mRNA probes with neutravidin lacking the 
FLAG tag (NA) and were used as a negative control. Merge images of HuR (blue), 
PDCD4 mRNA (red) and PLA between HuR and PDCD4 mRNA (green) are shown. All 
image planes are represented. Scale bar, 10 µm. (E) Probe volume (µm3) measured for 
each untransfected and HuR-GFP transfected cell exposed or unexposed to ActD 
(Untransfected: n=46 cells; Untransfected, +ActD: n=125; HuR-GFP transfected: n=51; 
HuR-GFP transfected, +ActD: n=62). (F) PLA frequency normalized to the probe volume 
(µm-3) for each cell. * represents p 0.025, p 0.05; ** represents p>0.001, p<0.025; *** 






FIGURE 5.5: HuR modulates PDCD4 protein levels. (A) MCF-7 cells transiently 
transfected with Scramble or HuR siRNA were subjected to immunoblot analysis with 
PDCD4, Tubulin, or HuR antibody. (B) Results of (A) were quantified as described in 
Experimental Procedures. The level of PDCD4 protein is normalized to tubulin loading 
control and siScramble set to 1.0. (C) qRT-PCR analysis of total RNA isolated from 
siRNA-treated cells demonstrates no significant difference in PDCD4 steady-state 
mRNA levels upon HuR knockdown. (D) MCF-7 cells were treated with ActD and 
collected at the indicated time points after drug addition. Total RNA isolated from ActD-
treated cells was subjected to qRT-PCR analysis with RPLP0, PDCD4 and c-Myc 
primers. mRNA levels were normalized to time zero and are represented as % of amount 
present at time 0. The half-life of the c-Myc and PDCD4 transcripts was calculated to be 
1.5 and 5.5 hours, respectively. (E) MCF-7 cells transfected with Scramble or HuR 
siRNA were treated with ActD and collected at the indicated time points after drug 
addition. Results are analyzed and presented as in (D). No significant difference in 
PDCD4 mRNA half-life was observed between scramble and HuR knockdown samples. 
(F) Immunoblot analysis of total protein isolated from the samples in (E) to detect 
PDCD4, Tubulin and HuR reveal a sharp decrease in PDCD4 protein upon treatment with 
ActD. (G) Quantification of data from panel F reveals a significant difference in PDCD4 
protein levels shortly after ActD treatment. Data points represent the mean ± SEM for 
n=3 independent experiments. * represents p<0.05. Images are representative of n=3 
independent experiments. (Wigington, Jung et al. 2014) 
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FIGURE 5.6: The RNA binding protein, TIA1, interacts with PDCD4 mRNA. (A) A 
recent TIA1 iCLIP study reveals two predicted TIA1 binding sites (shown here in blue) 
within the first 200 nt of the PDCD4 3′UTR that overlap with the validated HuR binding 
sites (green) defined here. The red asterisk denotes the well-defined miR-21 seed region. 
(B) Endogenous TIA1 protein was immunoprecipitated from MCF-7 cells using TIA1 
antibody-coated protein A beads alongside isotype control Goat IgG-coated beads. 
Proteins from the Input, unbound (UB) and Bound fractions were subjected to 
immunoblotting with TIA1 antibody. TIA1 was detected in the HuR-bound fraction but 
not the control IgG bound fraction. TIA1 is alternatively spliced to generate two distinct 
protein products that correspond to the two bands detected. (C) qRT-PCR analysis of 
RNA isolated from the TIA1 RNA-IP using PDCD4, CYCS and PTMA primers reveals 
clear enrichment of these transcripts upon TIA1 pulldown. A control mRNA, GAPDH, 
did not co-precipitate with TIA1. Values represent the mean ± SEM for n=3 independent 
experiments. * represents p<0.05. (D) PLAs performed with TIA1 antibody and PDCD4 
3′UTR probes 1-3 reveal interactions between TIA1 and the PDCD4 3′UTR. (E) Probe 
volume (µm3) measured for each untransfected (n=11 cells) and TIA1-GFP transfected 
(n=15) cell. (F) The PLA frequency normalized to the probe volume (µm-3) for each cell. 
*** represents p<0.001 (Mann-Whitney rank sum test). (Wigington, Jung et al. 2014)
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FIGURE 5.7: HuR and TIA1 compete for binding to the PDCD4 3′ UTR. A) 
Visualization of HuR protein, PDCD4 mRNA and interaction between HuR and PDCD4 
mRNA (PLA) in control cells transfected with scrambled siRNA (siScr), or siRNA 
directed against either HuR (siHuR) or TIA1 (siTIA1). Merged images of HuR (white), 
PDCD4 mRNA (red), PLA (green) and nuclei (blue) are also shown. All image planes 
are represented. Scale bar, 10 µm. B) Visualization of GFP, PDCD4 mRNA and 
interaction between HuR and PDCD4 mRNA in TIA1-GFP transfected cells. Merged 
images of GFP (white), PDCD4 mRNA (red), PLA (green) and nuclei (blue) are also 
shown. All image planes are represented. Scale bar, 10 µm. C) HuR-PDCD4 mRNA PLA 
frequency normalized to probe volume (µm-3) for untransfected (n=46 cells), siScramble 
(n=81), siHuR (n=25), HuR-GFP (n=51), siTIA1 (n=97), and TIA1-GFP (n=69) cells. 
*** represents p<0.001 (one-way ANOVA with Dunn’s method). D) Visualization of 
TIA1 protein, PDCD4 mRNA and PLA interaction between TIA1 and PDCD4 mRNA in 
siScramble (siScr), siHuR and siTIA1 transfected cells. Merged images of TIA1 (white), 
PDCD4 mRNA (red), PLA (green) and nuclei (blue) are also shown. All image planes 
are represented. Scale bar, 10 µm. E) Visualization of GFP, PDCD4 mRNA and PLA 
interaction between TIA1 and PDCD4 mRNA in HuR-GFP transfected cells. Merged 
images of HuR (white), PDCD4 mRNA (red), PLA (green) and nuclei (blue) are shown. 
All image planes are represented. Scale bar, 10 µm. F) TIA1-PDCD4 mRNA PLA 
frequency normalized to probe volume (µm-3) for untransfected (n=55 cells), siScramble 
(n=49), siHuR (n=66), HuR-GFP (n=46), siTIA1 (n=44), and TIA1-GFP (n=76) cells. 





FIGURE 5.8: Model for post-transcriptional regulation of the PDCD4 transcript. 
(A) HuR binds two independent regions proximal to the stop codon (UGA) in the 
PDCD4 3’UTR. Our data suggest that HuR (green rectangles) binding to the PDCD4 
transcript maintains the level of PDCD4 protein present in these cells (Figure 5.5) and 
therefore may positively regulate the translation of PDCD4, possibly through competition 
with TIA1 (blue circle). The PDCD4 3’UTR is a well-studied target of miR-21 (red 
asterisk), and therefore may represent a site of dynamic interplay between miRNA 
machinery and HuR. (B) Either Reduction of HuR or overexpression of TIA1, causes an 
increase in TIA1-PDCD4 interactions, suggesting that HuR and TIA1 compete for 
binding to an overlapping binding site within the PDCD4 3’UTR. (C) The PDCD4 
transcript is post-transcriptional regulated by a number of different factors, including the 
splicing factor, Serine/Arginine-rich Splicing Factor 3 (SRSF3; pink hexagon) and miR-
21 (red line). This study uncovers an additional point of regulation on the PDCD4 




Materials and methods 
MCF-7 cells (ATCC HTB-22; Estrogen Receptor positive [ER+] breast cancer 
cell line) were obtained from ATCC and maintained in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% FBS and antibiotics. DNA plasmids and 
siRNA (Invitrogen) were transfected into cultured cells using Lipofectamine2000 
(Invitrogen) or Neon Electroporation System (Invitrogen) according to manufacturer's 
protocol. Cells were plated on No 1.5 glass coverslips (Ted Pella) one day prior to 
transfection for imaging. 
A FLAG fusion construct for HuR was generated using PCR primers that include 
the FLAG sequence, creating an N-terminally FLAG tagged protein. The PCR product 
was then subcloned into the pcDNA3.1 vector (Invitrogen). The HuR RNA binding 
mutant (HuR(BM); N21A, Y109A, R147A) was generated by site-directed mutagenesis 
using the Quikchange Kit (Stratagene). Primers used throughout the study are shown in 
Table 1. MCF-7 cells were transfected with 0.8 µg HuR-GFP or 0.8 µg TIA1-GFP 
plasmid (gifts from Dr. Myriam Gorospe, NIH/NIA). mRNA-targeted probes were 
delivered 36 h after plasmid transfection. A set of three pre-designed Stealth siRNAs 
(Assay ID numbers s4608, s4609, and s4610; Invitrogen) or 200 nM On-TARGET 
SMARTPool HuR siRNA (Thermo Scientific Dharmacon) were employed for 
knockdown of HuR. For control, 200 nM On-TARGETplus Non-targeting siRNA #1 
(Thermo Scientific Dharmacon) was used. mRNA-targeted probes were delivered 48 h 
after siRNA transfection. 
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MCF-7 cells were harvested and washed in 1X PBS and then lysed on ice in 
RIPA-2 buffer (150 mM NaCl, 1% NP40, 0.5% deoxycholate, 0.1% SDS, 50 mM Tris 
pH 8.0) containing protease inhibitors (PLAC: 3 μg/ml of pepstatin, leupeptin, aprotinin, 
and chymostatin and 0.5 mM PMSF). Immunoblotting was performed using standard 
methods. Briefly, 30 μg of total protein lysate per sample was resolved by SDS-PAGE 
and transferred onto a nitrocellulose membrane. For immunoblotting, a 1:1,000 dilution 
of HuR or TIA1 antibody (Santa Cruz; Clones 3A2 and c-20, respectively), a 1:4,000 
dilution of PDCD4 antibody (Rockland; Rabbit polyclonal), or a 1:5,000 dilution of α-
tubulin antibody (Sigma; Clone DM1A) was used followed by 1:3,000 dilutions of HRP-
conjugated goat anti-mouse IgG, HRP-conjugated goat anti-rabbit IgG, or HRP-
conjugated mouse anti-goat IgG secondary antibodies (Jackson ImmunoResearch). 
Total RNA was isolated from MCF-7 cells using TRIzol reagent (Invitrogen) in 
accordance with the manufacturer’s instructions. Reverse transcriptase reactions with M-
MLV RT (Invitrogen) used 1 g of RNA for a final concentration of 50 ng/μL cDNA per 
sample that was used for quantitative RT-PCR. 
For qRT-PCR analyses, 1 g of total RNA was transcribed to cDNA as described 
above.  Relative mRNA levels were measured by quantitative PCR analysis of triplicate 
samples of 5 ng cDNA with QuantiTect SYBR Green Master Mix using an Applied 
Biosystems real time machine (ABI).  Results were analyzed using the ∆∆CT method and 
normalized to the 18s rRNA or RPLP0 transcript.  Statistical significance was determined 
using One-Way ANOVA. 
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RNA-IPs to assay endogenous HuR/PDCD4 mRNA interactions were performed using 
standard methods (Jain, Devine et al. 2011). Briefly, MCF-7 cells were grown to 
confluency in 100-mm dishes and rinsed twice with ice cold PBS. Lysates were prepared 
with an equal pellet volume of polysome lysis buffer (PLB; 10 mM HEPES pH 7.0, 100 
mM KCl, 5 mM MgCl2, 0.5% NP-40, 1 mM DTT, RNase OUT [Invitrogen], and 1 
cOmplete protease inhibitor tablet [Roche]) and stored at -80°C. Protein A sepharose 
beads (Santa Cruz) were incubated at 4°C overnight with either mouse IgG or HuR 
antibody (Santa Cruz). Beads coated in antibody were resuspended in NT2 buffer (50 
mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl2, 0.05% NP-40) supplemented with 
RNase OUT (Invitrogen) and 1 mM DTT. Thawed and clarified cell lysates were added 
and the bead-antibody-cell lysate mixture was incubated at 4°C for 2 hours while 
tumbling end over end. After incubation, beads were spun down and washed 5 times with 
cold NT2 buffer. The bound RNA was isolated with TRIzol (Invitrogen) and purified 
according to manufacturer’s instructions.  
To detect FLAG-HuR/PDCD4 mRNA interactions, MCF-7 cells were grown to 
near confluency in 100-mm plates and transfected with pcDNA3, FLAG-HuR, or -
HuR(BM) plasmids. After 48 hours, cell lysates were prepared and frozen as described 
above. FLAG-M2 magnetic beads (Sigma) were resuspended in supplemented NT2 
buffer described above. Thawed and clarified cell lysates were added to beads and 
incubated at 4°C for 2 hours while tumbling end over end. After incubation, beads were 
magnetized and washed 5 times with cold NT2 buffer. FLAG-HuR/RNA complexes were 
eluted with excess FLAG peptide (Sigma) and bound RNA was isolated with TRIzol 
(Invitrogen) and purified according to manufacturer’s instructions. 
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Prior to visualization by indirect immunofluorescence, MCF-7 cells were fixed 
with 1-2% formaldehyde (EM Science) for 10 min, permeabilized with 0.1%Triton X-
100 for 5 min, and incubated with Hoechst or DAPI (Invitrogen) to mark the position of 
the nucleus. To localize endogenous HuR, FLAG-HuR, or HuR-GFP by 
immunofluorescence, cells were probed with mouse monoclonal anti-HuR (1:1,000; 3A2, 
Santa Cruz), mouse monoclonal anti-FLAG (1:1,000; M2, Sigma), or goat polyclonal 
anti-GFP (1:500; ab5450, Abcam) antibody followed by staining with Texas Red or 
Fluorescein-conjugated secondary antibodies (Jackson ImmunoResearch). For 
immunostaining endogenous TIA1 or TIA1-GFP, cells were probed with polyclonal 
rabbit anti-TIA1 (1:500; AV40981, Sigma) or anti-GFP (1:500; ab5450, Abcam) 
antibody followed by staining with Cy3 or Fluorescein-conjugated secondary antibody 
(Jackson ImmunoResearch). Images were obtained using an Olympus IX81 microscope 
with a 0.3 numerical aperture (NA) 100  Zeiss Plan-Neofluor objective or an Axiovert 
200 M microscope (Zeiss) with a 1.4 NA 63  Plan-Apochromat objective unless 
otherwise stated. Images were captured using a Hamamatsu digital camera with 
Slidebook software (version 1.63) or Volocity acquisition software (PerkinElmer) and 
globally processed for brightness and contrast using Adobe Photoshop. 
To determine the precise length of the PDCD4 3′UTR in human cell lines, we 
isolated RNA from HeLa (ATCC CCL-2), MDA-MB-231 (ATCC HTB-26) and MCF-7 
(ATCC HTB-22) cells using TRIzol reagent (Invitrogen) in accordance with the 
manufacturer’s instructions. Reverse transcriptase reactions were carried out as follows: 1 
g of RNA was combined with 1 L of dNTPs (10 mM), 1 L of the 3′RACE adaptor 
(See Table 1; 10 mM) and DEPC-treated water for a total volume of 13 L. Samples 
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were incubated at 65oC for 5 minutes and then transferred to ice. To the RNA mixture-
3′RACE adaptor mixture, 4 L 5X First-Strand buffer (Invitrogen), 1 L 0.1 M DTT and 
1 L RNaseOUT (40 U/L; Invitrogen) were added. Samples were incubated at 42oC for 
2 minutes before adding 1 uL SuperScript III RT (200 U/L; Invitrogen), briefly 
vortexing, and returning to 42oC for 50 minutes. Following first strand synthesis, samples 
were heated to 70oC for 15 minutes to denature the RT enzyme. For each PCR reaction, 
40 ng of cDNA was used along with the outer 3′RACE primer and a gene-specific inner 
primer (see Table 1) with the AmpliTaq Gold 360 Master Mix (Invitrogen), according to 
manufacturer’s instructions. PCR products were resolved on a 2% agarose gel and 
confirmed by TOPO cloning (Invitrogen) and sequencing. 
To assess direct binding of HuR to the PDCD4 transcript, DNA sequences 
corresponding to the 3′UTRs of c-Myc and GAPDH as well as various regions of the 
PDCD4 3′UTR (full length, 5′290, Δ290, 1-100, 101-200, and 201-290) were amplified 
by PCR and inserted into pGEM T-easy vectors (Promega) and linearized by digestion 
with SpeI (New England Biolabs). Biotinylated RNA probes were generated by in vitro 
transcription using the T7 Maxiscript kit (Ambion) with Biotin-11-cytidine-5′-
triphosphate (biotin-11-CTP; Roche). Biotinylated CTP and normal CTP were used at a 
ratio of 1:4 to ensure adequate transcription yield and sufficient labeling. 
Nonincorporated nucleotides were removed with a G-25 column (GE Healthcare Bio-
Sciences) followed by ethanol precipitation. RNA concentration was determined by A260 
absorption and the quality was examined by denatured RNA electrophoresis. MCF-7 cells 
were lysed in IP buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.5 mM 
DTT, 1% NP-40 supplemented with cOmplete protease inhibitor tablets [Roche] and 
174 
 
RNase OUT [Invitrogen]), spun at 13,000 RPM for 20 minutes at 4°C, and ~200 μg of 
purified cell lysate were rotated end-over-end with 400 ng of biotinylated RNA probe for 
20 minutes at room temperature. To precipitate biotinylated RNA probes from MCF-7 
cell lysates, NeutrAvidin beads (Thermo Scientific) pre-blocked with BSA (Roche) were 
added and rotated end-over-end for 30 minutes at 4°C. After precipitation, the beads were 
washed 5 times in IP buffer and then subjected to elution by boiling in reducing sample 
buffer (RSB). Bound proteins were analyzed by immunoblotting to detect HuR. 
To measure mRNA stability in MCF-7 cells, 5 μg/ml actinomycin D (Sigma) was 
added to the growth medium to inhibit transcription and cells were harvested 0, 1, 6, and 
9 hours later.  To measure mRNA stability in MCF-7 cells with reduced HuR levels, cells 
were transfected with HuR siRNA 24 hours after seeding. Following a 48-hour 
incubation with siRNA, 5 μg/ml actinomycin D was added to the growth medium and 
cells were harvested 0, 2, 3, 4, 5, and 6 hours later. Total RNA was extracted from cells 
(described above) and analyzed by qRT-PCR. Half-lives were determined by 
normalization to 18s rRNA and to time 0. 
Probes were synthesized as previously described (Santangelo, Lifland et al. 2009; 
Jung, Lifland et al. 2013). Briefly, FLAG-hyNic (Solulink) was added to 4FB-modified 
(Solulink) neutravidin (Thermo Scientific Pierce) according to the manufacturer’s 
protocol. For each probe, 2′-O-methyl RNA-DNA oligonucleotide chimeras 
complementary to the target sequence were designed with a 5′-biotin and dT-C6-NH2 
internal modifications (Biosearch Technologies). Cy3B NHS ester fluorophores (GE 
Healthcare) or Dylight 650 NHS Ester fluorophores (Thermo Scientific Pierce) were 
conjugated to the oligonucleotide amino groups using the manufacturer’s protocol. Free 
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dye was removed using 30 kDa Amicon spin columns (EMD Millipore). The purified, 
labeled oligonucleotides were tetramerized by incubation for 1 hour at room temperature 
with untagged or FLAG-tagged neutravidin. Free ligands were removed using 30 kDa 
Amicon spin columns (EMD Millipore). Three probes each targeting different sequences 
in the 3′ UTR of PDCD4 mRNA (Table 2) were assembled separately prior to delivery 
and combined during delivery. To deliver total 60nM probes targeting PDCD4 mRNA, 
20 nM of each probe was combined. 
For probe delivery, cells were washed in Dulbecco’s phosphate buffered saline 
(DPBS) without Ca2+ and Mg 2+ (Lonza) and subsequently, incubated with 0.15 U/mL 
activated streptolysin O (Sigma) in OptiMEM (Invitrogen) containing 60 nM PDCD4 
mRNA probes for 10 min at 37C. Delivery media were replaced with growth media for 
15 min to restore membrane integrity before actinomycin D treatment or fixation. For 
actinomycin D treatment, cells were incubated for 90 min at 37C with 5 µg/mL 
actinomycin D (Sigma) in growth media and fixed at the end of the exposure. 
The Proximity Ligation Assay (PLA) was performed as previously described 
(Jung, Lifland et al. 2013). Cells were fixed with 1% paraformaldehyde (Electron 
Microscopy Science) in PBS for 10 min, permeabilized with 0.2% Triton X-100 (Sigma) 
for 5 min, and blocked for 1 h with a blocking solution. The blocking solution consisted 
of 0.5% Tween-20 (CalBioChem), 0.1% Triton X-100, 0.1% gelatin (Aurion), 2% 
donkey serum (Sigma), and 1% bovine serum albumin (BSA) (EMD) in PBS. Cells were 
washed with PBS, incubated in two primary antibodies, one against the FLAG-tagged 
neutravidin and one against the protein of interest. For anti-FLAG antibodies, either 
rabbit polyclonal (1:2000; F7425, Sigma) or mouse monoclonal (1:2000; M2, Sigma) 
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anti-FLAG antibody was used. Mouse monoclonal anti-HuR (1:750; 3A2, Santa Cruz) 
was used to detect HuR, and rabbit polyclonal anti-TIA1 (1:1500; AV40981, Sigma) was 
used to detect TIA1. After washing with Duolink wash solution (Olink Bioscience), the 
cells were incubated with species-corresponding oligonucleotide-labeled PLA probes 
(Olink Bioscience) diluted in 0.05% Tween-20 in PBS and washed with Duolink wash 
solution. The ligation and rolling circle amplification reaction (Olink Bioscience) were 
performed as instructed in the manufacturer’s protocol. The cells were then 
immunostained and DAPI-stained (Invitrogen) and mounted on slides using Prolong 
(Invitrogen). 
All the images were collected using an Axiovert 200 M microscope (Zeiss) with a 
63 , NA 1.4 Plan-Apochromat objective and an ORCA-ER AG camera (Hamamatsu). 
The images were acquired using the Volocity acquisition software (PerkinElmer). Image 
stacks were recorded at 200 nm intervals to sample volumes for iterative deconvolution 
using Volocity’s deconvolution algorithms. Probe and PLA signal quantification and 
Mander’s coefficients were computed in Volocity and imported into Excel (Microsoft) 
and Sigma Plot (Systat) for further analysis and plotting. Images presented have been 
linearly contrast enhanced for clarity. All calculations were performed directly on raw, 
deconvolved widefield data. 
The RNA volume and PLA frequency normalized to the RNA volume were 
measured using Volocity (PerkinElmer). Each cell was identified by the probe signal or 
immunofluorescence and analyzed individually. The Mander’s coefficient calculation for 
probe colocalization was performed using Volocity. We analyzed three representative 
images. In Sigma Plot, all pairwise multiple comparison procedure was performed with 
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Tukey method to compare the Mander’s coefficients for each probe. The RNA volume 
was determined based on standard deviation intensity of the probe. The PLA signal 
initially was identified as objects by their standard deviation intensity then separated into 
individual punctae using the ‘separate touching objects’ tool. The punctae were further 
filtered based on size and maximum intensity. For each experiment, we analyzed at least 
ten images of each coverslip and three repeated experiments. In Sigma Plot, when 
comparing more than two groups, all pairwise multiple comparison procedure was 
performed with Dunn’s method to compare the RNA volume and PLA frequency. When 
comparing two groups, Mann-Whitney rank sum test was used. 
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 Combining multiply-labeled tetravalent RNA imaging probes (MTRIPs) and 
proximity ligation assay (PLA) to visualize and quantify RNA-protein interactions in situ 
have allowed for the detection of mRNA-cytoskeleton and mRNA-RBP interactions, 
which underlie post-transcriptional localization and regulation of mRNAs. Using this 
method, we revealed a novel mechanism for RBPs to regulate the translation of a tumor 
suppressor, programmed cell death 4 (PDCD4). Nevertheless, several aspects of this 
method can be improved. Additionally, this method can be further applied to samples 
other than cultured cells, such as clinical biopsy and tissues.  
Probe design and delivery  
 When performing PLA experiments, the interactants, mRNAs and proteins, are 
under-sampled in order to detect their binding randomly for comparative analyses 
between different samples with varying levels of mRNA or RNA-binding proteins (RBP). 
Usually, the RNA probes and primary antibodies against the probes are used in 
concentrations that provide minimal non-specific binding in samples with the highest 
amount of RNA probes or RBPs. To minimize non-specific interactions and dynamic 
range of mRNA granules, we typically use RNA probes at concentrations (30-60nM) less 
than the concentration (90nM) that results in the maximum intensity for the mRNA 
granules. Reduced concentrations are used to best distribute the probes uniformly across 
the mRNA granules, to sample the mRNAs randomly, and to visualize most mRNAs 
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optimally. However, while delivering less probes allows for detection of relative 
differences between samples, it has an unwanted effect of possibly detecting only a few 
interactions in samples with the lowest level of mRNAs.  
In order to improve this method so that mRNAs can be detected more accurately 
without sacrificing the dynamic range of probe imaging (imaging only a few granules 
with the highest fluorescent intensity), probes with fluorophores can be delivered at a less 
concentration of 30-60nM, while probes without fluorophores are delivered at a 
concentration (60-30nM) such that the total probe concentration equals the concentration 
that results in the maximum intensity (90nM). This may allow for maximizing both the 
sampling of mRNA and the frequency of mRNA-protein interactions. 
RNA-protein interaction detection 
 PLA relies on two enzymatic reactions: ligase and phi29 DNA polymerase. The 
ligase allows for bridging of two oligonucleotide tails on the secondary antibodies, 
termed PLA probes, bound to the interactants when the two interactants are less than 30-
40 nm apart. Phi29 DNA polymerase allows for one of the two oligonucleotides on the 
secondary antibodies to serve as a primer for rolling circle amplification (RCA). Three 
mismatched exonuclease-resistant 2'O-methyl RNA nucleotides at the 3' end prevent the 
other of the two oligonucleotides from acting as a primer. This reaction results in a coiled 
single-stranded DNA, the PLA product, complementary to the circular DNA strand and 
covalently bound to the antibody-antigen complex. The PLA product is detectable by 
hybridizing complementary fluorophore-labeled oligonucleotides.  
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 Although these enzymatic reactions are generally predictable, it can be variable 
and difficult to optimize. Ensuring uniform enzymatic reactions across all the samples is 
impossible. When using primary antibody concentrations that allow for maximal 
coverage of the samples as detected by fluorophore bound secondary antibodies, non-
specific signal is prevalently observed in negative controls lacking the primary antibody. 
Although comparatively, significantly more signal is observed in the positive control, the 
experimental results are often difficult to demonstrate with such high variable levels of 
non-specific PLA products. This prevalence of non-specific signal and variability in PLA 
products due to non-uniform distribution of enzymatic reactions can be resolved 
potentially by using a method that does not rely on enzymatic reactions.  
 Hybridization chain reaction (HCR) is a method that uses two fluorophore-bound 
DNAs in hairpin motif that contain complementary sequences that allow for the opening 
and binding of the hairpins, which result in a long, fluorescent strand of two opened DNA 
hairpins bound together by Watson-and-Crick pairing. Although these DNA hairpins 
remain closed and do not open at room temperature, they can open and bind more readily 
at higher temperatures. HCR may replace the enzymatic reactions. Theoretically, a DNA 
sequence can be designed to encode a complementary sequence to the two 
oligonucleotides on the PLA probes as well as a sequence that can initiate the opening of 
fluorophore-bound DNA hairpins. This DNA can bind to the oligonucleotides on the 
PLA probes in close proximity via Watson-and-Crick pairing and can be detected by a 
cascade of opened fluorophore-bound DNA hairpin strands. 
 This HCR method would allow for detection of protein-protein or RNA-protein 
interactions without necessitating enzymes. Moreover, the components of this method are 
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all DNA; therefore, less costly than conventional PLA. The DNA reactants can be easily 
designed and purchased commercially. These DNA binding and hairpin reactions can be 
achieved by simply modifying the conventional fluorescent in situ hybridization protocol. 
There may be numerous advantages to using HCR rather than conventional PLA. 
However, further studies must be performed to demonstrate the benefits of HCR. 
Detecting multiple interactions 
 The PLA may be modified to detect interactions between more than two 
biomolecules. For example, it may be used to detect whether one mRNA is 
simultaneously bound to two proteins. This may be useful in detecting the interplay 
between RBPs and miRNAs in post-transcriptional regulation of mRNAs. PLA maybe 
used to sense interactions between RBPs and the RNA-inducing silencing complex 
(RISC) with specific mRNAs. This would allow for the coordination of RBPs and 
miRNAs to be studied. 
 In order to achieve this, the current PLA used for RNA-protein interactions need 
to be modified. Additional PLA probes and bridging DNA sequences would need to be 
designed and synthesized such that the PLA product is synthesized only when all three 
oligonucleotide strands on the PLA probes are in proximity. They should be designed to 
achieve high specificity and to avoid inaccurate detection in the presence of two of the 
three components. This may be further modified such that PLA of one fluorescent signal 
would be present for interactions consisting of two of the components and another 
fluorescent signal in a different color would be present for interactions consisting of all 




 Our current PLA method could easily be adapted for high-throughput analysis. 
For example, cells can be plated into multi-well plates. Each well with a few cells can be 
examined for specific interactions. Interactions between an array of RBPs and specific 
mRNAs can be examined rapidly using a plate reader or a microscope. A useful 
experiment would be to first determine the baseline variability in mRNA-RBP 
interactions for various cell population. Quantitative characterization of the distribution 
of these interactions for various mRNAs and RBPs would be helpful in establishing the 
cell-to-cell variability for these post-transcriptional regulatory events.  
 Moreover, implementing PLA in a high-throughput setting would streamline the 
experiments that examine how multiple RBPs affect the expression of multiple genes. For 
example, how a group of RBPs affect expression of a family of cytokine genes can be 
studied by examining interactions between these RBPs and these cytokine mRNAs in 
multi-well plates. The level of mRNA can be detected via mRNA probe signal, the 
frequency of interactions via PLA signal, and the protein signal via ELISA. Using these 
methods, multiple genes and multiple RBPs can be studied rapidly. 
Broadening the application 
 In our lab, PLA experiments have only been performed in cells grown on 
coverslips. Although they were effective experimental models for demonstrating the 
method and describing acute changes in the cells, applying this method to biopsied cells 
or tissues would allow for more clinically relevant questions to be addressed. 
Additionally, PLA may be applied to cells grown in three-dimensional settings may allow 
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for detection of RNA-protein interaction changes in spatial variations. Further 
experiments would need to be performed to accurately apply this method in different 
settings, such as tissues and three-dimensional cellular models. However, these samples 
may be thinly sliced and examined with PLA by using a modified version of the 
conventional immunohistochemistry protocols. 
Investigating post-transcriptional regulations 
 Our examination of competition between HuR and TIA1 for post-transcriptional 
regulation of PDCD4 demonstrate that RBPs may modulate mRNA and protein levels of 
a gene not only by binding to their targets but also by influencing the binding of other 
RBPs and possibly, miRNAs. To study how various RBPs regulate the gene expression 
coordinately, PLA can be used to further examine interactions of other RBPs, such as 
tristetraprolin, TIAR, or CUG-BP, with mRNAs. Identifying the locations of these RBPs 
and whether they bind cooperatively or competitively with the other RBPs can help 
establish a model system for examining how changes in RBPs modulate mRNAs and 
their translation. We can also study how RBPs affect miRNA binding or vice versa by 
examining interactions between the RNA-induced silencing complex (RISC) and RBPs. 
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